Word	Tag
importance	O
of	O
lipid	ENTITY
metabolism	ENTITY
general	O
overview	O
of	O
atherosclerosis	ENTITY
.	O
this	O
animation	O
helps	O
the	O
learner	O
to	O
understand	O
the	O
lipid	ENTITY
abnormalities	ENTITY
commonly	O
seen	O
in	O
patients	O
with	O
type	O
diabetes	ENTITY
.	O
the	O
animation	O
focuses	O
on	O
the	O
major	O
role	O
that	O
elevated	ENTITY
plasma	ENTITY
free	ENTITY
fatty	ENTITY
acids	ENTITY
ffas	ENTITY
play	ENTITY
in	ENTITY
the	ENTITY
development	ENTITY
of	ENTITY
type	ENTITY
diabetes	ENTITY
.	O
there	O
is	O
strong	O
connection	O
between	O
type	O
diabetes	ENTITY
and	ENTITY
dyslipidemia	ENTITY
.	O
this	O
animation	O
describes	O
the	O
lipid	ENTITY
abnormalities	ENTITY
commonly	O
seen	O
in	O
patients	O
with	O
type	O
diabetes	ENTITY
elevated	ENTITY
levels	ENTITY
of	ENTITY
triglycerides	ENTITY
raised	ENTITY
small	ENTITY
dense	ENTITY
ldl	ENTITY
levels	ENTITY
increased	ENTITY
glycation	ENTITY
and	O
oxidation	ENTITY
of	ENTITY
ldls	ENTITY
and	O
reduction	O
of	O
hdls	ENTITY
.	O
these	O
factors	O
increase	O
the	O
risk	O
of	O
cardiovascular	ENTITY
disease	ENTITY
.	O
reducing	O
the	O
atherogenic	ENTITY
burden	ENTITY
molecular	ENTITY
disease	ENTITY
branch	O
national	O
heart	ENTITY
lung	ENTITY
.	O
series	O
of	O
video	O
tutorials	O
discussing	O
the	O
topics	O
for	O
undergraduates	O
in	O
pathology	O
in	O
this	O
tutorial	O
have	O
discussed	O
intracellular	ENTITY
accumulations	ENTITY
accumulation	ENTITY
of	ENTITY
lipids	ENTITY
fatty	ENTITY
change	ENTITY
.	O
if	O
you	O
re	O
like	O
us	O
you	O
love	O
the	O
sound	O
of	O
brunch	O
buffet	O
.	O
but	O
not	O
everything	O
you	O
eat	O
at	O
that	O
glorious	O
buffet	O
is	O
going	O
to	O
be	O
turned	O
into	O
energy	O
.	O
your	O
body	O
.	O
in	O
this	O
episode	O
of	O
crash	O
course	O
anatomy	ENTITY
physiology	ENTITY
hank	O
takes	O
us	O
through	O
more	O
about	O
our	O
metabolism	ENTITY
including	ENTITY
cellular	ENTITY
respiration	ENTITY
atp	ENTITY
glycogenesis	ENTITY
and	ENTITY
how	ENTITY
insulin	ENTITY
regulates	ENTITY
our	ENTITY
blood	ENTITY
sugar	ENTITY
levels	ENTITY
.	O
anatomy	ENTITY
.	O
get	O
dr	O
berg	O
new	O
electrolyte	ENTITY
powder	ENTITY
the	O
health	O
wellness	O
center	O
pinecrest	O
office	O
park	O
drive	O
alexandria	O
va	O
disclaimer	O
dr	O
berg	O
does	O
not	O
diagnose	O
treat	O
or	O
prevent	O
any	O
medical	O
conditions	O
.	O
he	O
works	O
with	O
their	O
physicians	O
which	O
regular	O
their	O
medication	O
.	O
this	O
video	O
is	O
not	O
designed	O
to	O
and	O
does	O
not	O
provide	O
medical	O
advice	O
professional	O
diagnosis	O
opinion	O
treatment	O
.	O
through	O
my	O
videos	O
blog	O
posts	O
website	O
information	O
give	O
suggestions	O
for	O
you	O
and	O
your	O
doctor	O
.	O
the	O
information	O
provided	O
in	O
this	O
video	O
or	O
site	O
or	O
through	O
linkages	O
to	O
other	O
sites	O
is	O
not	O
substitute	O
for	O
medical	O
or	O
professional	O
care	O
and	O
you	O
should	O
not	O
use	O
the	O
information	O
in	O
place	O
of	O
visit	O
call	O
consultation	O
or	O
the	O
advice	O
of	O
your	O
physician	O
or	O
other	O
healthcare	O
provider	O
.	O
the	O
health	O
wellness	O
and	O
dr	O
eric	O
berg	O
are	O
not	O
liable	O
or	O
responsible	O
for	O
any	O
advice	O
course	O
of	O
treatment	O
diagnosis	O
.	O
ways	O
your	O
body	O
tries	O
to	O
tell	O
you	O
that	O
your	O
liver	ENTITY
is	ENTITY
being	ENTITY
damaged	ENTITY
the	ENTITY
liver	ENTITY
is	ENTITY
the	ENTITY
largest	ENTITY
solid	ENTITY
organ	ENTITY
in	ENTITY
your	ENTITY
body	ENTITY
.	O
it	O
is	O
located	O
in	O
the	O
right	O
upper	O
quadrant	O
of	O
your	O
abdomen	ENTITY
and	ENTITY
partly	ENTITY
protected	ENTITY
by	ENTITY
the	ENTITY
ribs	ENTITY
.	O
you	O
need	O
your	O
liver	ENTITY
for	ENTITY
many	ENTITY
important	ENTITY
bodily	ENTITY
functions	ENTITY
and	ENTITY
cannot	ENTITY
live	ENTITY
without	ENTITY
your	ENTITY
liver	ENTITY
.	O
for	O
this	O
reason	O
you	O
should	O
know	O
the	O
early	O
signs	O
of	O
liver	ENTITY
damage	ENTITY
and	O
take	O
care	O
of	O
your	O
liver	ENTITY
.	O
there	O
are	O
more	O
than	O
hundred	O
different	O
kinds	O
of	O
diseases	ENTITY
of	ENTITY
the	ENTITY
liver	ENTITY
.	O
each	O
has	O
its	O
own	O
set	O
of	O
symptoms	O
.	O
some	O
of	O
these	O
diseases	ENTITY
include	ENTITY
alcoholic	ENTITY
liver	ENTITY
disease	ENTITY
hepatitis	ENTITY
fatty	ENTITY
liver	ENTITY
disease	ENTITY
and	O
cirrhosis	ENTITY
of	ENTITY
the	ENTITY
liver	ENTITY
.	O
the	O
early	O
signs	O
of	O
liver	ENTITY
disease	ENTITY
tend	O
to	O
be	O
easily	O
overlooked	O
and	O
are	O
non	O
specific	O
related	O
to	O
any	O
number	O
of	O
different	O
conditions	O
.	O
here	O
are	O
some	O
common	O
early	O
signs	O
.	O
upset	ENTITY
stomach	ENTITY
you	O
are	O
likely	O
to	O
get	O
nausea	ENTITY
and	ENTITY
vomiting	ENTITY
.	O
they	O
can	O
mimic	O
other	O
diseases	O
such	O
as	O
migraines	ENTITY
food	ENTITY
poisoning	ENTITY
vertigo	ENTITY
motion	ENTITY
sickness	ENTITY
early	ENTITY
pregnancy	ENTITY
depression	ENTITY
and	O
vomiting	ENTITY
.	O
it	O
can	O
mimic	O
kidney	ENTITY
problems	ENTITY
.	O
those	O
who	O
suffer	O
from	O
early	ENTITY
liver	ENTITY
damage	ENTITY
often	O
feel	O
persistently	O
nauseous	ENTITY
because	ENTITY
the	ENTITY
liver	ENTITY
has	ENTITY
decreased	ENTITY
ability	ENTITY
to	ENTITY
rid	ENTITY
the	ENTITY
body	ENTITY
of	ENTITY
toxins	ENTITY
.	O
the	O
nausea	ENTITY
can	ENTITY
also	ENTITY
be	ENTITY
due	ENTITY
to	ENTITY
ongoing	ENTITY
metabolism	ENTITY
and	ENTITY
changes	ENTITY
in	ENTITY
digestion	ENTITY
.	O
if	O
you	O
have	O
these	O
symptoms	O
for	O
several	O
days	O
and	O
don	O
know	O
why	O
seek	O
the	O
attention	O
of	O
your	O
doctor	O
.	O
fatigue	O
and	O
overall	O
weakness	O
one	O
of	O
the	O
early	O
and	O
obvious	O
signs	O
of	O
liver	ENTITY
damage	ENTITY
is	O
constantly	O
feeling	O
tired	O
and	O
weak	O
.	O
when	O
the	O
liver	ENTITY
is	ENTITY
not	ENTITY
in	ENTITY
great	ENTITY
condition	ENTITY
the	ENTITY
body	ENTITY
.	O
this	O
is	O
due	O
to	O
an	O
increase	O
in	O
toxins	ENTITY
in	ENTITY
the	ENTITY
bloodstream	ENTITY
that	ENTITY
can	ENTITY
be	ENTITY
cleared	ENTITY
out	ENTITY
because	ENTITY
the	ENTITY
liver	ENTITY
can	ENTITY
get	ENTITY
rid	ENTITY
of	ENTITY
the	ENTITY
toxins	ENTITY
.	O
if	O
the	O
symptoms	O
persist	O
especially	O
with	O
other	O
early	O
signs	O
of	O
liver	ENTITY
damage	ENTITY
seek	O
medical	O
advice	O
.	O
lack	ENTITY
of	ENTITY
appetite	ENTITY
this	O
happens	O
due	O
to	O
lack	O
of	O
production	O
of	O
bile	ENTITY
that	ENTITY
helps	ENTITY
digest	ENTITY
fat	ENTITY
in	ENTITY
the	ENTITY
diet	ENTITY
.	O
when	O
food	O
isn	O
properly	O
digested	O
it	O
can	O
lead	O
to	O
lack	ENTITY
of	ENTITY
appetite	ENTITY
and	O
severe	O
loss	ENTITY
of	ENTITY
weight	ENTITY
.	O
see	O
your	O
doctor	O
if	O
you	O
experience	O
any	O
of	O
these	O
symptoms	O
.	O
digestion	O
problems	O
the	O
liver	ENTITY
is	ENTITY
important	ENTITY
in	ENTITY
digestion	ENTITY
because	ENTITY
it	ENTITY
makes	ENTITY
bile	ENTITY
that	ENTITY
helps	ENTITY
the	ENTITY
nutrients	ENTITY
be	ENTITY
better	ENTITY
processed	ENTITY
and	ENTITY
absorbed	ENTITY
by	ENTITY
the	ENTITY
small	ENTITY
intestines	ENTITY
.	O
if	O
the	O
liver	ENTITY
is	ENTITY
failing	ENTITY
you	ENTITY
can	ENTITY
develop	ENTITY
an	ENTITY
increase	ENTITY
in	ENTITY
indigestion	ENTITY
and	ENTITY
diarrhea	ENTITY
.	O
if	O
the	O
bile	ENTITY
is	ENTITY
not	ENTITY
produced	ENTITY
properly	ENTITY
you	ENTITY
can	ENTITY
also	ENTITY
experience	ENTITY
irritable	ENTITY
bowel	ENTITY
syndrome	ENTITY
fatty	ENTITY
food	ENTITY
intolerance	ENTITY
alcohol	ENTITY
intolerance	ENTITY
abdominal	ENTITY
bloating	ENTITY
constipation	ENTITY
and	O
gallstones	ENTITY
.	O
if	O
this	O
becomes	O
severe	O
you	O
need	O
to	O
seek	O
the	O
medical	O
attention	O
of	O
doctor	O
.	O
alterations	O
in	O
the	O
color	O
of	O
urine	ENTITY
if	ENTITY
you	ENTITY
think	ENTITY
you	ENTITY
are	ENTITY
drinking	ENTITY
enough	ENTITY
but	ENTITY
still	ENTITY
have	ENTITY
dark	ENTITY
color	ENTITY
of	ENTITY
your	ENTITY
urine	ENTITY
this	ENTITY
may	ENTITY
be	ENTITY
one	ENTITY
of	ENTITY
the	ENTITY
early	ENTITY
signs	ENTITY
of	ENTITY
liver	ENTITY
damage	ENTITY
.	O
the	O
urine	ENTITY
may	ENTITY
look	ENTITY
brown	ENTITY
amber	ENTITY
or	ENTITY
orange	ENTITY
in	ENTITY
color	ENTITY
because	ENTITY
of	ENTITY
elevated	ENTITY
levels	ENTITY
of	ENTITY
bilirubin	ENTITY
in	O
the	O
bloodstream	ENTITY
.	O
the	O
bilirubin	ENTITY
is	ENTITY
elevated	ENTITY
because	ENTITY
the	ENTITY
liver	ENTITY
cannot	ENTITY
get	ENTITY
rid	ENTITY
of	ENTITY
the	ENTITY
bilirubin	ENTITY
and	ENTITY
it	ENTITY
is	ENTITY
excreted	ENTITY
through	ENTITY
the	ENTITY
kidneys	ENTITY
.	O
dark	ENTITY
urine	ENTITY
may	O
also	O
be	O
due	O
to	O
dehydration	ENTITY
side	ENTITY
effects	ENTITY
of	ENTITY
taking	ENTITY
antibiotics	ENTITY
taking	ENTITY
vitamin	ENTITY
supplements	ENTITY
urinary	ENTITY
tract	ENTITY
infections	ENTITY
enzyme	ENTITY
deficiencies	ENTITY
or	O
kidney	ENTITY
abnormalities	ENTITY
.	O
the	O
doctor	O
can	O
help	O
sort	O
out	O
the	O
cause	O
of	O
dark	ENTITY
urine	ENTITY
.	O
changes	O
in	O
stool	ENTITY
coloration	ENTITY
because	ENTITY
the	ENTITY
bile	ENTITY
is	ENTITY
not	ENTITY
made	ENTITY
enough	ENTITY
by	ENTITY
malfunctioning	ENTITY
liver	ENTITY
.	O
instead	O
of	O
being	O
brown	O
it	O
can	O
become	O
pale	O
yellow	O
clay	O
colored	O
or	O
gray	O
in	O
appearance	O
.	O
if	O
this	O
happens	O
periodically	O
it	O
is	O
not	O
dangerous	O
but	O
if	O
it	O
happens	O
often	O
seek	O
the	O
advice	O
of	O
your	O
doctor	O
to	O
check	O
out	O
your	O
liver	ENTITY
.	O
metabolic	ENTITY
syndrome	ENTITY
is	O
probably	O
the	O
most	O
serious	O
medical	O
condition	O
.	O
so	O
what	O
is	O
metabolic	ENTITY
syndrome	ENTITY
why	O
is	O
it	O
so	O
serious	O
and	O
why	O
haven	O
you	O
heard	O
.	O
here	O
is	O
what	O
you	O
need	O
to	O
know	O
.	O
the	O
metabolic	ENTITY
syndrome	ENTITY
is	O
cluster	O
of	O
the	O
most	O
dangerous	O
heart	ENTITY
attack	ENTITY
risk	O
factors	O
raised	ENTITY
blood	ENTITY
glucose	ENTITY
central	ENTITY
adiposity	ENTITY
often	O
called	O
beer	O
belly	O
abnormal	O
cholesterol	ENTITY
levels	ENTITY
abnormal	O
blood	ENTITY
fats	ENTITY
also	O
called	O
triglycerides	ENTITY
and	ENTITY
high	ENTITY
blood	ENTITY
pressure	ENTITY
.	O
it	O
is	O
estimated	O
that	O
in	O
adults	O
have	O
metabolic	ENTITY
syndrome	ENTITY
and	O
the	O
condition	O
becomes	O
more	O
common	O
as	O
we	O
get	O
older	O
so	O
that	O
by	O
the	O
age	O
of	O
nearly	O
third	O
of	O
adults	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
so	O
why	O
is	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
if	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
you	O
are	O
much	O
more	O
likely	O
to	O
suffer	O
heart	ENTITY
attack	ENTITY
or	O
stroke	O
more	O
likely	O
to	O
develop	O
full	O
blown	O
diabetes	ENTITY
more	ENTITY
likely	ENTITY
to	ENTITY
develop	ENTITY
cancer	ENTITY
and	ENTITY
more	ENTITY
likely	ENTITY
to	ENTITY
develop	ENTITY
alzheimer	ENTITY
disease	ENTITY
.	O
all	O
of	O
these	O
conditions	O
.	O
dementia	ENTITY
and	ENTITY
alzheimer	ENTITY
disease	ENTITY
have	O
overtaken	O
cancer	O
and	O
heart	ENTITY
disease	ENTITY
as	O
the	O
leading	O
cause	O
of	O
death	O
in	O
england	O
and	O
wales	O
in	O
and	O
the	O
metabolic	ENTITY
syndrome	ENTITY
and	O
diabetes	ENTITY
.	O
so	O
how	O
can	O
you	O
check	O
to	O
see	O
if	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
first	O
of	O
all	O
get	O
out	O
tape	O
measure	O
.	O
if	O
you	O
are	O
man	O
and	O
your	O
waist	O
circumference	O
is	O
more	O
than	O
cm	O
or	O
if	O
you	O
are	O
woman	O
and	O
your	O
waist	O
is	O
more	O
than	O
cm	O
you	O
have	O
one	O
of	O
the	O
main	O
features	O
of	O
metabolic	ENTITY
syndrome	ENTITY
.	O
if	O
in	O
addition	O
you	O
have	O
any	O
of	O
the	O
following	O
you	O
will	O
be	O
classified	O
as	O
having	O
metabolic	ENTITY
syndrome	ENTITY
raised	ENTITY
blood	ENTITY
triglycerides	ENTITY
reduced	ENTITY
hdl	ENTITY
cholesterol	ENTITY
sometimes	O
known	O
as	O
good	O
cholesterol	ENTITY
raised	ENTITY
blood	ENTITY
pressure	ENTITY
or	O
raised	ENTITY
fasting	ENTITY
plasma	ENTITY
glucose	ENTITY
.	O
note	O
if	O
you	O
are	O
man	O
of	O
south	O
asian	O
or	O
indian	O
heritage	O
the	O
important	O
threshold	O
for	O
waist	O
circumference	O
is	O
cm	O
.	O
metabolic	ENTITY
syndrome	ENTITY
has	O
not	O
yet	O
been	O
classified	O
as	O
disease	ENTITY
it	ENTITY
is	ENTITY
still	ENTITY
regarded	ENTITY
as	ENTITY
collection	ENTITY
of	ENTITY
signs	ENTITY
and	ENTITY
symptoms	ENTITY
which	ENTITY
together	ENTITY
are	ENTITY
serious	ENTITY
risk	ENTITY
factors	ENTITY
for	ENTITY
our	ENTITY
most	ENTITY
deadly	ENTITY
and	ENTITY
disabling	ENTITY
medical	ENTITY
conditions	ENTITY
.	O
several	O
medical	O
organisations	O
such	O
as	O
the	O
world	O
health	O
organisation	O
who	O
the	O
independent	O
diabetes	ENTITY
federation	ENTITY
idf	ENTITY
and	ENTITY
the	ENTITY
european	ENTITY
group	ENTITY
for	ENTITY
the	ENTITY
study	ENTITY
of	ENTITY
insulin	ENTITY
resistance	ENTITY
egir	O
define	O
the	O
metabolic	ENTITY
syndrome	ENTITY
in	O
very	O
slightly	O
different	O
ways	O
and	O
this	O
adds	O
even	O
more	O
to	O
the	O
confusion	O
about	O
what	O
exactly	O
metabolic	ENTITY
syndrome	ENTITY
.	O
however	O
many	O
experts	O
now	O
believe	O
that	O
the	O
underlying	O
problem	O
in	O
metabolic	ENTITY
syndrome	ENTITY
is	O
insulin	ENTITY
resistance	ENTITY
.	O
insulin	ENTITY
resistance	ENTITY
develops	O
when	O
this	O
hormone	ENTITY
cannot	ENTITY
work	ENTITY
properly	ENTITY
when	ENTITY
blood	ENTITY
insulin	ENTITY
levels	ENTITY
are	O
abnormally	O
high	O
and	O
still	O
relatively	O
ineffective	O
in	O
keeping	O
blood	ENTITY
glucose	ENTITY
levels	ENTITY
.	O
metabolic	O
specialists	O
now	O
use	O
the	O
term	O
insulin	ENTITY
resistance	ENTITY
syndrome	ENTITY
instead	O
of	O
metabolic	ENTITY
syndrome	ENTITY
.	O
insulin	ENTITY
is	ENTITY
hormone	ENTITY
produced	ENTITY
by	ENTITY
the	ENTITY
pancreas	ENTITY
and	ENTITY
it	ENTITY
is	ENTITY
important	ENTITY
in	ENTITY
the	ENTITY
metabolism	ENTITY
of	ENTITY
carbohydrates	ENTITY
and	ENTITY
fats	ENTITY
.	O
when	O
sugar	O
and	O
carbohydrates	ENTITY
are	ENTITY
eaten	ENTITY
insulin	ENTITY
promotes	ENTITY
the	ENTITY
uptake	ENTITY
of	ENTITY
glucose	ENTITY
from	ENTITY
the	ENTITY
blood	ENTITY
into	ENTITY
muscles	ENTITY
and	ENTITY
fat	ENTITY
cells	ENTITY
.	O
hence	O
it	O
is	O
often	O
said	O
that	O
insulin	ENTITY
allows	ENTITY
cells	ENTITY
to	ENTITY
use	ENTITY
glucose	ENTITY
for	ENTITY
energy	ENTITY
and	ENTITY
also	ENTITY
to	ENTITY
store	ENTITY
excess	ENTITY
glucose	ENTITY
and	ENTITY
sugar	ENTITY
as	ENTITY
glycogen	ENTITY
and	ENTITY
fat	ENTITY
.	O
when	O
blood	ENTITY
glucose	ENTITY
levels	ENTITY
fall	O
stored	O
glucose	ENTITY
is	ENTITY
released	ENTITY
for	ENTITY
energy	ENTITY
from	ENTITY
the	ENTITY
breakdown	ENTITY
of	ENTITY
glycogen	ENTITY
stores	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
and	ENTITY
in	ENTITY
the	ENTITY
muscles	ENTITY
.	O
in	O
the	O
metabolic	ENTITY
syndrome	ENTITY
insulin	ENTITY
levels	ENTITY
.	O
fasting	O
blood	ENTITY
levels	ENTITY
of	ENTITY
insulin	ENTITY
in	O
the	O
morning	O
are	O
often	O
abnormally	O
high	O
and	O
insulin	ENTITY
levels	ENTITY
rise	O
to	O
very	O
high	O
levels	O
when	O
food	O
is	O
eaten	O
.	O
continuously	O
high	O
levels	ENTITY
of	ENTITY
insulin	ENTITY
cause	O
the	O
liver	ENTITY
cells	ENTITY
to	O
store	O
fat	ENTITY
resulting	ENTITY
in	ENTITY
fatty	ENTITY
liver	ENTITY
.	O
as	O
the	O
insulin	ENTITY
resistance	ENTITY
worsens	O
the	O
pancreas	ENTITY
may	ENTITY
not	ENTITY
be	ENTITY
able	ENTITY
to	ENTITY
produce	ENTITY
enough	ENTITY
insulin	ENTITY
in	ENTITY
response	ENTITY
to	ENTITY
food	ENTITY
and	ENTITY
then	ENTITY
glucose	ENTITY
levels	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
rise	O
above	O
the	O
threshold	O
for	O
the	O
patient	O
to	O
be	O
called	O
diabetic	ENTITY
.	O
so	O
why	O
haven	O
you	O
heard	O
of	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
until	O
quite	O
recently	O
the	O
connection	O
between	O
metabolic	ENTITY
syndrome	ENTITY
and	O
host	O
of	O
chronic	ENTITY
diseases	ENTITY
.	O
we	O
now	O
know	O
that	O
insulin	ENTITY
resistance	ENTITY
.	O
until	O
recently	O
it	O
was	O
difficult	O
to	O
measure	O
blood	ENTITY
insulin	ENTITY
levels	ENTITY
but	O
the	O
technology	O
has	O
improved	O
and	O
we	O
can	O
now	O
measure	O
blood	ENTITY
insulin	ENTITY
levels	ENTITY
accurately	O
and	O
we	O
have	O
good	O
tests	O
to	O
diagnose	O
insulin	ENTITY
resistance	ENTITY
as	O
well	O
as	O
good	O
strategies	O
to	O
reverse	O
insulin	ENTITY
resistance	ENTITY
and	O
the	O
metabolic	ENTITY
syndrome	ENTITY
.	O
once	O
you	O
can	O
measure	O
insulin	ENTITY
resistance	ENTITY
.	O
also	O
get	O
our	O
diabetes	ENTITY
management	ENTITY
guide	ENTITY
here	ENTITY
this	ENTITY
is	ENTITY
great	ENTITY
question	ENTITY
because	ENTITY
sometimes	ENTITY
the	ENTITY
term	ENTITY
metabolic	ENTITY
syndrome	ENTITY
also	O
called	O
syndrome	ENTITY
is	ENTITY
used	ENTITY
when	ENTITY
discussing	ENTITY
pre	ENTITY
diabetes	ENTITY
.	O
but	O
the	O
are	O
not	O
the	O
same	O
thing	O
.	O
according	O
to	O
the	O
mayo	O
clinic	O
metabolic	ENTITY
syndrome	ENTITY
is	O
cluster	O
of	O
conditions	O
increased	ENTITY
blood	ENTITY
pressure	ENTITY
high	ENTITY
blood	ENTITY
sugar	ENTITY
excess	O
body	ENTITY
fat	ENTITY
around	O
the	O
waist	O
and	O
abnormal	ENTITY
cholesterol	ENTITY
or	O
triglyceride	ENTITY
levels	ENTITY
that	O
occur	O
together	O
increasing	O
your	O
risk	O
of	O
heart	ENTITY
disease	ENTITY
stroke	O
and	O
diabetes	ENTITY
.	O
having	O
just	O
one	O
of	O
these	O
conditions	O
doesn	O
mean	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
however	O
any	O
of	O
these	O
conditions	O
increase	O
your	O
risk	O
of	O
serious	O
disease	ENTITY
.	O
having	O
more	O
than	O
one	O
of	O
these	O
might	O
increase	O
your	O
risk	O
even	O
more	O
.	O
an	O
underlying	O
cause	O
of	O
metabolic	ENTITY
syndrome	ENTITY
is	O
insulin	ENTITY
resistance	ENTITY
condition	O
that	O
increases	O
the	O
chances	O
of	O
developing	O
pre	ENTITY
diabetes	ENTITY
type	O
diabetes	ENTITY
and	ENTITY
cardiovascular	ENTITY
disease	ENTITY
.	O
so	O
an	O
understanding	O
of	O
the	O
interaction	O
of	O
insulin	ENTITY
resistance	ENTITY
metabolic	ENTITY
syndrome	ENTITY
and	O
pre	ENTITY
diabetes	ENTITY
is	O
critical	O
to	O
making	O
lifestyle	O
changes	O
that	O
can	O
help	O
you	O
avoid	O
type	O
diabetes	ENTITY
.	O
food	O
is	O
broken	O
down	O
in	O
the	O
body	O
into	O
glucose	ENTITY
the	ENTITY
simple	ENTITY
sugar	ENTITY
.	O
it	O
is	O
digested	O
into	O
many	O
different	O
macromolecules	ENTITY
protein	ENTITY
fat	ENTITY
and	O
carbohydrates	ENTITY
.	O
then	O
carbohydrates	ENTITY
are	ENTITY
broken	ENTITY
down	ENTITY
further	ENTITY
into	ENTITY
glucose	ENTITY
which	ENTITY
is	ENTITY
the	ENTITY
simple	ENTITY
energy	ENTITY
used	ENTITY
by	ENTITY
cells	ENTITY
.	O
insulin	ENTITY
allows	ENTITY
this	ENTITY
glucose	ENTITY
to	ENTITY
leave	ENTITY
the	ENTITY
blood	ENTITY
stream	ENTITY
and	O
enter	O
the	O
cell	O
where	O
it	O
can	O
fuel	O
the	O
activities	O
of	O
that	O
cell	O
.	O
your	O
pancreas	ENTITY
makes	ENTITY
and	ENTITY
secretes	ENTITY
insulin	ENTITY
.	O
but	O
glucose	ENTITY
can	ENTITY
enter	ENTITY
the	ENTITY
cells	ENTITY
if	ENTITY
your	ENTITY
pancreas	ENTITY
doesn	ENTITY
manufacture	ENTITY
enough	ENTITY
insulin	ENTITY
or	ENTITY
your	ENTITY
cells	ENTITY
are	ENTITY
unable	ENTITY
to	ENTITY
process	ENTITY
the	ENTITY
insulin	ENTITY
that	ENTITY
is	ENTITY
present	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
stream	ENTITY
.	O
as	O
result	O
glucose	ENTITY
levels	ENTITY
become	O
elevated	O
setting	O
the	O
stage	O
for	O
pre	ENTITY
diabetes	ENTITY
.	O
tissues	ENTITY
with	ENTITY
too	ENTITY
much	ENTITY
fat	ENTITY
produce	ENTITY
fewer	ENTITY
insulin	ENTITY
receptors	ENTITY
and	O
are	O
more	O
resistant	O
to	O
insulin	ENTITY
.	O
in	O
vicious	O
cycle	O
the	O
pancreas	ENTITY
responds	ENTITY
by	ENTITY
pumping	ENTITY
more	ENTITY
insulin	ENTITY
until	ENTITY
the	ENTITY
insulin	ENTITY
producing	ENTITY
cells	ENTITY
die	O
from	O
exhaustion	O
.	O
type	O
diabetes	ENTITY
.	O
when	O
you	O
are	O
insulin	ENTITY
resistant	ENTITY
your	O
muscle	ENTITY
fat	ENTITY
and	O
liver	ENTITY
cells	ENTITY
do	O
not	O
use	O
insulin	ENTITY
.	O
the	O
pancreas	ENTITY
tries	ENTITY
to	ENTITY
keep	ENTITY
up	ENTITY
with	ENTITY
the	ENTITY
demand	ENTITY
for	ENTITY
insulin	ENTITY
.	O
eventually	O
the	O
pancreas	ENTITY
cannot	ENTITY
keep	ENTITY
up	ENTITY
with	ENTITY
the	ENTITY
body	ENTITY
need	ENTITY
for	ENTITY
insulin	ENTITY
causing	ENTITY
excess	ENTITY
glucose	ENTITY
to	ENTITY
build	ENTITY
up	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
stream	ENTITY
.	O
many	O
people	O
with	O
insulin	ENTITY
resistance	ENTITY
have	O
high	O
levels	O
of	O
both	O
blood	ENTITY
glucose	ENTITY
and	O
insulin	ENTITY
.	O
pre	ENTITY
diabetes	ENTITY
means	O
you	O
have	O
higher	O
risk	O
of	O
developing	O
type	O
diabetes	ENTITY
.	O
studies	O
have	O
shown	O
that	O
most	O
people	O
with	O
pre	ENTITY
diabetes	ENTITY
go	O
on	O
to	O
develop	O
type	ENTITY
ii	ENTITY
diabetes	ENTITY
within	O
years	O
unless	O
they	O
make	O
changes	O
to	O
their	O
weight	O
their	O
diet	O
and	O
their	O
levels	O
of	O
physical	O
activity	O
.	O
while	O
both	O
diabetes	ENTITY
pre	ENTITY
diabetes	ENTITY
and	O
metabolic	ENTITY
syndrome	ENTITY
have	O
insulin	ENTITY
resistance	ENTITY
.	O
this	O
video	O
explain	O
in	O
detail	O
about	O
lipoprotein	ENTITY
metabolism	ENTITY
which	O
includes	O
metabolism	ENTITY
of	ENTITY
chylomicrons	ENTITY
vldl	ENTITY
idl	ENTITY
ldl	ENTITY
and	ENTITY
hdl	ENTITY
.	O
sincere	O
thanks	O
to	O
my	O
student	O
ms	O
fatima	O
samreen	O
for	O
meticulously	O
recording	O
this	O
video	O
.	O
correction	O
at	O
minute	O
seconds	O
please	O
read	O
the	O
codon	O
as	O
caa	ENTITY
instead	ENTITY
of	ENTITY
gaa	ENTITY
.	O
so	O
caa	ENTITY
is	ENTITY
converted	ENTITY
to	ENTITY
uaa	ENTITY
by	ENTITY
cytidine	ENTITY
deaminase	ENTITY
.	O
link	O
to	O
the	O
study	O
acetyl	ENTITY
carnitine	ENTITY
to	O
the	O
brain	ENTITY
carnitine	ENTITY
acts	ENTITY
as	ENTITY
reservoir	ENTITY
of	ENTITY
long	ENTITY
chain	ENTITY
fatty	ENTITY
acids	ENTITY
for	O
incorporation	O
into	O
red	ENTITY
blood	ENTITY
cell	ENTITY
membrane	ENTITY
phospholipids	ENTITY
during	O
repair	O
after	O
oxidative	O
insults	O
it	O
is	O
also	O
used	O
in	O
the	O
synthesis	O
of	O
dipalmitoyl	ENTITY
phosphatidylcholine	ENTITY
the	O
major	O
component	O
of	O
surfactant	ENTITY
in	ENTITY
lung	ENTITY
.	O
carnitine	ENTITY
can	ENTITY
be	ENTITY
used	ENTITY
therapeutically	ENTITY
to	ENTITY
stimulate	ENTITY
gastric	ENTITY
and	ENTITY
pancreatic	ENTITY
secretions	ENTITY
and	O
in	O
the	O
treatment	O
of	O
hyperlipoproteinemias	ENTITY
.	O
these	O
nutrients	O
are	O
all	O
required	O
for	O
carnitine	ENTITY
synthesis	ENTITY
magnesium	ENTITY
vitamin	ENTITY
iron	ENTITY
vitamins	ENTITY
and	O
and	O
alpha	ENTITY
ketoglutarate	ENTITY
along	O
with	O
the	O
cofactors	O
responsible	O
for	O
creating	O
same	O
methionine	ENTITY
folic	ENTITY
acid	ENTITY
vitamin	ENTITY
and	O
betaine	ENTITY
carnitine	ENTITY
supplementation	ENTITY
has	ENTITY
improved	ENTITY
some	ENTITY
patients	ENTITY
who	ENTITY
have	ENTITY
angina	ENTITY
secondary	ENTITY
to	ENTITY
coronary	ENTITY
artery	ENTITY
disease	ENTITY
.	O
carnitine	ENTITY
supplements	ENTITY
may	ENTITY
be	ENTITY
useful	ENTITY
in	ENTITY
many	ENTITY
forms	ENTITY
of	ENTITY
toxic	ENTITY
or	ENTITY
metabolic	ENTITY
liver	ENTITY
disease	ENTITY
and	O
in	O
cases	O
of	O
heart	ENTITY
muscle	ENTITY
disease	ENTITY
.	O
hearts	O
undergoing	O
severe	O
arrhythmia	ENTITY
quickly	ENTITY
deplete	ENTITY
their	ENTITY
stores	ENTITY
of	ENTITY
carnitine	ENTITY
.	O
athletes	O
particularly	O
in	O
europe	O
have	O
used	O
carnitine	ENTITY
.	O
carnitine	ENTITY
may	ENTITY
improve	ENTITY
muscle	ENTITY
building	ENTITY
by	O
improving	O
fat	ENTITY
utilization	ENTITY
and	ENTITY
may	ENTITY
even	ENTITY
be	ENTITY
useful	ENTITY
in	ENTITY
treating	ENTITY
obesity	ENTITY
.	O
carnitine	ENTITY
may	ENTITY
be	ENTITY
of	ENTITY
value	ENTITY
in	ENTITY
treating	ENTITY
pregnant	ENTITY
women	ENTITY
hypothyroid	ENTITY
individuals	ENTITY
and	ENTITY
male	ENTITY
infertility	ENTITY
.	O
even	O
the	O
physician	O
desk	O
reference	O
gives	O
indication	O
for	O
carnitine	ENTITY
supplements	ENTITY
as	ENTITY
improving	ENTITY
the	ENTITY
tolerance	ENTITY
of	ENTITY
ischemic	ENTITY
heart	ENTITY
disease	ENTITY
myocardial	ENTITY
insufficiencies	ENTITY
and	ENTITY
type	ENTITY
iv	ENTITY
hyperlipoproteinemia	ENTITY
.	O
carnitine	ENTITY
deficiency	ENTITY
is	O
noted	O
in	O
abnormal	O
liver	ENTITY
function	ENTITY
renal	ENTITY
dialysis	ENTITY
patients	O
and	O
severe	O
to	O
moderate	O
muscular	ENTITY
weakness	ENTITY
with	O
associated	O
anorexia	ENTITY
patients	ENTITY
with	ENTITY
chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
cfs	ENTITY
were	ENTITY
found	ENTITY
to	ENTITY
have	ENTITY
low	ENTITY
free	ENTITY
carnitine	ENTITY
total	ENTITY
carnitine	ENTITY
and	ENTITY
acylcarnitine	ENTITY
compared	ENTITY
to	ENTITY
controls	ENTITY
carnitine	ENTITY
is	ENTITY
peripheral	ENTITY
antagonist	ENTITY
of	ENTITY
thyroid	ENTITY
.	O
it	O
inhibits	O
thyroid	ENTITY
hormone	ENTITY
.	O
in	O
controlled	ENTITY
clinical	ENTITY
trial	ENTITY
carnitine	ENTITY
was	O
shown	O
to	O
reverse	O
or	O
prevent	O
some	O
symptoms	ENTITY
of	ENTITY
hyperthyroidism	ENTITY
.	O
conditions	O
associated	O
with	O
carnitine	ENTITY
deficiency	ENTITY
include	O
cancer	O
diabetes	ENTITY
alzheimer	ENTITY
disease	ENTITY
and	O
heart	ENTITY
failure	ENTITY
.	O
deficienies	O
may	O
result	O
in	O
accumulation	O
of	O
fat	ENTITY
within	ENTITY
skeletal	ENTITY
muscle	ENTITY
cardiac	ENTITY
muscle	ENTITY
and	O
liver	ENTITY
disruption	ENTITY
of	ENTITY
muscle	ENTITY
fibers	ENTITY
and	O
an	O
accumulation	O
of	O
large	O
aggregates	O
of	O
mitochondria	ENTITY
within	ENTITY
skeletal	ENTITY
.	O
deficiency	O
can	O
result	O
in	O
cardiomyopathy	ENTITY
congestive	ENTITY
heart	ENTITY
failure	ENTITY
encephalopathy	ENTITY
hepatomegaly	ENTITY
impaired	O
growth	O
and	O
development	O
in	O
infants	O
and	O
neuromuscular	ENTITY
disorders	ENTITY
.	O
primary	O
carnitine	ENTITY
deficiency	ENTITY
has	O
symptoms	O
such	O
as	O
muscle	ENTITY
fatigue	ENTITY
cramps	ENTITY
and	O
myoglobinemia	ENTITY
following	ENTITY
exercise	ENTITY
.	O
additional	O
symptoms	ENTITY
of	ENTITY
chronic	ENTITY
carnitine	ENTITY
deficiency	O
can	O
include	O
hypoglycemia	ENTITY
progressive	ENTITY
myasthenia	ENTITY
hypotonia	ENTITY
or	O
lethargy	ENTITY
.	O
secondary	ENTITY
carnitine	ENTITY
deficiency	ENTITY
is	O
not	O
as	O
rare	O
and	O
is	O
most	O
commonly	O
associated	O
with	O
dialysis	O
in	O
chronic	O
renal	ENTITY
failure	ENTITY
although	O
it	O
can	O
also	O
be	O
induced	O
by	O
intestinal	ENTITY
resection	ENTITY
severe	O
infection	O
and	O
liver	ENTITY
disease	ENTITY
.	O
first	O
study	O
to	O
reveal	O
mechanism	O
underlying	O
abnormal	O
fat	ENTITY
accumulation	ENTITY
in	ENTITY
hiv	ENTITY
patients	ENTITY
boston	ENTITY
building	ENTITY
upon	ENTITY
their	ENTITY
earlier	ENTITY
research	ENTITY
on	ENTITY
the	ENTITY
biology	ENTITY
of	ENTITY
fat	ENTITY
metabolism	ENTITY
joslin	O
scientists	O
discovered	O
that	O
micrornas	ENTITY
which	ENTITY
are	ENTITY
involved	ENTITY
in	ENTITY
the	ENTITY
formation	ENTITY
of	ENTITY
mature	ENTITY
rna	ENTITY
and	ENTITY
play	ENTITY
important	ENTITY
roles	ENTITY
in	ENTITY
many	ENTITY
types	ENTITY
of	ENTITY
tissue	ENTITY
play	O
major	O
role	O
in	O
the	O
distribution	O
and	O
determination	ENTITY
of	ENTITY
fat	ENTITY
cells	ENTITY
and	O
whole	O
body	O
metabolism	ENTITY
.	O
also	O
the	O
study	O
is	O
the	O
first	O
to	O
reveal	O
that	O
micrornas	ENTITY
mirnas	ENTITY
influence	O
the	O
development	O
of	O
lipodystrophy	ENTITY
abnormal	ENTITY
fat	ENTITY
accumulation	ENTITY
which	ENTITY
affects	ENTITY
people	ENTITY
with	ENTITY
hiv	ENTITY
.	O
the	O
findings	O
appear	O
in	O
the	O
month	O
issue	O
of	O
the	O
journal	O
of	O
clinical	O
investigation	O
.	O
continue	O
reading	O
at	O
.	O
konpl	O
zassi	O
.	O
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
series	ENTITY
of	ENTITY
disorders	ENTITY
due	O
to	O
inborn	ENTITY
errors	ENTITY
in	ENTITY
lipid	ENTITY
metabolism	ENTITY
resulting	O
in	O
the	O
abnormal	O
accumulation	O
of	O
lipids	ENTITY
in	ENTITY
the	ENTITY
wrong	ENTITY
places	ENTITY
examples	ENTITY
include	ENTITY
gaucher	ENTITY
fabry	ENTITY
and	O
niemann	ENTITY
pick	ENTITY
diseases	ENTITY
and	O
metachromatic	ENTITY
leukodystrophy	ENTITY
.	O
how	O
to	O
pronounce	O
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
definition	O
of	O
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
audio	O
dictionary	O
how	O
to	O
say	O
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
what	O
is	O
the	O
meaning	O
of	O
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
pronounce	O
lipid	ENTITY
storage	ENTITY
diseases	ENTITY
.	O
symptoms	O
of	O
potassium	ENTITY
deficiency	ENTITY
of	O
any	O
nutrient	O
in	O
the	O
body	O
is	O
undesirable	O
and	O
potassium	ENTITY
.	O
diet	ENTITY
deficient	ENTITY
in	O
it	O
may	O
lead	O
to	O
symptoms	O
like	O
fatigue	O
and	O
muscle	ENTITY
weakness	ENTITY
.	O
other	O
indications	O
for	O
its	O
deficiency	O
include	O
inactive	O
reflexes	O
abnormal	ENTITY
heartbeat	ENTITY
heart	ENTITY
palpitations	ENTITY
anemia	ENTITY
and	O
severe	ENTITY
headaches	ENTITY
.	O
potassium	ENTITY
deficient	ENTITY
people	ENTITY
may	ENTITY
also	ENTITY
experience	ENTITY
high	ENTITY
blood	ENTITY
pressure	ENTITY
pain	O
in	O
their	O
intestines	ENTITY
swelling	ENTITY
in	ENTITY
their	ENTITY
glands	ENTITY
and	ENTITY
diabetes	ENTITY
.	O
important	O
sources	O
of	O
potassium	ENTITY
.	O
also	O
you	O
can	O
get	O
an	O
ample	O
amount	O
of	O
this	O
mineral	O
.	O
apart	O
from	O
those	O
nuts	O
lime	O
beans	O
potatoes	O
and	O
poultry	O
are	O
other	O
products	O
to	O
be	O
included	O
in	O
the	O
potassium	ENTITY
.	O
however	O
the	O
important	O
sources	O
of	O
this	O
mineral	O
also	O
include	O
avocados	O
bananas	O
and	O
coconut	O
water	O
.	O
stabilizes	O
blood	ENTITY
sugar	ENTITY
decrease	O
in	O
the	O
potassium	ENTITY
level	ENTITY
causes	ENTITY
drop	ENTITY
in	ENTITY
blood	ENTITY
sugar	ENTITY
.	O
decrease	O
in	O
blood	ENTITY
sugar	ENTITY
can	O
cause	O
sweating	O
headache	ENTITY
weakness	ENTITY
trembling	ENTITY
and	ENTITY
nervousness	ENTITY
.	O
intake	O
of	O
potassium	ENTITY
chloride	ENTITY
and	ENTITY
sodium	ENTITY
.	O
this	O
is	O
also	O
why	O
diabetics	O
are	O
encouraged	O
to	O
keep	O
their	O
potassium	ENTITY
levels	ENTITY
normal	ENTITY
to	ENTITY
reduce	ENTITY
the	ENTITY
chances	ENTITY
of	ENTITY
unpredictable	ENTITY
spikes	ENTITY
and	ENTITY
plunges	ENTITY
in	ENTITY
their	ENTITY
glucose	ENTITY
and	ENTITY
insulin	ENTITY
levels	ENTITY
by	O
stabilizing	O
the	O
blood	ENTITY
sugar	ENTITY
levels	O
.	O
reduces	O
muscle	ENTITY
disorders	ENTITY
sufficient	O
concentration	O
of	O
this	O
mineral	O
is	O
required	O
for	O
the	O
regular	O
contraction	O
.	O
most	O
of	O
the	O
potassium	ENTITY
ions	ENTITY
in	O
the	O
human	O
body	O
are	O
located	O
in	O
the	O
muscle	ENTITY
cells	ENTITY
.	O
it	O
maintains	O
optimal	O
muscle	ENTITY
and	ENTITY
nerve	ENTITY
function	ENTITY
and	O
helps	O
to	O
keep	O
our	O
reflexes	O
fast	O
because	O
it	O
stimulates	O
the	O
neural	O
connectivity	O
of	O
muscles	ENTITY
and	ENTITY
the	ENTITY
brain	ENTITY
.	O
prevents	O
cramps	O
muscle	ENTITY
cramps	ENTITY
are	O
common	O
result	O
of	O
low	O
levels	O
of	O
potassium	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
condition	ENTITY
called	O
hypokalemia	ENTITY
.	O
if	O
you	O
consume	O
banana	O
every	O
day	O
you	O
can	O
easily	O
prevent	O
muscle	ENTITY
cramps	ENTITY
because	O
bananas	O
have	O
rich	O
potassium	ENTITY
.	O
stabilizes	O
blood	ENTITY
pressure	ENTITY
potassium	ENTITY
is	ENTITY
helpful	ENTITY
in	ENTITY
reversing	ENTITY
the	ENTITY
role	ENTITY
of	ENTITY
sodium	ENTITY
.	O
thus	O
it	O
acts	O
as	O
vital	O
component	O
that	O
maintains	O
the	O
normality	O
of	O
blood	ENTITY
pressure	ENTITY
in	O
the	O
human	O
body	O
.	O
this	O
further	O
reduces	O
the	O
risk	O
of	O
heart	ENTITY
diseases	ENTITY
and	O
ypertension	ENTITY
.	O
regulation	ENTITY
of	ENTITY
blood	ENTITY
pressure	ENTITY
is	O
one	O
of	O
the	O
most	O
important	O
functions	O
of	O
this	O
powerful	O
mineral	O
.	O
as	O
mentioned	O
earlier	O
it	O
has	O
vasodilation	ENTITY
properties	ENTITY
that	ENTITY
work	ENTITY
to	ENTITY
relieve	ENTITY
the	ENTITY
tension	ENTITY
of	ENTITY
blood	ENTITY
vessels	ENTITY
which	O
is	O
one	O
of	O
the	O
main	O
causes	O
of	O
high	ENTITY
blood	ENTITY
pressure	ENTITY
.	O
strengthens	O
muscles	ENTITY
one	ENTITY
of	ENTITY
the	ENTITY
useful	ENTITY
benefits	ENTITY
of	ENTITY
MT>potassium	ENTITY
is	O
its	O
role	O
in	O
ensuring	O
the	O
proper	O
growth	O
of	O
muscle	ENTITY
tissues	ENTITY
and	O
the	O
utilization	O
of	O
energy	O
released	O
during	O
metabolism	ENTITY
.	O
the	O
muscle	ENTITY
including	ENTITY
those	ENTITY
all	ENTITY
important	ENTITY
cardiac	ENTITY
muscles	ENTITY
are	O
prone	O
to	O
paralysis	O
due	O
to	O
deficiency	ENTITY
of	ENTITY
potassium	ENTITY
in	ENTITY
person	ENTITY
diet	ENTITY
.	O
stimulating	O
cell	O
growth	O
and	O
providing	O
the	O
metabolic	O
energy	O
to	O
do	O
so	O
is	O
vital	O
function	O
of	O
potassium	ENTITY
.	O
also	O
without	O
the	O
contraction	O
and	O
relaxation	O
that	O
potassium	ENTITY
allows	ENTITY
muscles	ENTITY
to	ENTITY
perform	ENTITY
exercise	ENTITY
.	O
boosts	O
metabolism	ENTITY
potassium	ENTITY
assists	ENTITY
in	ENTITY
the	ENTITY
metabolic	ENTITY
processing	ENTITY
of	ENTITY
various	ENTITY
nutrients	ENTITY
like	ENTITY
fats	ENTITY
and	ENTITY
carbohydrates	ENTITY
.	O
thus	O
it	O
is	O
of	O
great	O
value	O
in	O
extracting	O
the	O
energy	O
from	O
nutrients	O
that	O
are	O
consumed	O
.	O
studies	O
have	O
shown	O
that	O
this	O
mineral	O
is	O
also	O
an	O
integral	O
part	O
in	O
the	O
synthesis	O
of	O
protein	O
which	O
has	O
an	O
impact	O
on	O
tissue	ENTITY
regeneration	ENTITY
cell	ENTITY
growth	O
and	O
an	O
overall	O
balanced	O
metabolism	ENTITY
.	O
boosts	O
heart	ENTITY
health	ENTITY
the	ENTITY
health	ENTITY
benefits	ENTITY
of	ENTITY
potassium	ENTITY
ensure	ENTITY
good	ENTITY
health	ENTITY
for	ENTITY
the	ENTITY
heart	ENTITY
as	ENTITY
well	ENTITY
as	ENTITY
the	ENTITY
kidneys	ENTITY
.	O
it	O
plays	O
an	O
irreplaceable	O
role	O
in	O
regulating	O
the	O
functions	O
of	O
the	O
metabolism	ENTITY
and	ENTITY
keeping	ENTITY
the	ENTITY
heart	ENTITY
and	ENTITY
kidney	ENTITY
.	O
additionally	O
this	O
mineral	O
assists	O
the	O
kidney	ENTITY
in	ENTITY
removing	ENTITY
waste	ENTITY
through	ENTITY
the	ENTITY
process	ENTITY
of	ENTITY
excretion	ENTITY
.	O
however	O
it	O
is	O
strongly	O
advised	O
to	O
consult	O
your	O
doctor	O
to	O
get	O
recommendations	O
about	O
potassium	ENTITY
dosage	ENTITY
because	ENTITY
it	ENTITY
can	ENTITY
help	ENTITY
to	ENTITY
stimulate	ENTITY
the	ENTITY
body	ENTITY
to	ENTITY
absorb	ENTITY
more	ENTITY
calcium	ENTITY
than	ENTITY
necessary	ENTITY
which	ENTITY
can	ENTITY
actually	ENTITY
calcify	ENTITY
and	ENTITY
cause	ENTITY
kidney	ENTITY
problems	ENTITY
.	O
regulates	O
the	O
level	O
of	O
fluids	ENTITY
potassium	ENTITY
is	O
also	O
great	O
electrolyte	ENTITY
.	O
it	O
helps	O
in	O
regulating	O
the	O
level	O
of	O
fluids	O
in	O
the	O
body	O
and	O
thus	O
aids	O
in	O
number	O
of	O
critical	O
body	O
functions	O
.	O
furthermore	O
electrolytes	ENTITY
help	ENTITY
to	ENTITY
transmit	ENTITY
electrical	ENTITY
charges	ENTITY
throughout	ENTITY
the	ENTITY
body	ENTITY
from	ENTITY
the	ENTITY
brain	ENTITY
and	ENTITY
nervous	ENTITY
system	ENTITY
so	O
extra	O
electrolytes	ENTITY
.	O
if	O
premature	O
development	O
of	O
cardiovascular	ENTITY
disease	ENTITY
fatty	O
deposits	O
in	O
the	O
skin	O
or	O
tendons	ENTITY
caused	ENTITY
by	ENTITY
very	ENTITY
high	ENTITY
levels	ENTITY
lipids	ENTITY
blood	ENTITY
pain	O
enlargement	O
inflammation	ENTITY
abdominal	ENTITY
organs	ENTITY
such	O
as	O
liver	ENTITY
lipid	ENTITY
disorders	ENTITY
are	O
problems	O
with	O
various	O
forms	O
fat	ENTITY
that	ENTITY
carried	ENTITY
abnormal	ENTITY
blood	ENTITY
can	ENTITY
be	ENTITY
genetic	ENTITY
factors	ENTITY
lifestyle	ENTITY
apart	ENTITY
from	ENTITY
causes	ENTITY
disorders	ENTITY
diet	ENTITY
saturated	ENTITY
and	ENTITY
trans	ENTITY
will	ENTITY
also	ENTITY
increase	ENTITY
cholesterol	ENTITY
.	O
lipid	ENTITY
disorders	ENTITY
hormonal	ENTITY
and	O
high	ENTITY
blood	ENTITY
cholesterol	ENTITY
triglycerides	ENTITY
.	O
pathology	O
lipid	ENTITY
abnormalities	ENTITY
in	O
nephrotic	ENTITY
syndrome	ENTITY
.	O
disorders	O
like	O
gaucher	ENTITY
disease	ENTITY
and	O
tay	ENTITY
sachs	ENTITY
cause	O
problems	O
with	O
how	O
your	O
body	O
uses	O
lipids	ENTITY
jan	ENTITY
multiple	ENTITY
studies	ENTITY
have	ENTITY
revealed	ENTITY
that	ENTITY
the	ENTITY
early	ENTITY
stages	ENTITY
of	ENTITY
atherosclerosis	ENTITY
.	O
lipid	ENTITY
disorders	ENTITY
.	O
this	O
condition	O
can	O
cause	O
person	O
to	O
get	O
coronary	ENTITY
artery	ENTITY
dietary	O
causes	O
may	O
include	O
high	O
alcohol	O
intake	O
and	O
foods	O
containing	O
cholesterol	ENTITY
saturated	ENTITY
fat	ENTITY
why	O
choose	O
johns	O
hopkins	O
for	O
treatment	O
of	O
lipid	ENTITY
disorders	ENTITY
.	O
metabolic	ENTITY
disease	ENTITY
.	O
it	O
causes	O
buildup	O
of	O
fats	ENTITY
in	ENTITY
the	ENTITY
tissues	ENTITY
that	ENTITY
is	ENTITY
usually	ENTITY
fatal	ENTITY
early	ENTITY
life	ENTITY
lipid	ENTITY
disorders	ENTITY
hormonal	ENTITY
and	O
high	ENTITY
blood	ENTITY
cholesterol	ENTITY
triglycerides	ENTITY
.	O
pediatric	O
lipid	ENTITY
disorders	ENTITY
.	O
one	O
of	O
biopsy	O
for	O
lipid	ENTITY
storage	ENTITY
disease	ENTITY
involves	O
if	O
they	O
are	O
carrying	O
mutated	O
gene	ENTITY
that	ENTITY
causes	ENTITY
the	ENTITY
disorder	ENTITY
aug	ENTITY
lipids	ENTITY
include	O
fats	ENTITY
oils	ENTITY
and	O
cholesterol	ENTITY
.	O
primary	O
hyperlipidemia	ENTITY
is	ENTITY
usually	ENTITY
due	ENTITY
to	ENTITY
genetic	ENTITY
causes	ENTITY
such	ENTITY
as	ENTITY
mutation	ENTITY
in	ENTITY
receptor	ENTITY
protein	ENTITY
while	O
secondary	ENTITY
lipid	ENTITY
and	O
lipoprotein	ENTITY
abnormalities	ENTITY
are	O
common	O
the	O
general	O
population	O
regarded	O
modifiable	O
risk	O
storage	O
disorder	O
or	O
lipidosis	ENTITY
can	ENTITY
be	ENTITY
any	ENTITY
one	ENTITY
of	ENTITY
group	ENTITY
inherited	ENTITY
metabolic	ENTITY
disorders	ENTITY
over	O
time	O
this	O
excessive	O
fats	ENTITY
cause	ENTITY
permanent	ENTITY
cellular	ENTITY
tissue	ENTITY
damage	O
particularly	O
brain	ENTITY
peripheral	ENTITY
nervous	ENTITY
system	ENTITY
apr	ENTITY
most	ENTITY
hyperlipidemia	ENTITY
high	ENTITY
levels	ENTITY
blood	ENTITY
fat	ENTITY
.	O
dyslipidemia	ENTITY
endocrine	ENTITY
and	ENTITY
metabolic	ENTITY
disorders	ENTITY
msd	ENTITY
manual	ENTITY
familial	ENTITY
lipid	ENTITY
topic	ENTITY
overview	O
webmdjohns	O
hopkins	O
division	O
of	O
endocrinology	ENTITY
diabetes	ENTITY
diagnosing	ENTITY
storage	ENTITY
diseases	ENTITY
.	O
while	O
many	O
of	O
its	O
possible	O
causes	O
are	O
not	O
related	O
to	O
the	O
endocrine	ENTITY
lipid	ENTITY
disorders	ENTITY
such	O
as	O
high	ENTITY
cholesterol	ENTITY
can	O
increase	O
risk	O
heart	ENTITY
problems	ENTITY
some	O
people	O
have	O
disorders	O
caused	O
by	O
another	O
disease	ENTITY
or	ENTITY
medical	ENTITY
that	ENTITY
affect	ENTITY
metabolism	ENTITY
may	ENTITY
be	ENTITY
defects	ENTITY
in	ENTITY
structural	ENTITY
proteins	ENTITY
lipoprotein	ENTITY
particles	ENTITY
cell	ENTITY
receptors	ENTITY
recognize	O
various	O
abnormal	O
is	O
common	O
patients	O
with	O
renal	ENTITY
.	O
nyu	O
langone	O
physicians	O
diagnose	O
lipid	ENTITY
disorders	ENTITY
.	O
abnormalities	O
in	O
the	O
nephrotic	ENTITY
syndrome	ENTITY
causes	O
consequences	O
and	O
treatment	O
aug	O
tay	ENTITY
sachs	ENTITY
disease	ENTITY
is	O
lipid	ENTITY
disorder	ENTITY
.	O
lipid	ENTITY
disorders	ENTITY
hormonal	ENTITY
and	ENTITY
learn	ENTITY
about	ENTITY
overview	ENTITY
of	ENTITY
cholesterol	ENTITY
lipid	ENTITY
from	O
the	O
home	O
version	O
merck	O
manuals	O
foods	O
high	O
in	O
certain	O
types	O
fats	ENTITY
.	O
signs	O
that	O
indicate	O
problem	O
with	O
thyroid	ENTITY
gland	ENTITY
the	O
thyroid	ENTITY
located	ENTITY
in	ENTITY
the	ENTITY
neck	ENTITY
is	ENTITY
vital	ENTITY
body	ENTITY
gland	ENTITY
as	ENTITY
it	ENTITY
is	ENTITY
responsible	ENTITY
for	ENTITY
numerous	ENTITY
functions	ENTITY
in	ENTITY
the	ENTITY
body	ENTITY
.	O
it	O
produces	O
hormones	ENTITY
that	ENTITY
regulate	ENTITY
the	ENTITY
metabolism	ENTITY
so	ENTITY
the	ENTITY
imbalance	ENTITY
of	ENTITY
those	ENTITY
hormones	ENTITY
severely	ENTITY
affects	ENTITY
the	ENTITY
natural	ENTITY
balance	ENTITY
of	ENTITY
the	ENTITY
body	ENTITY
.	O
yet	O
the	O
thyroid	ENTITY
dysfunction	ENTITY
is	O
hard	O
to	O
be	O
diagnosed	O
as	O
its	O
symptoms	O
.	O
therefore	O
it	O
is	O
of	O
high	O
importance	O
to	O
recognize	O
its	O
symptoms	O
.	O
these	O
are	O
the	O
symptoms	O
of	O
thyroid	ENTITY
issues	ENTITY
that	ENTITY
should	ENTITY
not	ENTITY
be	ENTITY
ignored	ENTITY
frequent	ENTITY
pains	ENTITY
in	ENTITY
the	ENTITY
muscles	ENTITY
or	ENTITY
joints	ENTITY
this	O
is	O
an	O
indication	O
that	O
should	O
not	O
be	O
ignored	O
so	O
you	O
must	O
visit	O
your	O
doctor	O
and	O
check	O
whether	O
you	O
are	O
experiencing	O
thyroid	ENTITY
.	O
bloating	ENTITY
and	ENTITY
swelling	ENTITY
hypothyroidism	ENTITY
can	ENTITY
often	ENTITY
lead	ENTITY
to	ENTITY
bloating	ENTITY
.	O
on	O
the	O
other	O
hand	O
if	O
you	O
notice	O
swelling	ENTITY
or	ENTITY
puffiness	ENTITY
in	ENTITY
the	ENTITY
face	ENTITY
you	ENTITY
should	ENTITY
immediately	ENTITY
check	ENTITY
your	ENTITY
thyroid	O
gland	ENTITY
.	O
trembling	O
and	O
anxiety	O
sometimes	O
the	O
excessive	O
production	O
of	O
thyroid	ENTITY
hormones	ENTITY
may	O
lead	O
to	O
accelerated	O
metabolism	ENTITY
and	ENTITY
thus	ENTITY
can	ENTITY
make	ENTITY
you	ENTITY
feel	ENTITY
irritated	ENTITY
nervous	ENTITY
.	O
weight	O
changes	O
hypothyroidism	ENTITY
can	ENTITY
lead	ENTITY
to	ENTITY
unexplained	ENTITY
weight	ENTITY
gain	ENTITY
and	ENTITY
on	ENTITY
the	ENTITY
other	ENTITY
hand	ENTITY
hyperthyroidism	ENTITY
can	ENTITY
lead	ENTITY
.	O
irregular	ENTITY
menstruation	ENTITY
thyroid	ENTITY
problems	O
can	O
cause	O
two	O
kinds	O
of	O
abnormal	ENTITY
menstruation	ENTITY
hypothyroidism	ENTITY
leads	ENTITY
to	ENTITY
extremely	ENTITY
difficult	ENTITY
and	ENTITY
long	ENTITY
menstruation	ENTITY
and	ENTITY
hyperthyroidism	ENTITY
causes	ENTITY
small	ENTITY
flow	ENTITY
or	ENTITY
no	ENTITY
menstrual	ENTITY
cycle	ENTITY
.	O
change	O
in	O
mental	O
functions	O
reduced	O
levels	O
of	O
thyroid	ENTITY
hormones	ENTITY
cause	O
constant	O
fatigue	O
and	O
feelings	O
of	O
tiredness	O
and	O
dizziness	O
.	O
abnormal	O
reaction	O
to	O
the	O
temperature	O
outside	O
in	O
the	O
case	O
of	O
thyroid	ENTITY
gland	ENTITY
disorders	ENTITY
people	O
may	O
react	O
differently	O
to	O
the	O
temperature	O
outside	O
than	O
others	O
.	O
in	O
the	O
case	O
of	O
hyperthyroidism	ENTITY
people	ENTITY
feel	ENTITY
abnormal	ENTITY
warmness	ENTITY
while	ENTITY
the	ENTITY
ones	ENTITY
with	ENTITY
hypothyroidism	ENTITY
feel	ENTITY
unnatural	ENTITY
cold	ENTITY
.	O
hair	O
loss	O
facial	O
pallor	O
the	O
thyroid	ENTITY
gland	ENTITY
issues	O
can	O
also	O
be	O
manifested	O
by	O
hair	O
loss	O
weak	O
.	O
angela	O
poff	O
phd	O
discusses	O
the	O
metabolic	ENTITY
origins	ENTITY
of	ENTITY
cancer	ENTITY
and	O
potential	O
anticancer	ENTITY
effects	ENTITY
of	ENTITY
ketones	ENTITY
.	O
get	O
in	O
touch	O
angela	O
key	O
takeaways	O
metabolism	ENTITY
.	O
cancer	ENTITY
cells	ENTITY
.	O
the	O
warburg	O
effect	O
almost	O
years	O
ago	O
otto	O
warburg	O
showed	O
that	O
cancer	ENTITY
cells	ENTITY
don	O
undergo	O
normal	O
energy	ENTITY
metabolism	ENTITY
.	O
oxygen	O
and	O
the	O
warburg	O
effect	O
this	O
process	O
occurs	O
whether	O
oxygen	O
.	O
in	O
normal	ENTITY
cells	ENTITY
we	O
utilize	O
lactate	O
fermentation	O
when	O
oxygen	O
.	O
cancer	ENTITY
cells	ENTITY
do	O
this	O
even	O
when	O
oxygen	O
.	O
mitochondrial	ENTITY
dysfunction	ENTITY
there	O
is	O
widespread	O
mitochondrial	ENTITY
dysfunction	ENTITY
in	O
cancer	ENTITY
cell	ENTITY
division	O
every	O
time	O
your	O
cell	O
divides	O
it	O
has	O
to	O
copy	O
its	O
dna	ENTITY
.	O
mistakes	O
will	O
be	O
made	O
but	O
we	O
have	O
repair	O
.	O
lactic	ENTITY
acid	ENTITY
and	O
cancer	O
the	O
cancer	O
field	O
views	O
aerobic	ENTITY
glycolysis	ENTITY
or	O
the	O
warburg	O
effect	O
as	O
beneficial	O
adaptation	O
.	O
fat	ENTITY
consumption	ENTITY
and	ENTITY
cancer	ENTITY
fatty	ENTITY
acids	ENTITY
and	O
ketone	ENTITY
bodies	ENTITY
are	O
converted	O
into	O
acetyl	ENTITY
coa	ENTITY
to	O
enter	O
the	O
metabolic	O
pathways	O
at	O
the	O
level	O
.	O
hypoxia	ENTITY
inducible	ENTITY
factor	ENTITY
.	O
in	O
order	O
to	O
grow	O
past	O
certain	O
size	O
the	O
tumor	ENTITY
needs	ENTITY
to	ENTITY
make	ENTITY
its	ENTITY
own	ENTITY
new	ENTITY
blood	ENTITY
vessels	ENTITY
.	O
the	O
chaos	O
makes	O
the	O
blood	ENTITY
vessel	ENTITY
network	ENTITY
.	O
hyperbaric	ENTITY
oxygen	ENTITY
therapy	ENTITY
at	O
sea	O
level	O
we	O
breathe	O
oxygen	O
.	O
in	O
hbot	O
oxygen	O
.	O
oxygen	ENTITY
free	ENTITY
radical	ENTITY
production	O
in	O
some	O
parts	O
of	O
the	O
tumor	ENTITY
there	ENTITY
may	ENTITY
be	ENTITY
no	ENTITY
oxygen	ENTITY
and	ENTITY
parts	ENTITY
of	ENTITY
the	ENTITY
tumor	ENTITY
may	ENTITY
die	ENTITY
.	O
radiation	ENTITY
therapy	ENTITY
and	O
oxygen	O
.	O
oxygen	O
therapies	O
for	O
treatment	O
and	O
prevention	O
mitochondria	ENTITY
membranes	ENTITY
healthy	O
functioning	O
mitochondria	ENTITY
act	ENTITY
.	O
by	O
preserving	O
mitochondrial	ENTITY
membrane	ENTITY
in	O
turn	O
helps	O
to	O
preserve	O
mitochondrial	ENTITY
function	ENTITY
.	O
well	O
formulated	O
ketogenic	ENTITY
diet	ENTITY
helps	O
with	O
cell	ENTITY
membrane	ENTITY
integrity	ENTITY
.	O
insulin	ENTITY
signaling	ENTITY
and	ENTITY
cancer	ENTITY
insulin	ENTITY
is	O
potent	O
.	O
many	O
cancer	O
types	O
upregulate	O
insulin	ENTITY
receptors	ENTITY
and	O
igf	ENTITY
receptors	ENTITY
.	O
insulin	ENTITY
.	O
ketogenic	ENTITY
diet	ENTITY
and	O
glucose	ENTITY
we	ENTITY
don	ENTITY
always	ENTITY
get	ENTITY
remarkable	ENTITY
drop	ENTITY
in	ENTITY
circulating	ENTITY
blood	ENTITY
glucose	ENTITY
.	O
pro	ENTITY
oxidant	ENTITY
.	O
cancer	ENTITY
cells	ENTITY
at	O
basal	O
level	O
operate	O
under	O
more	O
free	ENTITY
radicals	ENTITY
.	O
the	O
effects	O
of	O
ketones	ENTITY
.	O
they	O
have	O
very	O
important	O
signaling	O
and	O
functional	O
roles	O
in	O
our	O
cells	O
that	O
have	O
nothing	O
to	O
do	O
with	O
their	O
role	O
as	O
energy	O
metabolites	ENTITY
.	O
inflammation	ENTITY
it	ENTITY
is	ENTITY
huge	ENTITY
component	ENTITY
in	ENTITY
cancer	ENTITY
origination	ENTITY
and	ENTITY
progression	ENTITY
.	O
ketosis	ENTITY
is	ENTITY
anti	ENTITY
inflammatory	ENTITY
.	O
beta	ENTITY
hydroxybutyrate	ENTITY
inhibits	O
the	O
assembly	O
of	O
the	O
nlrp	ENTITY
inflammasome	ENTITY
that	ENTITY
is	ENTITY
activated	ENTITY
during	ENTITY
cancer	ENTITY
ageing	ENTITY
and	O
many	O
chronic	ENTITY
illnesses	ENTITY
that	O
incite	O
inflammation	ENTITY
.	O
ketones	ENTITY
and	ENTITY
the	ENTITY
alterations	ENTITY
in	ENTITY
oxidative	ENTITY
stress	ENTITY
ketone	ENTITY
metabolism	ENTITY
decreases	O
free	ENTITY
radical	ENTITY
production	ENTITY
reducing	O
oxidative	O
stress	O
and	O
increasing	O
antioxidant	O
.	O
ketones	ENTITY
and	ENTITY
glycolysis	ENTITY
some	ENTITY
data	ENTITY
suggests	ENTITY
that	ENTITY
ketones	ENTITY
can	ENTITY
inhibit	ENTITY
.	O
restoring	O
anti	ENTITY
tumor	ENTITY
immunity	ENTITY
the	O
ketogenic	ENTITY
diet	ENTITY
restores	O
anti	ENTITY
tumor	ENTITY
immunity	ENTITY
.	O
ketogenic	ENTITY
cancer	ENTITY
benefits	O
there	O
is	O
not	O
lot	O
of	O
human	O
data	O
on	O
the	O
ketogenic	ENTITY
diet	ENTITY
and	O
cancer	O
.	O
there	O
are	O
clinical	O
trials	O
registered	O
now	O
.	O
dr	O
.	O
exogenous	O
ketones	ENTITY
the	ENTITY
study	ENTITY
of	ENTITY
exogenous	ENTITY
ketones	ENTITY
.	O
they	O
have	O
had	O
therapeutic	ENTITY
effect	ENTITY
in	O
wide	O
variety	O
of	O
seizure	O
.	O
exogenous	O
ketones	ENTITY
are	ENTITY
something	ENTITY
that	ENTITY
you	ENTITY
consume	ENTITY
that	ENTITY
is	ENTITY
either	ENTITY
already	ENTITY
ketone	ENTITY
or	ENTITY
is	ENTITY
converted	ENTITY
into	ENTITY
ketones	ENTITY
in	ENTITY
your	ENTITY
body	ENTITY
or	ENTITY
releases	ENTITY
ketones	ENTITY
.	O
what	O
is	O
non	ENTITY
alcoholic	ENTITY
fatty	ENTITY
liver	ENTITY
disease	ENTITY
.	O
nafld	ENTITY
is	ENTITY
type	ENTITY
of	ENTITY
liver	ENTITY
disease	ENTITY
where	O
fat	ENTITY
is	ENTITY
deposited	ENTITY
steatosis	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
due	O
to	O
non	O
alcohol	O
.	O
subscribe	O
this	O
video	O
is	O
licensed	O
under	O
creative	O
commons	O
cc	O
by	O
sa	O
international	O
license	O
which	O
means	O
that	O
you	O
re	O
free	O
to	O
share	O
and	O
adapt	O
it	O
so	O
long	O
as	O
you	O
follow	O
the	O
attribution	O
and	O
sharealike	O
terms	O
and	O
conditions	O
.	O
our	O
supporters	O
omar	O
berrios	O
alex	O
wright	O
.	O
support	O
the	O
deeper	O
cause	O
of	O
slow	O
metabolism	ENTITY
insulin	ENTITY
glucose	ENTITY
support	ENTITY
the	ENTITY
health	ENTITY
wellness	ENTITY
center	ENTITY
pinecrest	ENTITY
office	ENTITY
park	ENTITY
drive	ENTITY
alexandria	ENTITY
va	ENTITY
disclaimer	ENTITY
dr	ENTITY
berg	ENTITY
does	ENTITY
not	ENTITY
diagnose	ENTITY
treat	ENTITY
or	ENTITY
prevent	ENTITY
any	ENTITY
medical	ENTITY
conditions	ENTITY
.	O
he	O
works	O
with	O
their	O
physicians	O
which	O
regular	O
their	O
medication	O
.	O
this	O
video	O
is	O
not	O
designed	O
to	O
and	O
does	O
not	O
provide	O
medical	O
advice	O
professional	O
diagnosis	O
opinion	O
treatment	O
.	O
through	O
my	O
videos	O
blog	O
posts	O
website	O
information	O
give	O
suggestions	O
for	O
you	O
and	O
your	O
doctor	O
to	O
research	O
and	O
provide	O
general	O
information	O
for	O
educational	O
purposes	O
only	O
.	O
the	O
information	O
provided	O
in	O
this	O
video	O
or	O
site	O
.	O
the	O
health	O
wellness	O
and	O
dr	O
eric	O
berg	O
are	O
not	O
liable	O
or	O
responsible	O
for	O
any	O
advice	O
course	O
of	O
treatment	O
diagnosis	O
or	O
any	O
other	O
information	O
services	O
or	O
product	O
you	O
obtain	O
through	O
this	O
video	O
or	O
site	O
.	O
these	O
videos	O
are	O
designed	O
for	O
medical	O
students	O
studying	O
for	O
the	O
usmle	O
step	O
feel	O
free	O
to	O
comment	O
and	O
suggest	O
what	O
you	O
would	O
like	O
to	O
see	O
.	O
ketones	ENTITY
help	ENTITY
solve	ENTITY
cellular	ENTITY
energy	ENTITY
dysregulation	ENTITY
by	O
improving	O
mitochondrial	ENTITY
function	ENTITY
reducing	O
premature	ENTITY
cell	ENTITY
.	O
research	O
into	O
the	O
benefits	O
of	O
ketones	ENTITY
has	ENTITY
established	ENTITY
that	ENTITY
ketones	ENTITY
improve	ENTITY
brain	ENTITY
and	ENTITY
cognitive	ENTITY
function	ENTITY
ketones	ENTITY
are	ENTITY
an	ENTITY
effective	ENTITY
treatment	ENTITY
for	ENTITY
epilepsy	ENTITY
and	ENTITY
are	ENTITY
now	ENTITY
being	ENTITY
tested	ENTITY
on	ENTITY
other	ENTITY
brain	ENTITY
disorders	ENTITY
.	O
provide	O
neuroprotection	ENTITY
for	ENTITY
the	ENTITY
brain	ENTITY
ketones	ENTITY
protect	O
this	O
vital	O
organ	ENTITY
from	ENTITY
trauma	ENTITY
concussions	ENTITY
aging	ENTITY
.	O
optimize	O
energy	O
using	O
ketones	ENTITY
and	ENTITY
glucose	ENTITY
together	ENTITY
allows	ENTITY
optimal	ENTITY
use	ENTITY
of	ENTITY
the	ENTITY
body	ENTITY
.	O
control	O
glucose	ENTITY
ketones	ENTITY
put	ENTITY
less	ENTITY
pressure	ENTITY
on	ENTITY
the	ENTITY
body	ENTITY
to	ENTITY
produce	ENTITY
insulin	ENTITY
.	O
provide	O
anti	O
aging	O
effects	O
ketones	ENTITY
cleanse	ENTITY
and	ENTITY
de	ENTITY
junk	ENTITY
cells	ENTITY
by	O
producing	O
times	O
fewer	O
free	O
radicals	ENTITY
that	ENTITY
cause	ENTITY
cell	ENTITY
damage	ENTITY
and	ENTITY
premature	ENTITY
cell	ENTITY
death	ENTITY
.	O
facilitate	O
fat	O
loss	O
ketones	ENTITY
support	ENTITY
low	ENTITY
carb	ENTITY
diets	ENTITY
by	ENTITY
minimizing	ENTITY
the	ENTITY
keto	ENTITY
flu	ENTITY
and	O
keeping	O
metabolism	ENTITY
high	ENTITY
during	ENTITY
calorie	ENTITY
reduced	ENTITY
diet	ENTITY
that	O
consumes	O
fat	ENTITY
.	O
inhibit	ENTITY
cancer	ENTITY
growth	O
many	O
types	O
of	O
cancer	ENTITY
cells	ENTITY
have	O
difficulty	O
utilizing	O
ketones	ENTITY
.	O
getting	O
ketones	ENTITY
into	ENTITY
our	ENTITY
nutrition	ENTITY
the	ENTITY
average	ENTITY
american	ENTITY
will	ENTITY
never	ENTITY
see	ENTITY
starvation	ENTITY
or	ENTITY
famine	ENTITY
the	ENTITY
conditions	ENTITY
that	ENTITY
historically	ENTITY
triggered	ENTITY
the	ENTITY
endogenous	ENTITY
production	ENTITY
of	ENTITY
ketones	ENTITY
.	O
indeed	O
more	O
people	O
will	O
die	O
worldwide	O
this	O
year	O
of	O
obesity	ENTITY
related	ENTITY
diseases	ENTITY
than	ENTITY
from	ENTITY
hunger	ENTITY
.	O
virtually	O
no	O
citizen	O
will	O
experience	O
the	O
consecutive	O
days	O
of	O
starvation	O
or	O
undergo	O
the	O
multi	O
day	O
fast	O
required	O
to	O
trigger	O
their	O
ketone	ENTITY
.	O
until	O
recently	O
short	O
of	O
starvation	O
the	O
only	O
other	O
recognized	O
way	O
of	O
including	O
ketones	ENTITY
in	ENTITY
the	ENTITY
diet	ENTITY
was	ENTITY
to	ENTITY
induce	ENTITY
the	ENTITY
body	ENTITY
to	ENTITY
make	ENTITY
them	ENTITY
endogenously	ENTITY
through	ENTITY
low	ENTITY
carbohydrate	ENTITY
ketogenic	ENTITY
type	ENTITY
diet	ENTITY
that	O
forces	O
glucose	ENTITY
and	ENTITY
insulin	ENTITY
levels	ENTITY
down	ENTITY
thereby	ENTITY
inducing	ENTITY
the	ENTITY
body	ENTITY
to	ENTITY
burn	ENTITY
fatty	ENTITY
acids	ENTITY
to	O
make	O
ketones	ENTITY
.	O
this	O
approach	O
requires	O
strict	O
dietary	O
compliance	O
making	O
its	O
widespread	O
adoption	O
impossible	O
given	O
the	O
present	O
american	O
diet	O
.	O
recent	O
research	O
in	O
this	O
field	O
however	O
has	O
established	O
an	O
alternative	O
method	O
for	O
including	O
ketones	ENTITY
.	O
by	O
adding	O
ketones	ENTITY
to	ENTITY
the	ENTITY
diet	ENTITY
consuming	ENTITY
exogenous	ENTITY
ketones	ENTITY
many	ENTITY
of	ENTITY
the	ENTITY
advantages	ENTITY
of	ENTITY
ketosis	ENTITY
.	O
utilization	O
of	O
ketones	ENTITY
will	ENTITY
help	ENTITY
return	ENTITY
us	ENTITY
to	ENTITY
our	ENTITY
natural	ENTITY
state	ENTITY
of	ENTITY
nutritional	ENTITY
energy	ENTITY
balance	ENTITY
.	O
sugar	O
the	O
bitter	O
truth	O
about	O
your	O
sweet	O
tooth	O
bluestarnutraceuticals	O
com	O
.	O
descriptions	O
of	O
thyroid	ENTITY
pain	ENTITY
symptoms	ENTITY
about	ENTITY
percent	ENTITY
of	ENTITY
the	ENTITY
united	ENTITY
states	ENTITY
population	ENTITY
suffers	ENTITY
.	O
the	O
risk	O
for	O
developing	O
hypothyroidism	ENTITY
and	ENTITY
infertility	ENTITY
.	O
if	O
you	O
have	O
multiple	O
signs	O
and	O
symptoms	O
of	O
this	O
problem	O
ask	O
your	O
doctor	O
to	O
check	O
your	O
thyroid	ENTITY
hormone	ENTITY
levels	ENTITY
and	ENTITY
get	ENTITY
treatment	ENTITY
of	ENTITY
thyroid	ENTITY
.	O
here	O
are	O
the	O
signs	O
and	O
symptoms	O
that	O
you	O
have	O
an	O
underactive	ENTITY
thyroid	ENTITY
.	O
unexplained	O
weight	O
gain	O
weight	O
gain	O
without	O
any	O
change	O
in	O
diet	O
or	O
physical	O
activity	O
may	O
indicate	O
low	O
levels	O
of	O
thyroid	ENTITY
hormones	ENTITY
.	O
these	O
hormones	ENTITY
help	ENTITY
regulate	ENTITY
basal	ENTITY
metabolism	ENTITY
and	O
thermogenesis	ENTITY
as	ENTITY
well	ENTITY
as	ENTITY
the	ENTITY
metabolism	ENTITY
of	ENTITY
fats	ENTITY
and	O
glucose	ENTITY
.	O
an	O
underactive	ENTITY
thyroid	ENTITY
contributes	O
to	O
lower	O
metabolic	ENTITY
rate	ENTITY
.	O
if	O
you	O
have	O
unexplained	O
weight	O
gain	O
it	O
is	O
essential	O
to	O
consult	O
your	O
doctor	O
to	O
determine	O
the	O
exact	O
cause	O
and	O
get	O
hypothyroidism	ENTITY
.	O
dry	O
and	O
flaky	O
skin	O
if	O
you	O
are	O
following	O
your	O
usual	O
beauty	O
and	O
skin	O
care	O
regimen	O
and	O
haven	O
changed	O
any	O
of	O
the	O
products	O
you	O
use	O
but	O
your	O
skin	O
is	O
dry	O
and	O
itchy	O
it	O
could	O
be	O
symptom	O
of	O
hypothyroidism	ENTITY
or	ENTITY
thyroid	ENTITY
dry	ENTITY
skin	ENTITY
.	O
the	O
change	O
in	O
skin	ENTITY
texture	ENTITY
and	O
appearance	O
can	O
be	O
due	O
to	O
reduced	O
blood	ENTITY
circulation	ENTITY
one	O
of	O
the	O
side	O
effects	O
of	O
having	O
low	O
thyroid	ENTITY
hormones	ENTITY
.	O
in	O
addition	O
slowed	O
metabolism	ENTITY
due	ENTITY
to	ENTITY
low	ENTITY
thyroid	ENTITY
hormone	ENTITY
production	O
can	O
reduce	O
sweating	O
.	O
without	O
proper	O
sweating	O
the	O
skin	O
becomes	O
dry	O
and	O
flaky	O
.	O
as	O
these	O
skin	O
.	O
it	O
is	O
best	O
to	O
consult	O
your	O
doctor	O
to	O
see	O
if	O
there	O
is	O
an	O
underlying	O
health	O
condition	O
causing	O
these	O
skin	O
changes	O
.	O
muscle	ENTITY
soreness	ENTITY
and	ENTITY
pain	ENTITY
people	ENTITY
suffering	ENTITY
from	ENTITY
hypothyroidism	ENTITY
often	ENTITY
experience	ENTITY
muscle	ENTITY
weakness	ENTITY
pain	ENTITY
stiffness	O
or	O
cramping	O
.	O
there	O
may	O
also	O
be	O
general	ENTITY
joint	ENTITY
pain	ENTITY
.	O
low	O
metabolism	ENTITY
disrupts	ENTITY
how	ENTITY
your	ENTITY
body	ENTITY
burns	ENTITY
energy	ENTITY
which	ENTITY
can	ENTITY
affect	ENTITY
how	ENTITY
your	ENTITY
muscles	ENTITY
.	O
low	O
thyroid	ENTITY
often	ENTITY
increases	ENTITY
inflammation	ENTITY
that	ENTITY
may	ENTITY
be	ENTITY
contributing	ENTITY
to	ENTITY
your	ENTITY
muscle	ENTITY
and	ENTITY
joint	ENTITY
pain	ENTITY
.	O
in	O
fact	O
about	O
percent	O
of	O
the	O
hypothyroid	ENTITY
patients	ENTITY
had	ENTITY
predominantly	ENTITY
sensory	ENTITY
signs	ENTITY
of	ENTITY
sensorimotor	ENTITY
axonal	ENTITY
neuropathy	ENTITY
early	O
in	O
the	O
course	ENTITY
of	ENTITY
thyroid	ENTITY
disease	ENTITY
.	O
hair	ENTITY
losshypothyroidism	ENTITY
hair	O
loss	O
and	O
proper	O
functioning	O
of	O
the	O
thyroid	ENTITY
gland	ENTITY
is	O
essential	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
the	O
hair	ENTITY
follicles	ENTITY
and	O
an	O
underactive	ENTITY
thyroid	ENTITY
.	O
it	O
may	O
also	O
affect	O
eyebrows	O
and	O
body	O
hair	O
.	O
the	O
thyroid	ENTITY
hormones	ENTITY
thyroxine	ENTITY
and	O
triiodothyronine	ENTITY
modulate	ENTITY
several	ENTITY
aspects	ENTITY
of	ENTITY
hair	ENTITY
anatomy	ENTITY
from	ENTITY
the	ENTITY
hair	ENTITY
growth	ENTITY
cycle	ENTITY
to	O
the	O
hair	O
pigmentation	ENTITY
.	O
if	O
you	O
are	O
worried	O
about	O
hair	O
loss	O
and	O
other	O
hair	O
related	O
issues	O
see	O
your	O
doctor	O
to	O
get	O
your	O
thyroid	ENTITY
.	O
constant	O
fatigue	O
and	O
tiredness	O
fatigue	O
and	O
extreme	O
tiredness	O
are	O
very	O
common	O
in	O
people	O
who	O
have	O
an	O
underactive	ENTITY
thyroid	ENTITY
.	O
when	O
low	O
thyroid	ENTITY
hormones	ENTITY
flow	O
through	O
the	O
blood	ENTITY
cells	ENTITY
do	O
not	O
function	O
properly	O
leading	O
to	O
less	O
energy	O
fatigue	O
and	O
constant	O
tiredness	O
.	O
these	O
symptoms	O
persist	O
even	O
after	O
getting	O
proper	O
sleep	O
.	O
study	O
published	O
in	O
the	O
european	O
journal	O
of	O
endocrinology	O
notes	O
that	O
autoimmune	ENTITY
hypothyroidism	ENTITY
.	O
menstrual	ENTITY
and	ENTITY
fertility	ENTITY
problems	ENTITY
women	O
with	O
hypothyroidism	ENTITY
may	ENTITY
experience	ENTITY
menstrual	ENTITY
.	O
thyroid	ENTITY
hormones	ENTITY
have	O
great	O
influence	O
on	O
menstruation	ENTITY
thyroid	ENTITY
pregnancy	ENTITY
lactation	ENTITY
and	O
even	O
uterine	ENTITY
involution	ENTITY
after	O
childbirth	O
.	O
in	O
fact	O
the	O
study	O
puts	O
emphasis	O
on	O
the	O
assessment	O
of	O
thyroid	ENTITY
function	ENTITY
in	O
all	O
patients	O
with	O
menstrual	ENTITY
disorders	ENTITY
to	O
avoid	O
unnecessary	O
interventions	O
like	O
curettage	ENTITY
and	ENTITY
hysterectomy	ENTITY
.	O
infertility	ENTITY
can	ENTITY
also	ENTITY
be	ENTITY
due	ENTITY
to	ENTITY
undiagnosed	ENTITY
thyroidconditions	ENTITY
.	O
for	O
any	O
change	O
in	O
menstrual	ENTITY
pattern	ENTITY
as	ENTITY
well	ENTITY
as	ENTITY
problems	ENTITY
becoming	ENTITY
pregnant	ENTITY
it	ENTITY
is	ENTITY
important	ENTITY
to	ENTITY
get	ENTITY
your	ENTITY
thyroid	ENTITY
.	O
music	O
royalty	O
free	O
music	O
from	O
bensound	O
.	O
burn	O
carbohydrates	ENTITY
with	ENTITY
antioxidants	ENTITY
alpha	ENTITY
lipoic	ENTITY
acid	ENTITY
thomas	ENTITY
delauer	ENTITY
did	O
you	O
know	O
that	O
the	O
body	O
is	O
capable	O
of	O
producing	O
its	O
own	O
antioxidants	O
.	O
one	O
powerful	O
antioxidant	O
produced	O
by	O
the	O
body	O
is	O
alpha	ENTITY
lipoic	ENTITY
acid	ENTITY
.	O
alpha	ENTITY
lipoic	ENTITY
acid	ENTITY
is	O
found	O
in	O
every	O
cell	O
of	O
the	O
human	O
.	O
both	O
water	O
soluble	O
and	O
fat	ENTITY
soluble	ENTITY
so	ENTITY
able	ENTITY
to	ENTITY
act	ENTITY
throughout	ENTITY
the	ENTITY
body	ENTITY
.	O
antioxidants	O
attack	O
free	ENTITY
radicals	ENTITY
which	O
are	O
waste	O
products	O
that	O
occur	O
when	O
the	O
body	O
creates	O
energy	O
through	O
the	O
food	O
we	O
eat	O
.	O
free	ENTITY
radicals	ENTITY
can	O
also	O
come	O
from	O
exposure	O
to	O
toxins	O
and	O
pollutants	O
.	O
negative	O
effects	O
of	O
free	ENTITY
radicals	ENTITY
include	O
slows	O
metabolism	ENTITY
abnormal	ENTITY
cell	ENTITY
growth	ENTITY
and	ENTITY
proliferation	ENTITY
.	O
free	ENTITY
radicals	ENTITY
lead	O
to	O
cellular	O
damage	O
including	O
damage	O
to	O
organs	ENTITY
.	O
make	O
the	O
body	O
more	O
susceptible	O
to	O
infections	ENTITY
.	O
cancer	O
heart	ENTITY
disease	ENTITY
and	O
diabetes	ENTITY
.	O
how	O
else	O
can	O
ala	ENTITY
.	O
ala	ENTITY
for	ENTITY
fat	ENTITY
loss	O
and	O
building	O
muscle	ENTITY
multiple	ENTITY
studies	ENTITY
have	ENTITY
found	ENTITY
ala	ENTITY
.	O
one	O
study	O
followed	O
obese	ENTITY
diabetic	ENTITY
patients	ENTITY
for	O
weeks	O
with	O
either	O
mg	ENTITY
supplementation	ENTITY
of	ENTITY
ala	ENTITY
per	O
day	O
or	O
placebo	ENTITY
and	ENTITY
found	ENTITY
significant	ENTITY
effect	ENTITY
on	ENTITY
body	ENTITY
mass	ENTITY
index	ENTITY
and	ENTITY
triglyceride	ENTITY
levels	ENTITY
decreasing	O
bmi	ENTITY
and	ENTITY
triglyceride	ENTITY
levels	ENTITY
in	O
the	O
subjects	O
with	O
oral	O
ala	ENTITY
supplementation	ENTITY
.	O
protection	O
against	O
insulin	ENTITY
resistance	ENTITY
.	O
insulin	ENTITY
resistance	ENTITY
leads	O
to	O
decreased	O
glucose	ENTITY
uptake	ENTITY
in	ENTITY
fat	ENTITY
and	ENTITY
muscle	ENTITY
cells	ENTITY
.	O
ala	ENTITY
helps	ENTITY
to	ENTITY
turn	ENTITY
glucose	ENTITY
into	ENTITY
energy	ENTITY
or	ENTITY
fuel	ENTITY
for	ENTITY
your	ENTITY
body	ENTITY
through	ENTITY
insulin	ENTITY
signaling	ENTITY
when	ENTITY
insulin	ENTITY
binds	ENTITY
to	ENTITY
the	ENTITY
insulin	ENTITY
receptor	ENTITY
cascade	O
of	O
events	O
is	O
started	O
leading	O
to	O
increased	O
cellular	ENTITY
glucose	ENTITY
uptake	ENTITY
.	O
ala	ENTITY
has	ENTITY
been	ENTITY
shown	ENTITY
to	ENTITY
activate	ENTITY
this	ENTITY
cascade	ENTITY
of	ENTITY
events	ENTITY
leading	ENTITY
to	ENTITY
increased	ENTITY
glucose	ENTITY
uptake	ENTITY
in	O
fat	ENTITY
and	ENTITY
muscle	ENTITY
cells	ENTITY
.	O
this	O
is	O
done	O
not	O
through	O
an	O
effect	O
on	O
insulin	ENTITY
levels	ENTITY
but	O
by	O
triggering	O
the	O
same	O
sequence	O
of	O
events	O
leading	O
to	O
glucose	ENTITY
transport	ENTITY
for	O
energy	O
creation	O
.	O
ala	ENTITY
sort	ENTITY
of	ENTITY
mimics	ENTITY
insulin	ENTITY
.	O
studies	O
have	O
shown	O
that	O
this	O
shuttling	O
allows	O
more	O
glucose	ENTITY
to	ENTITY
enter	ENTITY
skeletal	ENTITY
muscle	ENTITY
cells	ENTITY
thus	O
more	O
glucose	ENTITY
burned	ENTITY
as	ENTITY
for	ENTITY
energy	ENTITY
more	ENTITY
energy	ENTITY
to	ENTITY
tear	ENTITY
and	ENTITY
rebuild	ENTITY
muscles	ENTITY
and	ENTITY
less	ENTITY
shuttled	ENTITY
to	ENTITY
be	ENTITY
stored	ENTITY
as	ENTITY
fat	ENTITY
.	O
when	O
more	O
glucose	ENTITY
is	ENTITY
delivered	ENTITY
to	ENTITY
muscle	ENTITY
cells	ENTITY
there	O
is	O
less	O
available	O
to	O
be	O
stored	O
as	O
fat	ENTITY
.	O
so	O
you	O
have	O
more	O
fuel	O
to	O
push	O
muscle	ENTITY
growth	ENTITY
and	ENTITY
less	ENTITY
glucose	ENTITY
stored	ENTITY
in	ENTITY
fat	ENTITY
cells	ENTITY
muscle	ENTITY
growth	O
and	O
less	O
fat	ENTITY
.	O
other	O
possible	O
uses	O
of	O
ala	ENTITY
ala	ENTITY
is	O
approved	O
in	O
germany	O
as	O
treatment	O
for	O
diabetes	ENTITY
and	ENTITY
for	ENTITY
symptoms	ENTITY
of	ENTITY
diabetes	ENTITY
.	O
cancer	O
memory	ENTITY
loss	ENTITY
chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
hiv	ENTITY
aids	ENTITY
heart	ENTITY
disease	ENTITY
eye	O
related	O
disorders	O
how	O
to	O
add	O
alpha	ENTITY
lipoic	ENTITY
acid	ENTITY
to	O
your	O
diet	O
foods	O
high	O
in	O
ala	ENTITY
broccolispinach	ENTITY
potatoes	ENTITY
red	ENTITY
meat	ENTITY
organ	ENTITY
.	O
you	O
can	O
also	O
take	O
supplements	O
.	O
the	O
bioavailability	O
of	O
supplemental	O
ala	ENTITY
has	ENTITY
been	ENTITY
shown	ENTITY
to	ENTITY
be	ENTITY
much	ENTITY
greater	ENTITY
than	ENTITY
that	ENTITY
of	ENTITY
dietary	ENTITY
ala	ENTITY
you	ENTITY
can	ENTITY
take	ENTITY
about	ENTITY
mg	ENTITY
for	ENTITY
antioxidant	ENTITY
purposes	ENTITY
up	ENTITY
to	ENTITY
mg	ENTITY
per	ENTITY
day	ENTITY
for	ENTITY
diabetic	ENTITY
purposes	ENTITY
as	ENTITY
directed	ENTITY
.	O
mg	O
to	O
mg	O
daily	O
is	O
common	O
dose	O
.	O
this	O
is	O
often	O
recommended	O
to	O
be	O
taken	O
on	O
an	O
empty	O
stomach	O
.	O
references	O
alpha	ENTITY
lipoic	ENTITY
acid	ENTITY
.	O
weight	O
loss	O
.	O
made	O
in	O
usa	O
.	O
safe	O
fast	O
weight	O
loss	O
.	O
fda	O
registered	O
and	O
licensed	O
manufacturing	O
learn	O
more	O
from	O
my	O
forlife	O
com	O
have	O
you	O
heard	O
.	O
lose	O
weight	O
without	O
hcg	ENTITY
instead	ENTITY
use	ENTITY
asap	ENTITY
.	O
hcg	ENTITY
is	ENTITY
fast	ENTITY
weight	ENTITY
loss	ENTITY
for	ENTITY
sure	ENTITY
but	ENTITY
you	ENTITY
must	ENTITY
go	ENTITY
to	ENTITY
the	ENTITY
doctor	ENTITY
to	ENTITY
get	ENTITY
injections	ENTITY
of	ENTITY
the	ENTITY
hcg	ENTITY
hormone	ENTITY
.	O
asap	O
is	O
not	O
hcg	ENTITY
but	ENTITY
protein	ENTITY
fragments	ENTITY
and	O
amino	ENTITY
acids	ENTITY
as	O
well	O
as	O
tribulus	ENTITY
terrestris	ENTITY
extract	ENTITY
.	O
asap	O
contains	O
only	O
certified	O
grade	O
raw	O
materials	O
and	O
is	O
made	O
in	O
the	O
usa	O
.	O
asap	O
also	O
helps	O
you	O
lose	O
weight	O
fast	O
by	O
focusing	O
on	O
losing	O
abnormal	O
fat	ENTITY
without	ENTITY
hormones	ENTITY
asap	ENTITY
allows	ENTITY
you	ENTITY
to	ENTITY
burn	ENTITY
abnormal	ENTITY
fat	ENTITY
stores	O
as	O
fuel	O
and	O
helps	O
reset	O
your	O
metabolism	ENTITY
.	O
if	O
you	O
are	O
on	O
low	ENTITY
calorie	ENTITY
diet	ENTITY
you	O
burn	O
structural	O
and	O
normal	O
fat	ENTITY
stores	ENTITY
in	ENTITY
your	ENTITY
body	ENTITY
.	O
asap	O
focuses	O
on	O
burning	ENTITY
abnormal	ENTITY
fat	ENTITY
while	O
you	O
follow	O
low	O
fat	ENTITY
low	ENTITY
carbohydrate	ENTITY
diet	ENTITY
for	O
to	O
weeks	O
this	O
will	O
reset	O
your	O
hypothalamus	ENTITY
so	ENTITY
your	ENTITY
body	ENTITY
can	ENTITY
burn	ENTITY
fat	ENTITY
.	O
what	O
is	O
asap	O
.	O
asap	O
contains	O
protein	O
fractions	O
and	O
amino	ENTITY
acids	ENTITY
that	O
allow	O
your	O
body	O
to	O
release	O
the	O
abnormal	O
fat	ENTITY
.	O
asap	O
contains	O
only	O
certified	O
grade	O
raw	O
materials	O
processed	O
according	O
to	O
good	O
manufacturing	O
practices	O
and	O
is	O
made	O
in	O
the	O
usa	O
.	O
asap	O
program	O
for	O
success	O
every	O
human	O
body	O
has	O
different	O
types	O
of	O
fat	ENTITY
structural	ENTITY
visceral	ENTITY
fat	ENTITY
in	O
and	O
around	O
muscles	ENTITY
cushioning	ENTITY
organs	ENTITY
padding	ENTITY
of	ENTITY
bottoms	ENTITY
of	ENTITY
feet	ENTITY
.	O
normal	O
dermal	ENTITY
fat	ENTITY
is	O
directly	O
under	O
the	O
skins	O
surface	O
and	O
provides	O
the	O
soft	O
cushioning	O
between	O
the	O
skin	O
and	O
frame	O
of	O
the	O
body	O
.	O
abnormal	O
adipose	ENTITY
fat	ENTITY
is	O
under	O
the	O
dermal	ENTITY
fat	ENTITY
and	O
not	O
available	O
for	O
use	O
by	O
the	O
metabolism	ENTITY
until	ENTITY
the	ENTITY
other	ENTITY
kinds	ENTITY
of	ENTITY
fat	ENTITY
.	O
abnormal	ENTITY
fat	ENTITY
can	O
be	O
viewed	O
as	O
famine	ENTITY
fat	ENTITY
.	O
it	O
is	O
stored	O
by	O
the	O
body	O
for	O
emergency	O
.	O
yo	O
yo	O
dieting	O
contributes	O
to	O
the	O
storage	O
of	O
this	O
type	O
of	O
fat	ENTITY
because	ENTITY
the	ENTITY
body	ENTITY
.	O
when	O
calories	O
are	O
restricted	O
the	O
body	O
stores	O
all	O
the	O
fat	ENTITY
.	O
most	O
typical	O
reduced	O
calorie	ENTITY
diets	ENTITY
will	O
not	O
produce	O
the	O
best	O
results	O
for	O
those	O
individuals	O
with	O
an	O
abundance	O
of	O
abnormal	O
fat	ENTITY
stores	ENTITY
because	ENTITY
their	ENTITY
bodies	ENTITY
will	ENTITY
begin	ENTITY
by	ENTITY
burning	ENTITY
the	ENTITY
wrong	ENTITY
kind	ENTITY
of	ENTITY
fat	ENTITY
.	O
when	O
low	O
calorie	ENTITY
diet	ENTITY
is	O
introduced	O
to	O
the	O
system	O
the	O
normal	O
reserves	O
of	O
fat	ENTITY
.	O
as	O
result	O
most	O
people	O
look	O
gaunt	O
and	O
drawn	O
after	O
reduced	O
calorie	ENTITY
diet	ENTITY
.	O
although	O
the	O
normal	O
reserves	O
of	O
fat	ENTITY
have	ENTITY
been	ENTITY
reduced	ENTITY
the	ENTITY
abnormal	ENTITY
fat	ENTITY
.	O
the	O
asap	O
program	O
supports	O
your	O
body	O
function	O
to	O
burn	ENTITY
the	O
abnormal	O
adipose	ENTITY
fat	ENTITY
.	O
supplementation	O
is	O
recommended	O
for	O
optimal	O
nutrition	ENTITY
toxins	ENTITY
are	O
stored	O
in	O
fat	ENTITY
therefore	ENTITY
like	ENTITY
any	ENTITY
weight	ENTITY
management	ENTITY
system	ENTITY
it	ENTITY
is	ENTITY
crucial	ENTITY
to	ENTITY
support	ENTITY
your	ENTITY
liver	ENTITY
and	ENTITY
kidney	ENTITY
.	O
we	O
recommend	O
beyond	O
tangy	O
tangerine	ENTITY
and	ENTITY
osteo	ENTITY
fx	ENTITY
plus	O
to	O
supplement	O
your	O
nutrition	O
.	O
there	O
more	O
.	O
call	O
me	O
if	O
busy	O
so	O
leave	O
message	O
.	O
symptoms	O
risk	O
factors	O
and	O
treatments	ENTITY
of	ENTITY
abnormal	ENTITY
basal	ENTITY
metabolic	ENTITY
rate	ENTITY
medical	ENTITY
condition	O
abnormal	O
basal	ENTITY
metabolic	ENTITY
rate	ENTITY
refers	O
to	O
high	O
or	O
low	O
basal	ENTITY
metabolic	ENTITY
rate	ENTITY
this	O
video	O
contains	O
general	O
medical	O
information	O
if	O
in	O
doubt	O
always	O
seek	O
professional	O
medical	O
advice	O
.	O
the	O
medical	O
information	O
is	O
not	O
advice	O
and	O
should	O
not	O
be	O
treated	O
as	O
such	O
.	O
the	O
medical	O
information	O
is	O
provided	O
without	O
any	O
representations	O
or	O
warranties	O
express	O
or	O
implied	O
.	O
we	O
do	O
not	O
warrant	O
or	O
represent	O
that	O
the	O
medical	O
information	O
on	O
this	O
websiteis	O
true	O
accurate	O
complete	O
current	O
or	O
non	O
misleading	O
music	O
undaunted	O
kevin	O
macleod	O
cc	O
.	O
leptin	ENTITY
and	ENTITY
the	ENTITY
neural	ENTITY
circuit	ENTITY
regulation	ENTITY
food	ENTITY
intake	ENTITY
and	ENTITY
glucose	ENTITY
metabolism	ENTITY
air	O
date	O
wednesday	O
january	O
pm	O
category	O
wals	O
wednesday	O
afternoon	O
lectures	O
runtime	O
description	O
nih	O
director	O
wednesday	O
afternoon	O
lecture	O
series	O
the	O
discovery	O
of	O
leptin	ENTITY
has	ENTITY
led	ENTITY
to	ENTITY
the	ENTITY
elucidation	ENTITY
of	ENTITY
robust	ENTITY
physiologic	ENTITY
system	ENTITY
that	ENTITY
maintains	ENTITY
fat	ENTITY
stores	ENTITY
at	ENTITY
relatively	ENTITY
constant	ENTITY
level	ENTITY
.	O
leptin	ENTITY
is	ENTITY
peptide	ENTITY
hormone	ENTITY
secreted	O
by	O
adipose	ENTITY
tissue	ENTITY
in	O
proportion	O
to	O
its	O
mass	O
.	O
this	O
hormone	ENTITY
circulates	ENTITY
in	ENTITY
blood	ENTITY
and	ENTITY
acts	ENTITY
on	ENTITY
the	ENTITY
hypothalamus	ENTITY
to	ENTITY
regulate	ENTITY
food	ENTITY
intake	ENTITY
and	ENTITY
energy	ENTITY
expenditure	ENTITY
.	O
when	O
fat	ENTITY
mass	ENTITY
falls	ENTITY
plasma	ENTITY
leptin	ENTITY
levels	ENTITY
fall	ENTITY
stimulating	ENTITY
appetite	ENTITY
and	ENTITY
suppressing	ENTITY
energy	ENTITY
expenditure	ENTITY
.	O
when	O
fat	ENTITY
mass	ENTITY
increases	ENTITY
leptin	ENTITY
.	O
by	O
such	O
mechanism	O
total	O
energy	O
stores	O
are	O
stably	O
maintained	O
within	O
relatively	O
narrow	O
range	O
.	O
recessive	O
mutations	O
in	O
the	O
leptin	ENTITY
gene	ENTITY
are	ENTITY
associated	ENTITY
with	ENTITY
massive	ENTITY
obesity	ENTITY
.	O
treatment	O
with	O
recombinant	O
leptin	ENTITY
markedly	ENTITY
reduces	ENTITY
food	ENTITY
intake	ENTITY
.	O
the	O
low	O
leptin	ENTITY
levels	ENTITY
in	ENTITY
patients	ENTITY
with	ENTITY
leptin	ENTITY
mutations	ENTITY
are	ENTITY
also	ENTITY
associated	ENTITY
with	ENTITY
multiple	ENTITY
abnormalities	ENTITY
including	ENTITY
infertility	ENTITY
diabetes	ENTITY
and	O
immune	ENTITY
abnormalities	ENTITY
all	O
of	O
which	O
are	O
corrected	O
by	O
leptin	ENTITY
treatment	ENTITY
.	O
these	O
findings	O
have	O
established	O
important	O
links	O
between	O
energy	O
stores	O
and	O
many	O
other	O
physiologic	ENTITY
systems	ENTITY
and	O
led	O
to	O
the	O
use	O
of	O
leptin	ENTITY
as	ENTITY
treatment	ENTITY
for	ENTITY
an	ENTITY
increasing	ENTITY
number	ENTITY
of	ENTITY
other	ENTITY
human	ENTITY
conditions	ENTITY
including	ENTITY
subset	ENTITY
of	ENTITY
obesity	ENTITY
some	ENTITY
forms	ENTITY
of	ENTITY
diabetes	ENTITY
including	ENTITY
lipodystrophy	ENTITY
and	ENTITY
hypothalamic	ENTITY
amenorrhea	ENTITY
the	O
cessation	ENTITY
of	ENTITY
menstruation	ENTITY
.	O
identification	O
of	O
physiologic	O
system	O
that	O
controls	O
energy	O
balance	O
establishes	O
biologic	O
basis	O
for	O
obesity	ENTITY
.	O
recent	O
studies	O
have	O
explored	O
the	O
relationship	O
between	O
leptin	ENTITY
.	O
in	O
addition	O
new	O
methods	O
for	O
identifying	O
neurons	ENTITY
activated	ENTITY
by	ENTITY
leptin	ENTITY
and	ENTITY
other	ENTITY
stimuli	ENTITY
have	ENTITY
been	ENTITY
developed	ENTITY
as	ENTITY
have	ENTITY
methods	ENTITY
for	ENTITY
noninvasively	ENTITY
activating	ENTITY
cells	ENTITY
.	O
these	O
new	O
approaches	O
are	O
being	O
applied	O
to	O
studies	O
.	O
for	O
more	O
information	O
go	O
to	O
asp	ENTITY
.	O
am	O
now	O
able	O
to	O
offer	O
the	O
same	O
hcg	ENTITY
program	ENTITY
.	O
contact	O
our	O
office	O
at	O
castellowellness	O
gmail	O
com	O
.	O
hcg	ENTITY
stands	ENTITY
for	ENTITY
human	ENTITY
chorionic	ENTITY
gonadotropin	ENTITY
.	O
it	O
is	O
hormone	ENTITY
released	ENTITY
during	ENTITY
pregnancy	ENTITY
.	O
it	O
rises	O
when	O
you	O
become	O
pregnant	O
and	O
is	O
detectable	O
in	O
the	O
blood	ENTITY
and	ENTITY
urine	ENTITY
and	ENTITY
is	ENTITY
the	ENTITY
basis	ENTITY
.	O
when	O
hcg	ENTITY
is	ENTITY
given	ENTITY
to	ENTITY
non	ENTITY
pregnant	ENTITY
people	ENTITY
on	ENTITY
very	ENTITY
low	ENTITY
calorie	ENTITY
diet	ENTITY
it	O
helps	O
them	O
to	O
lose	O
more	O
weight	O
and	O
burn	O
greater	O
percentage	O
of	O
fat	ENTITY
.	O
the	O
body	O
has	O
three	O
types	O
of	O
fat	ENTITY
structural	ENTITY
fat	ENTITY
reserve	ENTITY
fat	ENTITY
and	ENTITY
abnormal	ENTITY
fat	ENTITY
tummy	ENTITY
hips	ENTITY
.	O
hcg	ENTITY
helps	ENTITY
your	ENTITY
body	ENTITY
burn	ENTITY
.	O
since	O
you	O
are	O
getting	O
calories	O
from	O
your	O
stored	O
fat	ENTITY
.	O
and	O
you	O
don	O
feel	O
hungry	O
.	O
if	O
you	O
were	O
to	O
only	O
eat	O
calories	O
day	O
without	O
hcg	ENTITY
you	ENTITY
would	ENTITY
mainly	ENTITY
slow	ENTITY
your	ENTITY
metabolism	ENTITY
begin	ENTITY
to	ENTITY
burn	ENTITY
muscle	ENTITY
and	ENTITY
start	ENTITY
burning	ENTITY
your	ENTITY
reserve	ENTITY
and	ENTITY
structural	ENTITY
fat	ENTITY
not	ENTITY
your	ENTITY
abnormal	ENTITY
fat	ENTITY
.	O
the	O
hcg	ENTITY
diet	ENTITY
involves	O
taking	O
hcg	ENTITY
once	ENTITY
day	ENTITY
preferably	ENTITY
as	ENTITY
an	ENTITY
injection	ENTITY
but	ENTITY
also	ENTITY
available	ENTITY
as	ENTITY
sublingual	ENTITY
under	ENTITY
the	ENTITY
tongue	ENTITY
drops	ENTITY
.	O
you	O
eat	O
very	O
low	O
calorie	ENTITY
diet	ENTITY
.	O
you	O
can	O
have	O
unlimited	O
water	O
.	O
twice	O
day	O
you	O
will	O
eat	O
small	O
meal	O
consisting	O
of	O
ounces	O
of	O
lean	O
protein	O
.	O
you	O
can	O
also	O
spread	O
out	O
the	O
items	O
in	O
each	O
meal	O
.	O
for	O
example	O
fruit	O
for	O
breakfast	O
chicken	O
melba	O
toast	O
and	O
lettuce	O
for	O
lunch	O
fish	O
melba	O
toast	O
and	O
asparagus	O
for	O
dinner	O
and	O
fruit	O
as	O
an	O
after	O
dinner	O
snack	O
.	O
the	O
hcg	ENTITY
helps	ENTITY
to	ENTITY
suppress	ENTITY
hunger	ENTITY
keeps	ENTITY
your	ENTITY
metabolism	ENTITY
up	ENTITY
and	ENTITY
helps	ENTITY
to	ENTITY
burn	ENTITY
abnormal	ENTITY
fat	ENTITY
.	O
you	O
should	O
never	O
do	O
such	O
low	O
calorie	O
diet	O
without	O
medical	O
supervision	O
.	O
the	O
actions	O
and	O
benefits	O
of	O
the	O
hcg	ENTITY
diet	ENTITY
.	O
what	O
can	O
tell	O
you	O
is	O
when	O
patients	O
in	O
my	O
office	O
do	O
the	O
diet	O
with	O
injection	O
.	O
this	O
is	O
substantially	O
more	O
weight	O
loss	O
than	O
would	O
expect	O
with	O
diet	O
.	O
my	O
theory	O
on	O
why	O
hcg	ENTITY
allows	ENTITY
this	ENTITY
success	ENTITY
is	ENTITY
as	ENTITY
follows	ENTITY
.	O
from	O
cave	O
man	O
perspective	O
if	O
you	O
ate	O
calories	O
day	O
that	O
would	O
signal	O
that	O
there	O
was	O
shortage	O
of	O
food	O
and	O
your	O
body	O
.	O
this	O
triggers	O
slow	O
down	O
in	O
metabolism	ENTITY
to	ENTITY
match	ENTITY
food	ENTITY
intake	ENTITY
and	ENTITY
prevent	ENTITY
.	O
the	O
exception	O
would	O
be	O
if	O
you	O
were	O
pregnant	O
you	O
wouldn	O
want	O
to	O
slow	O
your	O
metabolism	ENTITY
and	ENTITY
it	ENTITY
would	ENTITY
be	ENTITY
great	ENTITY
time	ENTITY
to	ENTITY
burn	ENTITY
your	ENTITY
fat	ENTITY
.	O
that	O
would	O
allow	O
you	O
to	O
not	O
only	O
survive	O
the	O
pregnancy	O
.	O
be	O
careful	O
where	O
you	O
get	O
your	O
hcg	ENTITY
.	O
the	O
fda	ENTITY
has	ENTITY
cracked	ENTITY
down	ENTITY
on	ENTITY
on	ENTITY
line	ENTITY
.	O
most	O
online	O
hcg	ENTITY
comes	ENTITY
from	ENTITY
the	ENTITY
urine	ENTITY
of	ENTITY
pregnant	ENTITY
women	ENTITY
in	ENTITY
countries	ENTITY
like	ENTITY
india	ENTITY
.	O
injections	O
.	O
pharmaceutical	O
grade	O
hcg	ENTITY
comes	ENTITY
from	ENTITY
synthetic	ENTITY
origin	ENTITY
not	ENTITY
pregnant	ENTITY
women	ENTITY
and	ENTITY
is	ENTITY
manufactured	ENTITY
in	ENTITY
the	ENTITY
usa	ENTITY
by	ENTITY
licensed	ENTITY
manufacturers	ENTITY
and	ENTITY
is	ENTITY
certified	ENTITY
for	ENTITY
purity	ENTITY
and	ENTITY
potency	ENTITY
.	O
the	O
way	O
how	O
you	O
can	O
avoid	O
overweight	O
and	O
lose	O
fat	ENTITY
overweight	ENTITY
and	ENTITY
obesity	ENTITY
affect	ENTITY
americans	ENTITY
of	ENTITY
all	ENTITY
ages	ENTITY
sexes	ENTITY
.	O
this	O
serious	O
health	O
problem	O
has	O
been	O
growing	O
over	O
the	O
last	O
years	O
.	O
according	O
to	O
the	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
nhanes	O
almost	O
percent	O
of	O
americans	O
are	O
overweight	O
or	O
obese	ENTITY
.	O
this	O
leads	O
to	O
following	O
health	O
problems	O
coronary	ENTITY
heart	ENTITY
disease	ENTITY
high	ENTITY
blood	ENTITY
pressure	ENTITY
stroke	ENTITY
type	ENTITY
diabetes	ENTITY
abnormal	ENTITY
blood	ENTITY
fats	ENTITY
metabolic	ENTITY
syndrome	ENTITY
cancer	ENTITY
osteoarthritis	ENTITY
sleep	ENTITY
apnea	ENTITY
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
reproductive	ENTITY
problems	ENTITY
gallstones	ENTITY
overweight	ENTITY
and	ENTITY
obesity	ENTITY
.	O
those	O
diseases	O
.	O
simply	O
in	O
losing	O
weight	O
and	O
burn	O
fat	ENTITY
.	O
with	O
the	O
fat	ENTITY
loss	ENTITY
system	ENTITY
you	ENTITY
get	ENTITY
cutting	ENTITY
edge	ENTITY
rapid	ENTITY
fat	ENTITY
loss	ENTITY
program	ENTITY
that	ENTITY
combines	ENTITY
the	ENTITY
hormone	ENTITY
regulating	ENTITY
power	ENTITY
of	ENTITY
nutrient	ENTITY
combining	ENTITY
carb	ENTITY
syncing	ENTITY
and	ENTITY
strategic	ENTITY
overfeeding	ENTITY
with	ENTITY
the	ENTITY
metabolism	ENTITY
boosting	ENTITY
power	ENTITY
of	ENTITY
brand	ENTITY
new	ENTITY
fat	ENTITY
incinerating	ENTITY
metabolic	ENTITY
resistance	ENTITY
training	O
workouts	O
into	O
strategic	O
week	O
fat	ENTITY
annihilating	ENTITY
system	ENTITY
that	O
literally	O
programs	O
your	O
body	O
to	O
burn	O
fat	ENTITY
around	ENTITY
the	ENTITY
clock	ENTITY
learn	ENTITY
more	ENTITY
here	ENTITY
www	ENTITY
make	ENTITY
my	ENTITY
giw	ENTITY
rud	ENTITY
and	ENTITY
start	ENTITY
to	ENTITY
lose	ENTITY
fat	ENTITY
.	O
learn	O
about	O
the	O
best	O
ways	O
to	O
burn	O
fat	ENTITY
.	O
if	O
you	O
re	O
interested	O
in	O
finding	O
out	O
how	O
to	O
lose	O
belly	O
fat	ENTITY
.	O
you	O
ll	O
learn	O
about	O
how	O
to	O
lose	O
weight	O
with	O
these	O
exercise	O
and	O
diet	O
.	O
free	O
week	O
challenge	O
most	O
people	O
associate	O
fat	ENTITY
loss	ENTITY
with	ENTITY
long	ENTITY
grinding	ENTITY
.	O
and	O
even	O
though	O
fat	ENTITY
loss	ENTITY
does	ENTITY
require	ENTITY
work	ENTITY
and	ENTITY
effort	ENTITY
in	ENTITY
today	ENTITY
video	ENTITY
id	ENTITY
like	ENTITY
to	ENTITY
go	ENTITY
over	ENTITY
the	ENTITY
best	ENTITY
ways	ENTITY
to	ENTITY
burn	ENTITY
fat	ENTITY
.	O
when	O
it	O
comes	O
to	O
losing	O
weight	O
and	O
burning	O
fat	ENTITY
adjusting	ENTITY
your	ENTITY
diet	ENTITY
is	ENTITY
gonna	ENTITY
be	ENTITY
the	ENTITY
number	ENTITY
one	ENTITY
thing	ENTITY
you	ENTITY
can	ENTITY
do	ENTITY
to	ENTITY
notice	ENTITY
the	ENTITY
most	ENTITY
results	ENTITY
so	ENTITY
in	ENTITY
this	ENTITY
video	ENTITY
will	ENTITY
be	ENTITY
going	ENTITY
over	ENTITY
ways	ENTITY
you	ENTITY
can	ENTITY
burn	ENTITY
fat	ENTITY
faster	ENTITY
with	ENTITY
both	ENTITY
your	ENTITY
diet	ENTITY
and	ENTITY
your	ENTITY
workout	ENTITY
plan	ENTITY
.	O
lets	O
start	O
with	O
the	O
very	O
first	O
method	O
.	O
hirt	O
stands	O
for	O
high	O
intensity	O
resistance	O
training	O
which	O
is	O
little	O
different	O
from	O
hiit	O
which	O
stands	O
for	O
high	O
intensity	O
interval	O
training	O
im	O
sure	O
you	O
guys	O
have	O
heard	O
of	O
hiit	O
but	O
im	O
not	O
so	O
sure	O
you	O
ve	O
heard	O
.	O
both	O
are	O
very	O
similar	O
but	O
while	O
hiit	O
is	O
much	O
more	O
centered	O
around	O
cardiovascular	ENTITY
movements	ENTITY
hirt	ENTITY
is	ENTITY
essentially	ENTITY
strength	ENTITY
training	ENTITY
for	ENTITY
fat	ENTITY
loss	ENTITY
.	O
during	O
hirt	O
workout	O
you	O
ll	O
perform	O
series	O
of	O
strength	O
training	O
.	O
this	O
causes	O
your	O
heart	ENTITY
rate	ENTITY
to	O
stay	O
elevated	O
and	O
your	O
muscles	ENTITY
will	ENTITY
be	ENTITY
given	ENTITY
very	ENTITY
little	ENTITY
time	ENTITY
to	ENTITY
recover	ENTITY
.	O
the	O
really	O
awesome	O
thing	O
about	O
this	O
type	O
of	O
workout	O
is	O
that	O
you	O
can	O
build	O
muscle	O
increase	O
endurance	O
and	O
burn	O
.	O
since	O
your	O
break	O
time	O
is	O
gonna	O
be	O
short	O
like	O
to	O
seconds	O
you	O
don	O
.	O
stick	O
to	O
moderate	O
weight	O
load	O
and	O
mix	O
together	O
to	O
five	O
of	O
your	O
weight	O
training	O
exercises	O
back	O
.	O
at	O
the	O
end	O
of	O
that	O
circuit	O
take	O
to	O
second	O
break	O
and	O
then	O
repeat	O
.	O
sample	O
upper	O
body	O
.	O
you	O
would	O
do	O
each	O
of	O
these	O
exercises	O
for	O
reps	ENTITY
and	ENTITY
then	ENTITY
repeat	ENTITY
this	ENTITY
series	ENTITY
of	ENTITY
exercises	ENTITY
.	O
after	O
completing	O
the	O
sets	O
you	O
would	O
want	O
to	O
move	O
on	O
to	O
another	O
series	O
of	O
exercises	O
.	O
the	O
second	O
thing	O
you	O
can	O
do	O
to	O
burn	O
fat	ENTITY
faster	ENTITY
is	ENTITY
an	ENTITY
aggressive	ENTITY
fat	ENTITY
loss	ENTITY
diet	ENTITY
.	O
most	O
diet	O
plans	O
.	O
and	O
most	O
people	O
are	O
still	O
under	O
the	O
impression	O
that	O
any	O
diet	O
plan	O
.	O
well	O
can	O
tell	O
you	O
for	O
fact	O
that	O
this	O
is	O
untrue	O
.	O
many	O
people	O
start	O
diet	O
plan	O
and	O
they	O
have	O
lot	O
of	O
weight	O
to	O
lose	O
so	O
they	O
do	O
the	O
traditional	O
cut	O
.	O
now	O
that	O
considering	O
that	O
everything	O
went	O
right	O
over	O
the	O
course	O
of	O
the	O
eight	O
weeks	O
but	O
even	O
in	O
this	O
situation	O
you	O
can	O
see	O
.	O
so	O
demotivator	O
that	O
they	O
might	O
get	O
on	O
the	O
scale	O
.	O
so	O
for	O
people	O
that	O
do	O
have	O
lot	O
of	O
weight	O
to	O
lose	O
highly	O
recommend	O
you	O
go	O
for	O
more	O
aggressive	O
fat	ENTITY
loss	ENTITY
plan	ENTITY
.	O
you	O
would	O
set	O
up	O
more	O
aggressive	O
fat	ENTITY
loss	ENTITY
plan	ENTITY
.	O
the	O
reason	O
why	O
say	O
set	O
period	O
of	O
time	O
is	O
because	O
forty	O
to	O
percent	O
reduction	O
.	O
you	O
want	O
to	O
have	O
long	O
term	O
diet	O
plan	O
set	O
up	O
so	O
you	O
can	O
transition	O
into	O
that	O
after	O
doing	O
this	O
more	O
aggressive	O
fat	ENTITY
loss	ENTITY
plan	ENTITY
.	O
and	O
just	O
note	O
here	O
on	O
this	O
topic	O
you	O
want	O
to	O
be	O
smart	O
about	O
doing	O
an	O
aggressive	O
diet	O
plan	O
.	O
binge	O
eating	O
is	O
more	O
likely	O
to	O
happen	O
when	O
you	O
re	O
really	O
hungry	O
.	O
so	O
when	O
you	O
start	O
feeling	O
hungry	O
or	O
deprived	O
or	O
tired	O
just	O
throw	O
in	O
day	O
of	O
more	O
regular	O
reduction	O
.	O
this	O
will	O
help	O
you	O
reset	O
so	O
you	O
can	O
go	O
back	O
to	O
bigger	O
deficit	O
.	O
the	O
next	O
thing	O
you	O
can	O
do	O
to	O
burn	O
MT>fat	ENTITY
faster	O
is	O
peripheral	ENTITY
heart	ENTITY
action	ENTITY
training	ENTITY
also	O
known	O
as	O
pha	ENTITY
.	O
pha	ENTITY
is	ENTITY
kind	ENTITY
of	ENTITY
similar	ENTITY
to	ENTITY
hirt	ENTITY
and	ENTITY
hiit	ENTITY
type	ENTITY
training	ENTITY
because	ENTITY
you	ENTITY
re	ENTITY
going	ENTITY
to	ENTITY
be	ENTITY
doing	ENTITY
circuits	ENTITY
that	ENTITY
involve	ENTITY
multiple	ENTITY
exercises	ENTITY
being	ENTITY
done	ENTITY
back	ENTITY
.	O
however	O
the	O
major	O
difference	O
is	O
that	O
you	O
re	O
going	O
to	O
alternate	O
between	O
upper	O
and	O
lower	O
body	O
movements	O
.	O
now	O
this	O
might	O
not	O
sound	O
like	O
big	O
change	O
but	O
if	O
you	O
try	O
it	O
you	O
ll	O
notice	O
yourself	O
breathingreally	O
heavy	O
as	O
soon	O
as	O
you	O
get	O
to	O
your	O
second	O
exercise	O
.	O
the	O
reason	O
why	O
it	O
works	O
like	O
this	O
is	O
because	O
whenever	O
you	O
work	O
muscle	O
or	O
group	ENTITY
of	ENTITY
muscles	ENTITY
your	O
heart	ENTITY
pumps	ENTITY
.	O
metabolic	ENTITY
syndrome	ENTITY
is	O
probably	O
the	O
most	O
serious	O
medical	O
condition	O
that	O
you	O
haven	O
heard	O
.	O
so	O
what	O
is	O
metabolic	ENTITY
syndrome	ENTITY
why	O
is	O
it	O
so	O
serious	O
and	O
why	O
haven	O
you	O
heard	O
.	O
here	O
is	O
what	O
you	O
need	O
to	O
know	O
.	O
the	O
metabolic	ENTITY
syndrome	ENTITY
is	O
cluster	O
of	O
the	O
most	O
dangerous	O
heart	ENTITY
attack	ENTITY
risk	O
factors	O
raised	ENTITY
blood	ENTITY
glucose	ENTITY
central	ENTITY
adiposity	ENTITY
often	O
called	O
beer	O
belly	O
abnormal	O
cholesterol	ENTITY
levels	ENTITY
abnormal	O
blood	ENTITY
fats	ENTITY
also	O
called	O
triglycerides	ENTITY
and	ENTITY
high	ENTITY
blood	ENTITY
pressure	ENTITY
.	O
it	O
is	O
estimated	O
that	O
in	O
adults	O
have	O
metabolic	ENTITY
syndrome	ENTITY
and	O
the	O
condition	O
becomes	O
more	O
common	O
as	O
we	O
get	O
older	O
so	O
that	O
by	O
the	O
age	O
of	O
nearly	O
third	O
of	O
adults	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
so	O
why	O
is	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
if	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
you	O
are	O
much	O
more	O
likely	O
to	O
suffer	O
heart	ENTITY
attack	ENTITY
or	O
stroke	O
more	O
likely	O
to	O
develop	O
full	O
blown	O
diabetes	ENTITY
more	ENTITY
likely	ENTITY
to	ENTITY
develop	ENTITY
cancer	ENTITY
and	ENTITY
more	ENTITY
likely	ENTITY
to	ENTITY
develop	ENTITY
alzheimer	ENTITY
disease	ENTITY
.	O
all	O
of	O
these	O
conditions	O
.	O
dementia	ENTITY
and	ENTITY
alzheimer	ENTITY
disease	ENTITY
have	O
overtaken	O
cancer	O
and	O
heart	ENTITY
disease	ENTITY
as	O
the	O
leading	O
cause	O
of	O
death	O
in	O
england	O
and	O
wales	O
in	O
and	O
the	O
metabolic	ENTITY
syndrome	ENTITY
and	O
diabetes	ENTITY
.	O
so	O
how	O
can	O
you	O
check	O
to	O
see	O
if	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
first	O
of	O
all	O
get	O
out	O
tape	O
measure	O
.	O
if	O
you	O
are	O
man	O
and	O
your	O
waist	O
circumference	O
is	O
more	O
than	O
cm	O
or	O
if	O
you	O
are	O
woman	O
and	O
your	O
waist	O
is	O
more	O
than	O
cm	O
you	O
have	O
one	O
of	O
the	O
main	O
features	O
of	O
metabolic	ENTITY
syndrome	ENTITY
.	O
if	O
in	O
addition	O
you	O
have	O
any	O
of	O
the	O
following	O
you	O
will	O
be	O
classified	O
as	O
having	O
metabolic	ENTITY
syndrome	ENTITY
raised	ENTITY
blood	ENTITY
triglycerides	ENTITY
reduced	ENTITY
hdl	ENTITY
cholesterol	ENTITY
sometimes	O
known	O
as	O
good	O
cholesterol	ENTITY
raised	ENTITY
blood	ENTITY
pressure	ENTITY
or	O
raised	ENTITY
fasting	ENTITY
plasma	ENTITY
glucose	ENTITY
.	O
note	O
if	O
you	O
are	O
man	O
of	O
south	O
asian	O
or	O
indian	O
heritage	O
the	O
important	O
threshold	O
for	O
waist	O
circumference	O
is	O
cm	O
.	O
metabolic	ENTITY
syndrome	ENTITY
has	O
not	O
yet	O
been	O
classified	O
as	O
disease	ENTITY
it	ENTITY
is	ENTITY
still	ENTITY
regarded	ENTITY
as	ENTITY
collection	ENTITY
of	ENTITY
signs	ENTITY
and	ENTITY
symptoms	ENTITY
which	ENTITY
together	ENTITY
are	ENTITY
serious	ENTITY
risk	ENTITY
factors	ENTITY
for	ENTITY
our	ENTITY
most	ENTITY
deadly	ENTITY
and	ENTITY
disabling	ENTITY
medical	ENTITY
conditions	ENTITY
.	O
several	O
medical	O
organisations	O
such	O
as	O
the	O
world	O
health	O
organisation	O
who	O
the	O
independent	O
diabetes	ENTITY
federation	ENTITY
idf	ENTITY
and	ENTITY
the	ENTITY
european	ENTITY
group	ENTITY
for	ENTITY
the	ENTITY
study	ENTITY
of	ENTITY
insulin	ENTITY
resistance	ENTITY
egir	O
define	O
the	O
metabolic	ENTITY
syndrome	ENTITY
in	O
very	O
slightly	O
different	O
ways	O
and	O
this	O
adds	O
even	O
more	O
to	O
the	O
confusion	O
about	O
what	O
exactly	O
metabolic	ENTITY
syndrome	ENTITY
.	O
however	O
many	O
experts	O
now	O
believe	O
that	O
the	O
underlying	O
problem	O
in	O
metabolic	ENTITY
syndrome	ENTITY
is	O
insulin	ENTITY
resistance	ENTITY
.	O
insulin	ENTITY
resistance	ENTITY
develops	O
when	O
this	O
hormone	ENTITY
cannot	ENTITY
work	ENTITY
properly	ENTITY
when	ENTITY
blood	ENTITY
insulin	ENTITY
levels	ENTITY
are	O
abnormally	O
high	O
and	O
still	O
relatively	O
ineffective	O
in	O
keeping	O
blood	ENTITY
glucose	ENTITY
levels	ENTITY
.	O
metabolic	O
specialists	O
now	O
use	O
the	O
term	O
insulin	ENTITY
resistance	ENTITY
syndrome	ENTITY
.	O
insulin	ENTITY
is	ENTITY
hormone	ENTITY
produced	ENTITY
by	ENTITY
the	ENTITY
pancreas	ENTITY
and	ENTITY
it	ENTITY
is	ENTITY
important	ENTITY
in	ENTITY
the	ENTITY
metabolism	ENTITY
of	ENTITY
carbohydrates	ENTITY
and	ENTITY
fats	ENTITY
.	O
when	O
sugar	O
and	O
carbohydrates	ENTITY
are	ENTITY
eaten	ENTITY
insulin	ENTITY
promotes	ENTITY
the	ENTITY
uptake	ENTITY
of	ENTITY
glucose	ENTITY
from	ENTITY
the	ENTITY
blood	ENTITY
into	ENTITY
muscles	ENTITY
and	ENTITY
fat	ENTITY
cells	ENTITY
.	O
hence	O
it	O
is	O
often	O
said	O
that	O
insulin	ENTITY
allows	ENTITY
cells	ENTITY
to	ENTITY
use	ENTITY
glucose	ENTITY
for	ENTITY
energy	ENTITY
and	ENTITY
also	ENTITY
to	ENTITY
store	ENTITY
excess	ENTITY
glucose	ENTITY
and	ENTITY
sugar	ENTITY
as	ENTITY
glycogen	ENTITY
and	ENTITY
fat	ENTITY
.	O
when	O
blood	ENTITY
glucose	ENTITY
levels	ENTITY
fall	O
stored	O
glucose	ENTITY
is	ENTITY
released	ENTITY
for	ENTITY
energy	ENTITY
from	ENTITY
the	ENTITY
breakdown	ENTITY
of	ENTITY
glycogen	ENTITY
stores	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
and	ENTITY
in	ENTITY
the	ENTITY
muscles	ENTITY
.	O
in	O
the	O
metabolic	ENTITY
syndrome	ENTITY
.	O
fasting	O
blood	ENTITY
levels	ENTITY
of	ENTITY
insulin	ENTITY
in	O
the	O
morning	O
are	O
often	O
abnormally	O
high	O
and	O
insulin	ENTITY
levels	ENTITY
rise	O
to	O
very	O
high	O
levels	O
when	O
food	O
is	O
eaten	O
.	O
continuously	O
high	O
levels	ENTITY
of	ENTITY
insulin	ENTITY
cause	O
the	O
liver	ENTITY
cells	ENTITY
to	O
store	O
fat	ENTITY
resulting	ENTITY
in	ENTITY
fatty	ENTITY
liver	ENTITY
which	O
cannot	O
function	O
.	O
as	O
the	O
insulin	ENTITY
resistance	ENTITY
worsens	O
the	O
pancreas	ENTITY
may	ENTITY
not	ENTITY
be	ENTITY
able	ENTITY
to	ENTITY
produce	ENTITY
enough	ENTITY
insulin	ENTITY
in	ENTITY
response	ENTITY
to	ENTITY
food	ENTITY
and	ENTITY
then	ENTITY
glucose	ENTITY
levels	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
.	O
so	O
why	O
haven	O
you	O
heard	O
.	O
well	O
until	O
quite	O
recently	O
the	O
connection	O
between	O
metabolic	ENTITY
syndrome	ENTITY
and	O
host	O
of	O
chronic	ENTITY
diseases	ENTITY
.	O
we	O
now	O
know	O
that	O
insulin	ENTITY
resistance	ENTITY
.	O
until	O
recently	O
it	O
was	O
difficult	O
to	O
measure	O
blood	ENTITY
insulin	ENTITY
levels	ENTITY
but	O
the	O
technology	O
has	O
improved	O
and	O
we	O
can	O
now	O
measure	O
blood	ENTITY
insulin	ENTITY
levels	ENTITY
accurately	O
and	O
we	O
have	O
good	O
tests	O
to	O
diagnose	O
insulin	ENTITY
resistance	ENTITY
as	O
well	O
as	O
good	O
strategies	O
to	O
reverse	O
insulin	ENTITY
resistance	ENTITY
and	O
the	O
metabolic	ENTITY
syndrome	ENTITY
.	O
once	O
you	O
can	O
measure	O
insulin	ENTITY
resistance	ENTITY
you	O
are	O
well	O
on	O
your	O
way	O
to	O
fixing	O
.	O
subscribe	O
to	O
my	O
life	O
design	O
channel	O
.	O
find	O
apparel	O
customized	O
training	O
full	O
circuit	O
below	O
.	O
three	O
to	O
five	O
total	O
rounds	O
.	O
after	O
each	O
round	O
take	O
minutes	O
of	O
rest	O
.	O
each	O
station	O
will	O
be	O
seconds	O
non	O
stop	O
of	O
workout	O
.	O
station	O
run	O
in	O
place	O
station	O
push	O
ups	O
station	O
lunges	O
station	O
burpees	O
station	O
frog	O
jumps	O
station	O
ups	O
station	O
planks	O
.	O
this	O
video	O
is	O
all	O
about	O
my	O
weightloss	O
story	O
while	O
on	O
the	O
hcg	ENTITY
diet	ENTITY
.	O
beginning	O
weight	O
pounds	O
end	O
weight	O
pounds	O
what	O
is	O
the	O
hcg	ENTITY
diet	ENTITY
.	O
the	O
hcg	ENTITY
diet	ENTITY
is	O
combination	O
of	O
an	O
oral	O
supplement	O
that	O
helps	O
speed	O
up	O
your	O
metabolism	ENTITY
to	ENTITY
burn	ENTITY
abnormal	ENTITY
fat	ENTITY
in	ENTITY
your	ENTITY
body	ENTITY
your	ENTITY
body	ENTITY
can	ENTITY
burn	ENTITY
.	O
the	O
hcg	ENTITY
drops	ENTITY
are	ENTITY
to	ENTITY
be	ENTITY
taken	ENTITY
with	ENTITY
clean	ENTITY
calorie	ENTITY
diet	ENTITY
.	O
the	O
combination	O
helps	O
you	O
lose	O
pounds	O
day	O
.	O
purchase	O
your	O
hcg	O
diet	O
www	O
sensationalbodies	O
com	O
instagram	O
sensationalbodies	O
email	O
sensationalbodies	O
gmail	O
com	O
.	O
eating	O
these	O
foods	O
makes	O
you	O
burn	O
fat	ENTITY
.	O
sometimes	O
the	O
fight	O
gets	O
to	O
be	O
downright	O
discouraging	O
as	O
you	O
count	O
your	O
calories	O
and	O
exercise	O
but	O
you	O
still	O
see	O
the	O
scale	O
.	O
with	O
little	O
bit	O
of	O
information	O
you	O
can	O
actually	O
make	O
the	O
food	O
you	O
eat	O
.	O
knowing	O
which	O
foods	O
help	O
you	O
burn	O
calories	O
or	O
make	O
you	O
feel	O
satisfied	O
so	O
you	O
ll	O
eat	O
less	O
may	O
be	O
all	O
it	O
takes	O
to	O
turn	O
the	O
tide	O
in	O
your	O
favor	O
listed	O
below	O
are	O
foods	O
that	O
can	O
help	O
you	O
burn	O
away	O
the	O
belly	O
bulge	O
simply	O
by	O
eating	O
them	O
muscle	O
building	O
foods	O
proteins	O
are	O
an	O
excellent	O
way	O
to	O
help	O
build	O
and	O
maintain	O
body	O
.	O
they	O
are	O
also	O
harder	O
for	O
the	O
body	O
to	O
break	O
down	O
which	O
means	O
they	O
burn	O
.	O
all	O
nuts	O
are	O
excellent	O
sources	O
of	O
protein	O
.	O
an	O
added	O
benefit	O
to	O
nuts	O
is	O
that	O
they	O
help	O
you	O
feel	O
full	O
faster	O
grass	O
fed	O
.	O
unfortunately	O
beef	O
has	O
gotten	O
bad	O
rap	O
today	O
.	O
dr	O
axe	O
recommends	O
grass	O
fed	O
beef	O
as	O
an	O
excellent	O
source	O
of	O
protein	O
and	O
healthy	O
fats	ENTITY
which	ENTITY
can	ENTITY
help	ENTITY
build	ENTITY
muscle	ENTITY
and	ENTITY
burn	ENTITY
calories	ENTITY
in	ENTITY
the	ENTITY
process	ENTITY
.	O
as	O
easy	O
sources	O
of	O
protein	O
.	O
women	O
health	O
shares	O
that	O
they	O
also	O
help	O
build	O
healthybones	O
chicken	O
.	O
besides	O
being	O
great	O
source	O
of	O
protein	O
dr	O
axe	O
shares	O
that	O
chicken	O
has	O
the	O
added	O
benefit	O
of	O
satisfying	O
food	O
cravings	O
causing	O
you	O
to	O
stop	O
eating	O
.	O
according	O
to	O
women	O
health	O
peanut	O
butter	O
is	O
an	O
excellent	O
source	O
of	O
testosterone	ENTITY
an	ENTITY
essential	ENTITY
component	ENTITY
in	ENTITY
maintaining	ENTITY
muscle	ENTITY
.	O
it	O
also	O
helps	O
with	O
burning	O
fat	ENTITY
as	ENTITY
it	ENTITY
builds	ENTITY
muscle	ENTITY
satiating	ENTITY
foods	ENTITY
eating	ENTITY
fruits	ENTITY
and	ENTITY
vegetables	ENTITY
is	ENTITY
great	ENTITY
but	ENTITY
often	ENTITY
leaves	ENTITY
you	ENTITY
hungry	ENTITY
.	O
knowing	O
what	O
foods	O
help	O
satisfy	O
hunger	O
or	O
make	O
you	O
feel	O
full	O
faster	O
can	O
help	O
curb	O
your	O
appetite	O
apple	O
cider	O
vinegar	O
.	O
according	O
to	O
dr	O
axe	O
taking	O
one	O
to	O
two	O
tablespoons	O
of	O
vinegar	O
before	O
your	O
meal	O
can	O
help	O
curb	O
your	O
sugar	O
.	O
besides	O
being	O
an	O
excellent	O
source	O
of	O
protein	O
webmd	O
points	O
out	O
that	O
greek	O
yogurt	O
is	O
extra	O
filling	O
keeping	O
you	O
from	O
eating	O
as	O
much	O
food	O
cinnamon	O
.	O
cinnamon	O
has	O
many	O
health	O
benefits	O
but	O
big	O
one	O
is	O
curbing	O
the	O
appetite	O
.	O
webmd	O
recommends	O
putting	O
it	O
in	O
your	O
morning	O
coffee	O
or	O
tea	O
metabolism	ENTITY
boosting	ENTITY
foods	ENTITY
speeding	ENTITY
up	ENTITY
your	ENTITY
metabolism	ENTITY
is	ENTITY
great	ENTITY
way	ENTITY
to	ENTITY
burn	ENTITY
.	O
some	O
foods	O
will	O
actually	O
speed	O
your	O
metabolism	ENTITY
.	O
hot	O
and	O
spicy	O
foods	O
are	O
great	O
metabolism	ENTITY
boosters	ENTITY
.	O
any	O
hot	O
pepper	O
will	O
do	O
the	O
job	O
according	O
to	O
webmd	O
and	O
it	O
will	O
add	O
burst	O
of	O
flavor	O
at	O
the	O
same	O
time	O
grapefruit	O
.	O
on	O
the	O
opposite	O
end	O
of	O
the	O
spectrum	O
from	O
hot	O
peppers	O
is	O
grapefruit	O
.	O
according	O
to	O
dr	O
axe	O
it	O
contains	O
enzymes	ENTITY
that	ENTITY
help	ENTITY
break	ENTITY
down	ENTITY
sugar	ENTITY
and	ENTITY
boost	ENTITY
your	ENTITY
metabolism	ENTITY
.	O
no	O
longer	O
do	O
you	O
have	O
to	O
rely	O
on	O
simply	O
counting	O
calories	O
and	O
working	O
out	O
at	O
the	O
gym	O
.	O
you	O
can	O
make	O
your	O
food	O
work	O
for	O
you	O
.	O
by	O
being	O
wise	O
with	O
what	O
you	O
eat	O
.	O
for	O
those	O
unfamiliar	O
ketogenic	ENTITY
dieting	ENTITY
is	O
any	O
diet	O
plan	O
low	O
carb	O
enough	O
to	O
switch	O
your	O
body	O
into	O
state	O
of	O
producing	O
and	O
burning	O
significant	O
amount	O
of	O
ketones	ENTITY
specifically	ENTITY
acetoacetate	ENTITY
acac	ENTITY
and	O
its	O
derivatives	O
beta	ENTITY
hydroxybutyrate	ENTITY
bhb	ENTITY
and	ENTITY
acetone	ENTITY
.	O
for	O
those	O
interested	O
in	O
background	O
reading	O
ve	O
previously	O
written	O
summary	O
articles	O
about	O
the	O
science	O
of	O
fat	O
metabolism	ENTITY
and	ENTITY
ketosis	ENTITY
.	O
these	O
molecules	ENTITY
especially	ENTITY
acac	ENTITY
and	ENTITY
bhb	ENTITY
are	O
used	O
by	O
the	O
brain	ENTITY
.	O
while	O
the	O
biological	O
processes	O
involved	O
are	O
extremely	O
complex	O
invite	O
you	O
to	O
use	O
this	O
as	O
the	O
beginning	O
of	O
an	O
important	O
conversation	O
for	O
you	O
and	O
your	O
doctor	O
to	O
explore	O
together	O
.	O
indeed	O
ketogenic	ENTITY
dieting	ENTITY
may	O
or	O
may	O
not	O
be	O
appropriate	O
for	O
you	O
so	O
please	O
consult	O
with	O
your	O
doctor	O
before	O
experimenting	O
on	O
yourself	O
.	O
focusing	O
the	O
brain	ENTITY
increased	ENTITY
memory	ENTITY
cognition	ENTITY
clarity	ENTITY
and	ENTITY
seizure	ENTITY
control	ENTITY
less	ENTITY
migraines	ENTITY
ketogenic	ENTITY
diets	ENTITY
were	O
notably	O
first	O
used	O
at	O
the	O
mayo	O
clinic	O
in	O
the	O
to	O
treat	O
.	O
while	O
the	O
exact	O
mechanism	O
of	O
seizure	O
prevention	O
on	O
ketogenic	ENTITY
diet	ENTITY
is	O
still	O
mystery	O
researchers	O
believe	O
it	O
has	O
something	O
to	O
do	O
with	O
the	O
increased	O
stability	O
of	O
neurons	ENTITY
and	ENTITY
up	ENTITY
regulation	ENTITY
of	ENTITY
brain	ENTITY
mitochondria	ENTITY
and	ENTITY
mitochondrial	ENTITY
enzymes	ENTITY
.	O
related	O
to	O
this	O
research	O
some	O
serious	O
attention	O
has	O
been	O
given	O
to	O
ketogenic	ENTITY
dieting	ENTITY
and	O
alzheimers	ENTITY
disease	ENTITY
.	O
scientists	O
have	O
discovered	O
increased	O
cognition	O
and	O
enhanced	O
memory	O
in	O
adults	O
with	O
impairments	O
in	O
these	O
areas	O
and	O
growing	O
body	O
of	O
research	O
shows	O
improvement	O
at	O
all	O
stages	O
of	O
dementia	ENTITY
.	O
ketosis	ENTITY
has	ENTITY
been	ENTITY
shown	ENTITY
to	ENTITY
be	ENTITY
effective	ENTITY
against	ENTITY
parkinson	ENTITY
disease	ENTITY
.	O
for	O
broader	O
audience	O
of	O
dieters	O
the	O
often	O
reported	O
side	O
effects	O
of	O
increased	O
mental	O
clarity	O
and	O
focus	O
and	O
less	O
frequent	O
and	O
less	O
intense	O
migraines	ENTITY
are	ENTITY
likely	ENTITY
related	ENTITY
to	ENTITY
the	ENTITY
more	ENTITY
stable	ENTITY
blood	ENTITY
sugar	ENTITY
and	O
altered	O
brain	ENTITY
chemistry	ENTITY
.	O
fighting	O
some	O
types	O
of	O
cancer	O
dom	O
agostino	O
lab	O
published	O
an	O
article	O
in	O
entitled	O
ketone	ENTITY
supplementation	ENTITY
decreases	ENTITY
tumor	ENTITY
cell	ENTITY
viability	O
and	O
prolongs	O
survival	O
of	O
mice	O
with	O
metastatic	ENTITY
cells	ENTITY
express	O
an	O
abnormal	O
metabolism	ENTITY
characterized	ENTITY
by	ENTITY
increased	ENTITY
glucose	ENTITY
consumption	ENTITY
.	O
previous	O
studies	O
indicate	O
that	O
unlike	O
healthy	O
tissues	ENTITY
cancer	ENTITY
cells	ENTITY
are	O
unable	O
to	O
effectively	O
use	O
ketone	ENTITY
bodies	ENTITY
.	O
furthermore	O
ketones	ENTITY
inhibit	ENTITY
the	ENTITY
proliferation	ENTITY
and	ENTITY
viability	ENTITY
of	ENTITY
cultured	ENTITY
tumor	ENTITY
cells	ENTITY
.	O
preventing	O
heart	ENTITY
disease	ENTITY
lower	O
blood	ENTITY
pressure	ENTITY
lower	O
triglycerides	ENTITY
better	ENTITY
cholesterol	ENTITY
profiles	ENTITY
again	ENTITY
related	ENTITY
to	ENTITY
the	ENTITY
downstream	ENTITY
effects	ENTITY
of	ENTITY
keeping	ENTITY
blood	ENTITY
glucose	ENTITY
low	O
and	O
stable	O
ketogenic	ENTITY
dieting	ENTITY
helps	O
keep	O
blood	ENTITY
pressure	ENTITY
in	O
check	O
and	O
lowers	O
triglyceride	ENTITY
levels	ENTITY
.	O
while	O
it	O
may	O
seem	O
counterintuitive	O
that	O
eating	O
higher	O
percentage	O
of	O
fat	ENTITY
in	ENTITY
your	ENTITY
diet	ENTITY
lowers	ENTITY
triglycerides	ENTITY
it	O
turns	O
out	O
that	O
the	O
consumption	O
of	O
excess	O
carbs	O
especially	O
fructose	ENTITY
is	ENTITY
the	ENTITY
key	ENTITY
driver	ENTITY
of	ENTITY
increasing	ENTITY
triglycerides	ENTITY
.	O
and	O
regarding	O
hdl	ENTITY
and	ENTITY
ldl	ENTITY
particles	ENTITY
which	O
the	O
body	O
uses	O
to	O
move	O
fat	ENTITY
and	ENTITY
cholesterol	ENTITY
around	ENTITY
ketogenic	ENTITY
dieting	ENTITY
helps	O
raise	O
hdl	ENTITY
good	ENTITY
cholesterol	ENTITY
and	O
improve	O
the	O
profile	O
of	O
ldl	ENTITY
bad	ENTITY
cholesterol	ENTITY
.	O
improving	O
energy	O
levels	O
and	O
sleep	O
by	O
day	O
or	O
on	O
ketogenic	ENTITY
diet	ENTITY
most	O
people	O
report	O
an	O
increase	O
in	O
general	O
energy	O
levels	O
and	O
lack	O
of	O
cravings	O
for	O
carbs	O
.	O
the	O
mechanism	O
here	O
involves	O
both	O
stabilization	O
of	O
insulin	ENTITY
levels	ENTITY
and	ENTITY
readily	ENTITY
available	ENTITY
source	ENTITY
of	ENTITY
energy	ENTITY
for	ENTITY
our	ENTITY
brain	ENTITY
.	O
sleep	O
.	O
studies	O
have	O
shown	O
that	O
ketogenic	ENTITY
dieting	ENTITY
improves	O
sleep	O
by	O
decreasing	O
rem	ENTITY
and	ENTITY
increasing	ENTITY
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	O
while	O
the	O
exact	O
mechanism	O
is	O
unclear	O
it	O
likely	O
is	O
related	O
to	O
the	O
complex	O
biochemical	O
shifts	O
involving	O
the	O
brain	ENTITY
use	ENTITY
of	ENTITY
ketones	ENTITY
for	ENTITY
energy	ENTITY
combined	ENTITY
with	ENTITY
other	ENTITY
body	ENTITY
tissues	ENTITY
directly	ENTITY
burning	ENTITY
.	O
an	O
important	O
caveat	O
is	O
that	O
ketogenic	ENTITY
diet	ENTITY
temporarily	O
raises	O
uric	ENTITY
acid	ENTITY
levels	O
especially	O
when	O
dehydrated	ENTITY
but	ENTITY
over	ENTITY
time	ENTITY
they	ENTITY
come	ENTITY
down	ENTITY
.	O
combined	O
with	O
tons	O
of	O
anecdotal	ENTITY
evidence	ENTITY
over	ENTITY
the	ENTITY
years	ENTITY
there	ENTITY
is	ENTITY
an	ENTITY
entire	ENTITY
movement	ENTITY
behind	ENTITY
bodybuilders	ENTITY
using	ENTITY
ketogenic	ENTITY
approach	ENTITY
to	ENTITY
gain	ENTITY
more	ENTITY
muscle	ENTITY
and	ENTITY
less	ENTITY
fat	ENTITY
typically	ENTITY
muscle	ENTITY
gain	ENTITY
also	ENTITY
comes	ENTITY
with	ENTITY
fat	ENTITY
gain	ENTITY
so	ENTITY
there	ENTITY
understandable	ENTITY
attention	ENTITY
being	ENTITY
given	ENTITY
toward	ENTITY
preventing	ENTITY
.	O
in	O
addition	O
dr	O
stephen	O
phinney	O
and	O
dr	O
jeff	O
volek	O
have	O
number	O
of	O
papers	O
published	O
about	O
ketogenic	ENTITY
dieting	ENTITY
for	O
ultra	O
.	O
in	O
short	O
once	O
these	O
athletes	O
are	O
fully	O
fat	ENTITY
adapted	ENTITY
there	ENTITY
is	ENTITY
evidence	ENTITY
to	ENTITY
suggest	ENTITY
that	ENTITY
mental	ENTITY
and	ENTITY
physical	ENTITY
performance	ENTITY
is	ENTITY
significantly	ENTITY
improved	ENTITY
beyond	ENTITY
normal	ENTITY
carbohydrate	ENTITY
.	O
and	O
last	O
but	O
not	O
least	O
curbing	O
diabetes	O
obesity	ENTITY
and	ENTITY
metabolic	ENTITY
syndrome	ENTITY
.	O
support	O
.	O
lester	O
napoleon	O
green	O
born	O
june	O
or	O
may	O
according	O
to	O
him	O
better	O
known	O
by	O
his	O
stage	O
name	O
beetlejuice	O
often	O
abbreviated	O
to	O
beetle	O
or	O
beet	O
is	O
frequent	O
guest	O
on	O
the	O
howard	O
stern	O
show	O
and	O
member	O
of	O
stern	O
wack	O
pack	O
.	O
he	O
has	O
appeared	O
in	O
feature	O
films	O
as	O
well	O
as	O
performed	O
voice	O
.	O
beetlejuice	O
has	O
performed	O
with	O
various	O
howard	O
stern	O
show	O
related	O
comedians	O
including	O
those	O
that	O
perform	O
under	O
the	O
killers	O
of	O
comedy	O
tour	O
bannerthe	O
symptoms	O
related	O
to	O
liver	ENTITY
dysfunction	ENTITY
include	O
both	O
physical	O
signs	O
and	O
variety	O
of	O
symptoms	O
related	O
to	O
digestive	ENTITY
problems	ENTITY
.	O
the	O
malabsorption	ENTITY
of	ENTITY
fats	ENTITY
may	O
lead	O
to	O
symptoms	O
that	O
include	O
indigestionreflux	ENTITY
deficit	ENTITY
of	ENTITY
fatsoluble	ENTITY
vitamins	ENTITY
hemorrhoids	ENTITY
gall	ENTITY
stones	ENTITY
intolerance	ENTITY
to	O
fatty	ENTITY
foods	ENTITY
intolerance	ENTITY
to	O
alcohol	ENTITY
nausea	ENTITY
and	ENTITY
vomiting	ENTITY
attacks	ENTITY
abdominal	ENTITY
bloating	ENTITY
and	O
constipation	ENTITY
.	O
nervous	ENTITY
system	ENTITY
disorders	ENTITY
include	O
depression	O
mood	O
changes	O
especially	O
anger	O
and	O
irritability	O
poor	O
concentration	O
and	O
foggy	O
brain	ENTITY
overheating	ENTITY
of	ENTITY
the	ENTITY
body	ENTITY
especially	ENTITY
the	ENTITY
face	ENTITY
and	ENTITY
torso	ENTITY
and	ENTITY
recurrent	ENTITY
headaches	ENTITY
including	O
migraine	ENTITY
.	O
the	O
blood	ENTITY
sugar	ENTITY
problems	O
include	O
hypoglycaemia	ENTITY
.	O
abnormalities	O
in	O
the	O
level	O
of	O
fats	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
stream	ENTITY
whether	O
too	O
high	O
or	O
too	O
low	O
levels	ENTITY
of	ENTITY
lipids	ENTITY
.	O
hypercholesterolemia	ENTITY
elevated	ENTITY
ldl	ENTITY
cholesterol	ENTITY
reduced	ENTITY
hdl	ENTITY
cholesterol	ENTITY
elevated	O
triglycerides	ENTITY
clogged	ENTITY
arteries	ENTITY
leading	O
to	O
high	ENTITY
blood	ENTITY
pressure	ENTITY
heart	ENTITY
attacks	ENTITY
and	O
strokes	O
build	O
up	O
of	O
fat	ENTITY
in	ENTITY
other	ENTITY
body	ENTITY
organs	ENTITY
fatty	ENTITY
degeneration	ENTITY
of	ENTITY
organs	ENTITY
lumps	O
of	O
fat	ENTITY
in	ENTITY
the	ENTITY
skin	ENTITY
lipomas	ENTITY
and	O
other	O
fatty	ENTITY
tumors	ENTITY
excessive	O
weight	O
gain	O
which	O
may	O
lead	O
to	O
obesity	ENTITY
inability	ENTITY
to	ENTITY
lose	ENTITY
weight	ENTITY
even	ENTITY
while	ENTITY
dieting	ENTITY
sluggish	ENTITY
metabolism	ENTITY
protuberant	ENTITY
abdomen	ENTITY
pot	ENTITY
belly	ENTITY
cellulite	ENTITY
fatty	ENTITY
liver	ENTITY
and	O
roll	O
of	O
fat	ENTITY
around	ENTITY
the	ENTITY
upper	ENTITY
abdomen	ENTITY
.	O
citation	O
needed	O
or	O
too	O
low	O
levels	ENTITY
of	ENTITY
lipids	ENTITY
hypocholesterolemia	ENTITY
low	ENTITY
total	ENTITY
cholesterol	ENTITY
low	ENTITY
ldl	ENTITY
and	O
vldl	ENTITY
cholesterol	ENTITY
.	O
metabolic	ENTITY
syndrome	ENTITY
is	O
probably	O
the	O
most	O
serious	O
medical	O
condition	O
that	O
you	O
haven	O
heard	O
.	O
so	O
what	O
is	O
metabolic	ENTITY
syndrome	ENTITY
why	O
is	O
it	O
so	O
serious	O
and	O
why	O
haven	O
you	O
heard	O
.	O
here	O
is	O
what	O
you	O
need	O
to	O
know	O
.	O
the	O
metabolic	ENTITY
syndrome	ENTITY
is	O
cluster	O
of	O
the	O
most	O
dangerous	O
heart	ENTITY
attack	ENTITY
risk	O
factors	O
raised	ENTITY
blood	ENTITY
glucose	ENTITY
central	ENTITY
adiposity	ENTITY
often	O
called	O
beer	O
belly	O
abnormal	O
cholesterol	ENTITY
levels	ENTITY
abnormal	O
blood	ENTITY
fats	ENTITY
also	O
called	O
triglycerides	ENTITY
and	ENTITY
high	ENTITY
blood	ENTITY
pressure	ENTITY
.	O
it	O
is	O
estimated	O
that	O
in	O
adults	O
have	O
metabolic	ENTITY
syndrome	ENTITY
and	O
the	O
condition	O
becomes	O
more	O
common	O
as	O
we	O
get	O
older	O
so	O
that	O
by	O
the	O
age	O
of	O
nearly	O
third	O
of	O
adults	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
so	O
why	O
is	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
if	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
you	O
are	O
much	O
more	O
likely	O
to	O
suffer	O
heart	ENTITY
attack	ENTITY
or	O
stroke	O
more	O
likely	O
to	O
develop	O
full	O
blown	O
diabetes	ENTITY
more	ENTITY
likely	ENTITY
to	ENTITY
develop	ENTITY
cancer	ENTITY
and	ENTITY
more	ENTITY
likely	ENTITY
to	ENTITY
develop	ENTITY
alzheimer	ENTITY
disease	ENTITY
.	O
all	O
of	O
these	O
conditions	O
.	O
dementia	ENTITY
and	ENTITY
alzheimer	ENTITY
disease	ENTITY
have	O
overtaken	O
cancer	O
and	O
heart	ENTITY
disease	ENTITY
as	O
the	O
leading	O
cause	O
of<	O
death	O
in	O
england	O
and	O
wales	O
in	O
and	O
the	O
metabolic	ENTITY
syndrome	ENTITY
and	O
diabetes	ENTITY
.	O
so	O
how	O
can	O
you	O
check	O
to	O
see	O
if	O
you	O
have	O
metabolic	ENTITY
syndrome	ENTITY
.	O
well	O
first	O
of	O
all	O
get	O
out	O
tape	O
measure	O
.	O
if	O
you	O
are	O
man	O
and	O
your	O
waist	O
circumference	O
is	O
more	O
than	O
cm	O
or	O
if	O
you	O
are	O
woman	O
and	O
your	O
waist	O
is	O
more	O
than	O
cm	O
you	O
have	O
one	O
of	O
the	O
main	O
features	O
of	O
metabolic	ENTITY
syndrome	ENTITY
.	O
if	O
in	O
addition	O
you	O
have	O
any	O
of	O
the	O
following	O
you	O
will	O
be	O
classified	O
as	O
having	O
metabolic	ENTITY
syndrome	ENTITY
raised	ENTITY
blood	ENTITY
triglycerides	ENTITY
reduced	ENTITY
hdl	ENTITY
cholesterol	ENTITY
sometimes	O
known	O
as	O
good	O
cholesterol	ENTITY
raised	ENTITY
blood	ENTITY
pressure	ENTITY
or	O
raised	ENTITY
fasting	ENTITY
plasma	ENTITY
glucose	ENTITY
.	O
note	O
if	O
you	O
are	O
man	O
of	O
south	O
asian	O
or	O
indian	O
heritage	O
the	O
important	O
threshold	O
for	O
waist	O
circumference	O
is	O
cm	O
.	O
metabolic	ENTITY
syndrome	ENTITY
has	O
not	O
yet	O
been	O
classified	O
as	O
disease	ENTITY
it	ENTITY
is	ENTITY
still	ENTITY
regarded	ENTITY
as	ENTITY
collection	ENTITY
of	ENTITY
signs	ENTITY
and	ENTITY
symptoms	ENTITY
which	ENTITY
together	ENTITY
are	ENTITY
serious	ENTITY
risk	ENTITY
factors	ENTITY
for	ENTITY
our	ENTITY
most	ENTITY
deadly	ENTITY
and	ENTITY
disabling	ENTITY
medical	ENTITY
conditions	ENTITY
.	O
several	O
medical	O
organisations	O
such	O
as	O
the	O
world	O
health	O
organisation	O
who	O
the	O
independent	O
diabetes	ENTITY
federation	ENTITY
idf	ENTITY
and	ENTITY
the	ENTITY
european	ENTITY
group	ENTITY
for	ENTITY
the	ENTITY
study	ENTITY
of	ENTITY
insulin	ENTITY
resistance	ENTITY
egir	O
define	O
the	O
metabolic	ENTITY
syndrome	ENTITY
in	O
very	O
slightly	O
different	O
ways	O
and	O
this	O
adds	O
even	O
more	O
to	O
the	O
confusion	O
about	O
what	O
exactly	O
metabolic	ENTITY
syndrome	ENTITY
.	O
however	O
many	O
experts	O
now	O
believe	O
that	O
the	O
underlying	O
problem	O
in	O
metabolic	ENTITY
syndrome	ENTITY
is	O
insulin	ENTITY
resistance	ENTITY
.	O
insulin	ENTITY
resistance	ENTITY
develops	O
when	O
this	O
hormone	ENTITY
cannot	ENTITY
work	ENTITY
properly	ENTITY
when	ENTITY
blood	ENTITY
insulin	ENTITY
levels	ENTITY
are	O
abnormally	O
high	O
and	O
still	O
relatively	O
ineffective	O
in	O
keeping	O
blood	ENTITY
glucose	ENTITY
levels	ENTITY
.	O
metabolic	O
specialists	O
now	O
use	O
the	O
term	O
insulin	ENTITY
resistance	ENTITY
syndrome	ENTITY
.	O
insulin	ENTITY
is	ENTITY
hormone	ENTITY
produced	ENTITY
by	ENTITY
the	ENTITY
pancreas	ENTITY
and	ENTITY
it	ENTITY
is	ENTITY
important	ENTITY
in	ENTITY
the	ENTITY
metabolism	ENTITY
of	ENTITY
carbohydrates	ENTITY
and	ENTITY
fats	ENTITY
.	O
when	O
sugar	O
and	O
carbohydrates	ENTITY
are	ENTITY
eaten	ENTITY
insulin	ENTITY
promotes	ENTITY
the	ENTITY
uptake	ENTITY
of	ENTITY
glucose	ENTITY
from	ENTITY
the	ENTITY
blood	ENTITY
into	ENTITY
muscles	ENTITY
and	ENTITY
fat	ENTITY
cells	ENTITY
.	O
hence	O
it	O
is	O
often	O
said	O
that	O
insulin	ENTITY
allows	ENTITY
cells	ENTITY
to	ENTITY
use	ENTITY
glucose	ENTITY
for	ENTITY
energy	ENTITY
and	ENTITY
also	ENTITY
to	ENTITY
store	ENTITY
excess	ENTITY
glucose	ENTITY
and	ENTITY
sugar	ENTITY
as	ENTITY
glycogen	ENTITY
and	ENTITY
fat	ENTITY
.	O
when	O
blood	ENTITY
glucose	ENTITY
levels	ENTITY
fall	O
stored	O
glucose	ENTITY
is	ENTITY
released	ENTITY
for	ENTITY
energy	ENTITY
from	ENTITY
the	ENTITY
breakdown	ENTITY
of	ENTITY
glycogen	ENTITY
stores	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
and	ENTITY
in	ENTITY
the	ENTITY
muscles	ENTITY
.	O
in	O
the	O
metabolic	ENTITY
syndrome	ENTITY
.	O
fasting	O
blood	ENTITY
levels	ENTITY
of	ENTITY
insulin	ENTITY
in	O
the	O
morning	O
are	O
often	O
abnormally	O
high	O
and	O
insulin	ENTITY
levels	ENTITY
rise	O
to	O
very	O
high	O
levels	O
when	O
food	O
is	O
eaten	O
.	O
continuously	O
high	ENTITY
levels	ENTITY
of	ENTITY
insulin	ENTITY
cause	O
the	O
liver	ENTITY
cells	ENTITY
to	O
store	O
fat	ENTITY
resulting	ENTITY
in	ENTITY
fatty	ENTITY
liver	ENTITY
which	O
cannot	O
function	O
.	O
as	O
the	O
insulin	ENTITY
resistance	ENTITY
worsens	O
the	O
pancreas	ENTITY
may	ENTITY
not	ENTITY
be	ENTITY
able	ENTITY
to	ENTITY
produce	ENTITY
enough	ENTITY
insulin	ENTITY
in	ENTITY
response	ENTITY
to	ENTITY
food	ENTITY
and	ENTITY
then	ENTITY
glucose	ENTITY
levels	ENTITY
in	ENTITY
the	ENTITY
blood	ENTITY
.	O
so	O
why	O
haven	O
you	O
heard	O
.	O
well	O
until	O
quite	O
recently	O
the	O
connection	O
between	O
metabolic	ENTITY
syndrome	ENTITY
and	O
host	O
of	O
chronic	ENTITY
diseases	ENTITY
.	O
we	O
now	O
know	O
that	O
insulin	ENTITY
resistance	ENTITY
.	O
until	O
recently	O
it	O
was	O
difficult	O
to	O
measure	O
blood	ENTITY
insulin	ENTITY
levels	ENTITY
but	O
the	O
technology	O
has	O
improved	O
and	O
we	O
can	O
now	O
measure	O
blood	ENTITY
insulin	ENTITY
levels	ENTITY
accurately	O
and	O
we	O
have	O
good	O
tests	O
to	O
diagnose	O
insulin	ENTITY
resistance	ENTITY
as	O
well	O
as	O
good	O
strategies	O
to	O
reverse	O
insulin	ENTITY
resistance	ENTITY
and	O
the	O
metabolic	ENTITY
syndrome	ENTITY
.	O
once	O
you	O
can	O
measure	O
insulin	ENTITY
resistance	ENTITY
you	O
are	O
well	O
on	O
your	O
way	O
to	O
fixing	O
.	O
if	O
you	O
would	O
like	O
an	O
information	O
leaflet	O
on	O
metabolic	ENTITY
syndrome	ENTITY
.	O
https	O
peptidesdirect	O
com	O
au	O
aod	O
aod	O
is	O
peptide	ENTITY
amino	ENTITY
acids	ENTITY
long	ENTITY
which	ENTITY
mimics	ENTITY
small	ENTITY
portion	ENTITY
of	ENTITY
the	ENTITY
growth	ENTITY
hormone	ENTITY
that	O
has	O
the	O
fat	ENTITY
.	O
it	O
works	O
by	O
mimicking	O
the	O
way	O
natural	O
growth	ENTITY
hormone	ENTITY
regulates	O
fat	ENTITY
metabolism	ENTITY
but	O
without	O
the	O
adverse	O
effects	O
on	O
blood	ENTITY
sugar	ENTITY
and	O
growth	O
that	O
is	O
seen	O
if	O
unmodified	O
growth	ENTITY
hormone	ENTITY
.	O
it	O
stimulates	O
lipolysis	ENTITY
break	ENTITY
down	ENTITY
of	ENTITY
fat	ENTITY
and	ENTITY
inhibits	ENTITY
lipogenesis	ENTITY
non	ENTITY
fat	ENTITY
food	ENTITY
being	ENTITY
stored	ENTITY
in	ENTITY
the	ENTITY
body	ENTITY
as	ENTITY
fat	ENTITY
.	O
aod	O
has	O
been	O
shown	O
to	O
target	O
abnormal	O
fat	ENTITY
stores	ENTITY
and	ENTITY
to	ENTITY
prevent	ENTITY
fat	ENTITY
from	ENTITY
being	ENTITY
stored	ENTITY
in	ENTITY
the	ENTITY
cells	ENTITY
.	O
studies	O
have	O
shown	O
that	O
it	O
reduces	O
the	O
most	O
stubborn	O
.	O
it	O
also	O
has	O
other	O
benefits	O
including	O
increasing	ENTITY
muscle	ENTITY
mass	ENTITY
increasing	ENTITY
igf	ENTITY
insulin	ENTITY
growth	O
factor	O
in	O
positive	O
way	O
to	O
metabolise	O
fat	ENTITY
and	ENTITY
increase	ENTITY
the	ENTITY
amount	ENTITY
of	ENTITY
energy	ENTITY
burned	ENTITY
for	ENTITY
the	ENTITY
same	ENTITY
amount	ENTITY
of	ENTITY
activity	ENTITY
.	O
other	O
benefits	O
which	O
have	O
been	O
shown	O
include	O
an	O
improvement	O
in	O
osteoarthritis	ENTITY
.	O
it	O
does	O
this	O
by	O
increasing	O
cartilage	ENTITY
and	ENTITY
collagen	ENTITY
production	ENTITY
in	ENTITY
the	ENTITY
joints	ENTITY
to	ENTITY
increase	ENTITY
the	ENTITY
thickness	ENTITY
and	ENTITY
repair	ENTITY
some	ENTITY
of	ENTITY
the	ENTITY
damage	ENTITY
.	O
it	O
has	O
been	O
shown	O
to	O
improve	O
muscle	O
tendon	ENTITY
and	ENTITY
ligament	ENTITY
repair	ENTITY
improve	O
bone	O
density	O
which	O
may	O
have	O
positive	O
effects	O
on	O
osteoporosis	ENTITY
.	O
list	O
pleyxl	O
lauh	O
hzxeqn	O
aytdriw	O
.	O
subscribe	O
to	O
the	O
genechanger	O
youtube	O
.	O
want	O
to	O
lose	O
weight	O
and	O
melt	O
fat	ENTITY
.	O
unique	O
kit	O
.	O
bt	O
wdpfua	O
the	O
science	O
behind	O
hcgin	O
the	O
dr	O
.	O
simeons	O
.	O
was	O
looking	O
for	O
cure	O
for	O
obesity	ENTITY
.	O
his	O
research	O
on	O
this	O
subject	O
spanned	O
over	O
years	O
mostly	O
from	O
his	O
lab	O
in	O
italy	O
whereby	O
he	O
found	O
what	O
many	O
call	O
the	O
holy	O
grail	O
of	O
weight	O
loss	O
he	O
founded	O
the	O
research	O
that	O
lead	O
to	O
hcg	ENTITY
weight	ENTITY
loss	ENTITY
.	O
dr	O
simeons	O
found	O
that	O
given	O
the	O
right	O
circumstances	O
people	O
could	O
lose	O
as	O
much	O
as	O
pound	O
of	O
pure	O
fat	ENTITY
.	O
not	O
lean	O
muscle	O
or	O
water	O
weight	O
but	O
fat	ENTITY
.	O
most	O
people	O
thought	O
it	O
crazy	O
to	O
lose	O
pound	O
per	O
day	O
and	O
still	O
be	O
healthy	O
.	O
it	O
true	O
dr	O
.	O
over	O
the	O
years	O
other	O
doctors	O
began	O
studying	O
dr	O
simeons	O
unique	O
protocol	O
and	O
taking	O
it	O
back	O
.	O
most	O
came	O
to	O
the	O
same	O
conclusion	O
which	O
was	O
that	O
people	O
were	O
not	O
just	O
losing	O
pounds	O
and	O
inches	O
but	O
they	O
were	O
able	O
to	O
keep	O
it	O
off	O
using	O
the	O
hcg	ENTITY
program	ENTITY
.	O
the	O
answer	O
is	O
in	O
understanding	O
how	O
the	O
body	O
.	O
the	O
human	O
body	O
has	O
three	O
kinds	O
of	O
fat	ENTITY
.	O
the	O
first	O
is	O
the	O
structural	O
fat	ENTITY
which	ENTITY
fills	ENTITY
the	ENTITY
gaps	ENTITY
between	ENTITY
various	ENTITY
organs	ENTITY
sort	ENTITY
of	ENTITY
packing	ENTITY
material	ENTITY
.	O
structural	O
fat	ENTITY
also	ENTITY
performs	ENTITY
important	ENTITY
functions	ENTITY
as	ENTITY
bedding	ENTITY
the	ENTITY
kidneys	ENTITY
in	ENTITY
soft	ENTITY
elastic	ENTITY
tissue	ENTITY
protecting	O
the	O
coronary	ENTITY
arteries	ENTITY
and	O
keeping	O
the	O
skin	O
.	O
it	O
also	O
provides	O
the	O
springy	O
cushion	O
of	O
hard	O
fat	O
under	O
the	O
bones	ENTITY
of	ENTITY
the	ENTITY
feet	ENTITY
.	O
the	O
second	O
type	O
is	O
called	O
the	O
normal	O
fat	ENTITY
.	O
the	O
normal	O
fat	ENTITY
reserve	ENTITY
is	ENTITY
drawn	ENTITY
upon	ENTITY
when	ENTITY
the	ENTITY
nutritional	ENTITY
income	ENTITY
from	ENTITY
the	ENTITY
intestinal	ENTITY
tract	ENTITY
is	O
insufficient	O
to	O
meet	O
the	O
demand	O
.	O
such	O
normal	O
reserves	O
are	O
localized	O
all	O
over	O
the	O
body	O
.	O
fat	ENTITY
is	ENTITY
substance	ENTITY
which	ENTITY
packs	ENTITY
the	ENTITY
highest	ENTITY
caloric	ENTITY
value	ENTITY
into	ENTITY
the	ENTITY
smallest	ENTITY
space	ENTITY
so	ENTITY
that	ENTITY
normal	ENTITY
reserves	ENTITY
of	ENTITY
fuel	ENTITY
for	ENTITY
muscular	ENTITY
activity	ENTITY
and	ENTITY
the	ENTITY
maintenance	ENTITY
of	ENTITY
body	ENTITY
temperature	ENTITY
.	O
both	O
these	O
types	O
of	O
fat	ENTITY
structural	ENTITY
and	ENTITY
reserve	ENTITY
are	ENTITY
normal	ENTITY
and	ENTITY
even	ENTITY
if	ENTITY
the	ENTITY
body	ENTITY
stocks	ENTITY
them	ENTITY
to	ENTITY
capacity	ENTITY
this	ENTITY
can	ENTITY
never	ENTITY
be	ENTITY
called	ENTITY
obesity	ENTITY
.	O
the	O
third	O
type	O
of	O
fat	ENTITY
is	ENTITY
abnormal	ENTITY
fat	ENTITY
.	O
it	O
is	O
the	O
accumulation	O
of	O
abnormal	O
fat	ENTITY
that	ENTITY
is	ENTITY
found	ENTITY
in	ENTITY
people	ENTITY
who	ENTITY
are	ENTITY
obese	ENTITY
.	O
this	O
abnormal	O
fat	ENTITY
is	ENTITY
also	ENTITY
potential	ENTITY
reserve	ENTITY
of	ENTITY
fuel	ENTITY
but	ENTITY
unlike	ENTITY
the	ENTITY
normal	ENTITY
reserves	ENTITY
it	ENTITY
is	ENTITY
not	ENTITY
available	ENTITY
to	ENTITY
the	ENTITY
body	ENTITY
in	ENTITY
nutritional	ENTITY
emergency	ENTITY
.	O
the	O
reason	O
the	O
abnormal	O
fat	ENTITY
.	O
typical	O
dieters	O
will	O
lose	O
normal	O
fat	ENTITY
reserves	ENTITY
first	ENTITY
and	ENTITY
then	ENTITY
move	ENTITY
onto	ENTITY
the	ENTITY
structural	ENTITY
fat	ENTITY
.	O
by	O
the	O
time	O
people	O
get	O
to	O
the	O
point	O
that	O
they	O
can	O
target	O
the	O
abnormal	O
fat	ENTITY
they	ENTITY
have	ENTITY
become	ENTITY
too	ENTITY
week	ENTITY
and	ENTITY
too	ENTITY
hungry	ENTITY
and	ENTITY
don	ENTITY
quite	ENTITY
get	ENTITY
there	ENTITY
how	ENTITY
is	ENTITY
hcg	ENTITY
fat	ENTITY
loss	O
like	O
money	O
if	O
you	O
look	O
at	O
it	O
like	O
money	O
abnormal	O
fat	ENTITY
is	ENTITY
non	ENTITY
liquid	ENTITY
asset	ENTITY
and	ENTITY
reserve	ENTITY
fat	ENTITY
is	ENTITY
like	ENTITY
cash	ENTITY
or	ENTITY
liquid	ENTITY
.	O
your	O
body	O
can	O
use	O
reserve	O
fat	ENTITY
immediately	ENTITY
on	ENTITY
demand	ENTITY
.	O
but	O
abnormal	O
fat	ENTITY
sometimes	ENTITY
referred	ENTITY
to	ENTITY
as	ENTITY
stubborn	ENTITY
fat	ENTITY
cannot	ENTITY
be	ENTITY
accessed	ENTITY
on	ENTITY
demand	ENTITY
.	O
there	O
is	O
special	O
process	O
that	O
must	O
occur	O
in	O
order	O
for	O
you	O
to	O
access	O
your	O
abnormal	O
fat	ENTITY
.	O
much	O
like	O
the	O
process	O
you	O
must	O
go	O
through	O
to	O
access	O
non	O
liquid	O
assets	O
be	O
it	O
the	O
selling	O
of	O
stocks	O
and	O
bonds	O
or	O
even	O
selling	O
.	O
in	O
these	O
latter	O
cases	O
your	O
money	O
is	O
tied	O
up	O
and	O
not	O
immediately	O
accessible	O
.	O
this	O
video	O
presents	O
discussion	O
on	O
ectopic	O
fat	ENTITY
depots	ENTITY
by	ENTITY
three	ENTITY
experts	ENTITY
in	ENTITY
this	ENTITY
area	ENTITY
dr	ENTITY
ulf	ENTITY
smith	ENTITY
from	ENTITY
sweden	ENTITY
dr	ENTITY
marja	ENTITY
riitta	ENTITY
taskinen	ENTITY
from	ENTITY
finland	ENTITY
and	ENTITY
dr	ENTITY
.	O
dr	O
smith	O
introduces	O
the	O
notion	O
of	O
ectopic	O
fat	ENTITY
.	O
dr	O
taskinen	O
explains	O
that	O
the	O
liver	ENTITY
is	ENTITY
very	ENTITY
central	ENTITY
organ	ENTITY
because	O
of	O
its	O
importance	O
in	O
the	O
metabolism	ENTITY
of	ENTITY
triglyceride	ENTITY
rich	ENTITY
lipoproteins	ENTITY
.	O
an	O
imbalance	O
in	O
lipid	ENTITY
metabolism	ENTITY
may	O
cause	O
fatty	ENTITY
liver	ENTITY
and	O
an	O
atherogenic	ENTITY
.	O
moreover	O
she	O
explains	O
that	O
in	O
addition	O
to	O
fat	ENTITY
accumulation	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
and	ENTITY
in	ENTITY
visceral	ENTITY
depots	ENTITY
lipids	ENTITY
can	O
also	O
accumulate	O
around	O
the	O
heart	ENTITY
.	O
dr	O
jensen	O
recalls	O
that	O
some	O
individuals	O
are	O
able	O
to	O
expand	O
their	O
fat	ENTITY
depot	ENTITY
and	ENTITY
remain	ENTITY
healthy	ENTITY
while	ENTITY
others	ENTITY
with	ENTITY
the	ENTITY
same	ENTITY
amount	ENTITY
or	ENTITY
even	ENTITY
less	ENTITY
adipose	ENTITY
tissue	ENTITY
expansion	ENTITY
.	O
in	O
this	O
case	O
when	O
adipose	ENTITY
tissue	ENTITY
cannot	O
properly	O
store	O
lipids	ENTITY
the	ENTITY
excess	ENTITY
energy	ENTITY
ends	ENTITY
up	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
the	ENTITY
heart	ENTITY
and	ENTITY
the	ENTITY
muscle	ENTITY
cells	ENTITY
.	O
several	O
mechanisms	O
are	O
proposed	O
by	O
dr	O
.	O
finally	O
the	O
important	O
and	O
positive	O
role	O
that	O
could	O
be	O
played	O
by	O
the	O
exercising	O
skeletal	ENTITY
muscle	ENTITY
in	O
ectopic	O
fat	ENTITY
mobilization	ENTITY
.	O
produced	O
by	O
the	O
international	O
chair	O
on	O
cardiometabolic	O
risk	O
.	O
this	O
transmission	O
sends	O
the	O
healing	O
code	O
for	O
lipedema	ENTITY
abnormal	ENTITY
fat	ENTITY
distribution	ENTITY
in	ENTITY
lower	ENTITY
body	ENTITY
with	O
lymphatic	ENTITY
tissue	ENTITY
dysfunction	O
direct	O
into	O
your	O
stream	O
of	O
consciousness	O
like	O
energetic	O
update	O
for	O
your	O
system	O
it	O
will	O
give	O
you	O
the	O
right	O
code	O
to	O
normalize	O
the	O
dysfunction	O
.	O
add	O
the	O
transmission	O
.	O
support	O
my	O
work	O
and	O
this	O
channel	O
by	O
sharing	O
the	O
transmission	O
.	O
amino	O
diet	O
website	O
how	O
does	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
.	O
watch	O
this	O
short	O
video	O
clip	O
to	O
learn	O
how	O
this	O
program	O
.	O
video	O
transcript	O
dr	O
humble	O
finsand	O
consulted	O
with	O
internationally	O
renowned	O
european	O
scientists	O
and	O
experts	O
in	O
homeopathic	ENTITY
medicine	ENTITY
to	O
develop	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
.	O
he	O
has	O
been	O
using	O
the	O
program	O
.	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
will	O
mobilize	O
abnormal	O
fat	ENTITY
increase	ENTITY
thyroid	ENTITY
function	ENTITY
boost	O
metabolism	ENTITY
balance	ENTITY
your	ENTITY
hormones	ENTITY
suppress	ENTITY
your	ENTITY
appetite	ENTITY
detox	ENTITY
your	ENTITY
liver	ENTITY
.	O
the	O
key	O
components	O
to	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
are	O
balanced	O
low	ENTITY
glycemic	ENTITY
eating	O
plan	O
and	O
our	O
homeopathic	ENTITY
diet	ENTITY
drops	ENTITY
.	O
the	O
low	ENTITY
glycemic	ENTITY
eating	O
plan	O
allows	O
us	O
to	O
eat	O
carbohydrates	ENTITY
.	O
these	O
carbohydrates	ENTITY
.	O
they	O
enable	O
us	O
to	O
feel	O
full	O
faster	O
and	O
longer	O
causing	O
us	O
to	O
eat	O
.	O
when	O
we	O
are	O
not	O
subject	O
to	O
the	O
energy	O
bursts	O
and	O
crashes	O
associated	O
with	O
eating	O
large	O
amounts	O
of	O
carbohydrates	ENTITY
and	ENTITY
sugars	ENTITY
we	ENTITY
can	ENTITY
accomplish	ENTITY
more	ENTITY
and	ENTITY
burn	ENTITY
.	O
the	O
foods	O
allowed	O
on	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
are	O
fresh	O
fruits	O
and	O
vegetables	O
lean	O
proteins	O
beans	O
protein	O
shakes	O
some	O
healthy	O
fats	ENTITY
like	ENTITY
eggs	ENTITY
olive	ENTITY
oil	ENTITY
and	ENTITY
avocados	ENTITY
and	ENTITY
moderate	ENTITY
serving	ENTITY
of	ENTITY
carbohydrates	ENTITY
.	O
to	O
avoid	O
insulin	ENTITY
spikes	ENTITY
the	ENTITY
liquid	ENTITY
amino	ENTITY
diet	ENTITY
.	O
this	O
keeps	O
your	O
metabolism	ENTITY
burning	ENTITY
.	O
our	O
exclusive	O
homeopathic	ENTITY
diet	ENTITY
drops	ENTITY
have	O
nine	O
powerful	O
ingredients	O
all	O
registered	O
in	O
the	O
homeopathic	ENTITY
pharmacopeia	ENTITY
and	O
each	O
chosen	O
for	O
specific	O
function	O
to	O
make	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
the	O
safest	O
healthiest	O
and	O
most	O
effective	O
rapid	O
weight	O
loss	O
program	O
.	O
with	O
the	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
.	O
these	O
are	O
testimonials	O
from	O
real	O
liquid	O
.	O
we	O
are	O
so	O
confident	O
that	O
you	O
will	O
have	O
success	O
on	O
our	O
program	O
that	O
we	O
back	O
our	O
product	O
with	O
money	O
back	O
.	O
ready	O
to	O
get	O
started	O
.	O
to	O
order	O
online	O
visit	O
liquidaminodiet	O
com	O
.	O
if	O
you	O
have	O
questions	O
call	O
our	O
certified	O
health	O
coaces	O
at	O
when	O
ordering	O
use	O
the	O
promo	O
code	O
video	O
off	O
to	O
save	O
off	O
your	O
liquid	ENTITY
amino	ENTITY
diet	ENTITY
.	O
thank	O
you	O
for	O
watching	O
.	O
we	O
look	O
forward	O
to	O
sharing	O
your	O
weight	O
loss	O
.	O
madelung	ENTITY
disease	ENTITY
symptoms	O
diagnosis	O
treatments	O
.	O
madelung	O
deformity	O
background	O
anatomy	ENTITY
pathophysiology	ENTITY
.	O
madelung	ENTITY
disease	ENTITY
madelung	O
nord	O
national	O
organization	O
.	O
webcache	O
.	O
madelung	ENTITY
disease	ENTITY
.	O
since	O
then	O
approximately	O
patients	O
have	O
been	O
rep	O
madelung	ENTITY
disease	ENTITY
multiple	ENTITY
symmetric	ENTITY
lipomatosis	ENTITY
is	O
rare	O
characterized	O
by	O
abnormal	O
diffuse	O
lipomatosis	ENTITY
in	ENTITY
proximal	ENTITY
upper	ENTITY
limbs	ENTITY
and	O
neck	O
.	O
please	O
check	O
the	O
synonyms	O
listing	O
to	O
benign	ENTITY
symmetric	ENTITY
lipomatosis	ENTITY
is	O
skin	O
condition	O
characterized	O
by	O
extensive	O
fat	ENTITY
deposits	ENTITY
in	ENTITY
head	ENTITY
neck	ENTITY
and	O
shoulder	ENTITY
girdle	ENTITY
.	O
msl	ENTITY
multiple	ENTITY
symmetrical	ENTITY
lipomatosis	ENTITY
also	O
known	O
as	O
benign	ENTITY
symmetric	ENTITY
lipomatosis	ENTITY
or	O
madelung	ENTITY
disease	ENTITY
aug	O
information	O
including	O
symptoms	O
diagnosis	O
misdiagnosis	O
treatment	O
causes	O
patient	O
stories	O
videos	O
forums	O
prevention	O
.	O
the	O
german	O
surgeon	O
otto	O
wilhelm	O
madelung	O
was	O
the	O
first	O
to	O
give	O
detailed	O
description	O
of	O
disorder	ENTITY
madelung	ENTITY
deformity	ENTITY
is	O
usually	O
characterized	O
by	O
malformed	O
wrists	O
and	O
wrist	ENTITY
bones	ENTITY
even	O
though	O
considered	O
congenital	O
disorder	O
dec	O
disease	ENTITY
rare	ENTITY
acquired	O
fat	ENTITY
metabolism	ENTITY
multiple	O
symmetric	ENTITY
lipomas	ENTITY
with	O
typical	O
distribution	O
mainly	O
jul	O
lipomatosis	ENTITY
or	ENTITY
disease	ENTITY
condition	ENTITY
which	ENTITY
large	ENTITY
symmetrical	ENTITY
accumulation	ENTITY
read	ENTITY
medical	ENTITY
definition	ENTITY
lipomatosis	ENTITY
.	O
madelung	ENTITY
disease	ENTITY
madelung	O
nord	O
national	O
organization	O
for	O
rare	O
multiple	ENTITY
symmetric	ENTITY
lipomatosis	ENTITY
.	O
madelung	ENTITY
disease	ENTITY
case	O
report	O
and	O
literature	O
reviewernesto	O
lima	O
araujo	O
melo	O
ii	ENTITY
.	O
previous	O
jan	O
cushing	O
help	O
and	O
support	O
.	O
madelung	ENTITY
disease	ENTITY
nejmbenign	O
symmetric	ENTITY
lipomatosis	ENTITY
wikipediamadelung	O
with	O
multiple	O
.	O
diagnosis	O
and	O
treatment	O
of	O
madelung	ENTITY
disease	ENTITY
.	O
fdrs	O
madelung	O
description	O
fat	ENTITY
disorders	ENTITY
.	O
madelung	ENTITY
disease	ENTITY
case	O
report	O
and	O
discussion	O
of	O
treatment	O
madelung	O
associated	O
with	O
polyneuropathy	ENTITY
cushing	ENTITY
help	ENTITY
support	ENTITY
.	O
it	O
most	O
often	O
affects	O
men	O
of	O
mediterranean	O
ancestry	O
between	O
the	O
ages	O
and	O
who	O
have	O
history	O
alcohol	O
abuse	O
zhonghua	O
er	O
.	O
md	O
resident	O
of	O
radiology	O
madelung	ENTITY
disease	ENTITY
.	O
medical	O
definition	O
of	O
madelung	ENTITY
disease	ENTITY
medicinenet	O
.	O
madelung	ENTITY
disease	ENTITY
is	O
disorder	ENTITY
of	ENTITY
fat	ENTITY
metabolism	ENTITY
lipid	ENTITY
storage	O
that	O
results	O
in	O
an	O
unusual	O
accumulation	O
deposits	O
around	O
the	O
neck	O
and	O
shoulder	ENTITY
areas	ENTITY
multiple	ENTITY
symmetric	ENTITY
lipomatosis	ENTITY
rare	O
condition	O
characterized	O
by	O
growth	O
fatty	ENTITY
tumors	ENTITY
lipomas	ENTITY
neck	ENTITY
shoulders	ENTITY
upper	ENTITY
arms	ENTITY
or	O
trunk	ENTITY
.	O
genetic	O
and	O
rare	O
diseases	ENTITY
diagnosis	ENTITY
treatment	ENTITY
of	ENTITY
madelung	ENTITY
disease	ENTITY
radiology	O
reference	O
article	O
disease	O
karen	O
chen	O
xm	O
li	O
madelung	O
disease	O
also	O
known	O
as	O
launois	ENTITY
bensaude	ENTITY
syndrome	ENTITY
or	O
neck	O
lipomatosis	ENTITY
is	ENTITY
rare	ENTITY
benign	ENTITY
entity	ENTITY
clinically	ENTITY
characterised	ENTITY
by	ENTITY
the	ENTITY
presence	ENTITY
.	O
what	O
is	O
fatty	ENTITY
liver	ENTITY
common	O
signs	O
of	O
fatty	ENTITY
liver	ENTITY
is	O
reversible	O
condition	O
wherein	O
large	O
vacuoles	O
of	O
triglyceride	ENTITY
fat	ENTITY
accumulate	ENTITY
in	ENTITY
liver	ENTITY
cells	ENTITY
via	O
the	O
process	O
of	O
steatosis	ENTITY
abnormal	ENTITY
retention	ENTITY
of	ENTITY
lipids	ENTITY
within	ENTITY
cell	ENTITY
.	O
despite	O
having	O
multiple	O
causes	O
fatty	ENTITY
liver	ENTITY
can	O
be	O
considered	O
single	O
disease	ENTITY
that	ENTITY
occurs	ENTITY
worldwide	ENTITY
in	ENTITY
those	ENTITY
with	ENTITY
excessive	ENTITY
alcohol	ENTITY
intake	ENTITY
and	ENTITY
the	ENTITY
obese	ENTITY
with	ENTITY
or	ENTITY
without	ENTITY
effects	ENTITY
of	ENTITY
insulin	ENTITY
resistance	ENTITY
.	O
the	O
condition	O
.	O
when	O
this	O
process	O
of	O
fat	ENTITY
metabolism	ENTITY
is	O
disrupted	O
the	O
fat	ENTITY
can	ENTITY
accumulate	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
in	ENTITY
excessive	ENTITY
amounts	ENTITY
thus	ENTITY
resulting	ENTITY
in	ENTITY
fatty	ENTITY
liver	ENTITY
.	O
it	O
is	O
difficult	O
to	O
distinguish	O
alcoholic	O
fld	O
from	O
nonalcoholic	O
fld	O
and	O
both	O
show	O
microvesicular	O
and	O
macrovesicular	O
fatty	O
changes	O
at	O
different	O
stages	O
.	O
accumulation	O
of	O
fat	ENTITY
may	ENTITY
also	ENTITY
be	ENTITY
accompanied	ENTITY
by	ENTITY
progressive	ENTITY
inflammation	ENTITY
of	ENTITY
the	ENTITY
liver	ENTITY
hepatitis	ENTITY
called	O
steatohepatitis	ENTITY
.	O
by	O
considering	O
the	O
contribution	O
by	O
alcohol	ENTITY
fatty	ENTITY
liver	ENTITY
may	O
be	O
termed	O
alcoholic	O
steatosis	ENTITY
or	ENTITY
nonalcoholic	ENTITY
fatty	ENTITY
liver	ENTITY
disease	ENTITY
nafld	O
and	O
the	O
more	O
severe	O
forms	O
as	O
alcoholic	ENTITY
steatohepatitis	ENTITY
part	O
of	O
alcoholic	ENTITY
liver	ENTITY
disease	ENTITY
and	O
non	ENTITY
alcoholic	ENTITY
steatohepatitis	ENTITY
.	O
fatty	ENTITY
liver	ENTITY
typically	O
has	O
no	O
associated	O
symptoms	O
.	O
you	O
may	O
encounter	O
fatigue	O
or	O
vague	O
abdominal	ENTITY
.	O
your	O
liver	ENTITY
may	ENTITY
turn	ENTITY
out	ENTITY
to	ENTITY
be	ENTITY
somewhat	ENTITY
enlarged	ENTITY
.	O
be	O
that	O
as	O
it	O
may	O
abundance	O
fat	ENTITY
in	ENTITY
the	ENTITY
liver	ENTITY
can	O
cause	O
inflammation	ENTITY
.	O
in	O
the	O
event	O
that	O
your	O
liver	ENTITY
winds	ENTITY
up	ENTITY
noticeably	ENTITY
inflamed	ENTITY
you	ENTITY
may	ENTITY
have	ENTITY
symptoms	ENTITY
for	ENTITY
example	ENTITY
poor	ENTITY
appetite	ENTITY
.	O
weight	O
loss	O
.	O
abdominal	ENTITY
pain	ENTITY
.	O
physical	O
weakness	O
.	O
fatigue	O
.	O
confusion	O
.	O
in	O
the	O
event	O
that	O
fatty	ENTITY
liver	ENTITY
advances	O
to	O
cirrhosis	ENTITY
and	ENTITY
liver	ENTITY
failure	ENTITY
symptoms	O
can	O
include	O
an	O
enlarging	O
fluid	O
filled	O
abdomen	ENTITY
.	O
jaundice	ENTITY
of	ENTITY
the	ENTITY
skin	ENTITY
.	O
confusion	O
.	O
tendency	O
to	O
bleed	O
.	O
disclaimer	O
the	O
material	O
used	O
in	O
video	O
is	O
blong	O
to	O
wikipedia	O
org	O
we	O
used	O
this	O
material	O
under	O
creative	O
commons	O
licence	O
.	O
link	O
of	O
author	O
is	O
given	O
below	O
.	O
normal	O
and	O
elevated	ENTITY
blood	ENTITY
sugar	ENTITY
levels	ENTITY
.	O
if	O
you	O
re	O
like	O
us	O
you	O
love	O
the	O
sound	O
.	O
but	O
not	O
everything	O
you	O
eat	O
.	O
your	O
body	O
.	O
in	O
this	O
episode	O
of	O
crash	O
course	O
anatomy	ENTITY
physiology	ENTITY
hank	ENTITY
takes	ENTITY
us	ENTITY
through	ENTITY
more	ENTITY
about	ENTITY
our	ENTITY
metabolism	ENTITY
including	ENTITY
cellular	ENTITY
respiration	ENTITY
atp	ENTITY
glycogenesis	ENTITY
and	ENTITY
how	ENTITY
insulin	ENTITY
regulates	ENTITY
our	ENTITY
blood	ENTITY
sugar	ENTITY
levels	ENTITY
.	O
anatomy	ENTITY
.	O
diabetic	ENTITY
patients	ENTITY
frequently	O
develop	O
electrolyte	ENTITY
disorders	ENTITY
especially	O
the	O
role	O
of	O
incretins	ENTITY
in	ENTITY
glucose	ENTITY
homeostasis	ENTITY
and	O
diabetes	ENTITY
treatment	ENTITY
member	ENTITY
family	ENTITY
structurally	ENTITY
related	ENTITY
hormones	ENTITY
that	ENTITY
latter	ENTITY
when	ENTITY
excessive	ENTITY
contributes	ENTITY
to	ENTITY
hyperglycemia	ENTITY
.	O
epub	O
diabetes	ENTITY
mellitus	ENTITY
dm	O
is	O
becoming	O
lifestyle	O
related	O
pandemic	O
disease	ENTITY
.	O
understanding	O
the	O
role	O
of	O
energy	ENTITY
homeostasis	ENTITY
in	O
diabetes	ENTITY
what	ENTITY
is	ENTITY
relationship	ENTITY
between	ENTITY
and	ENTITY
diabetes	ENTITY
.	O
medical	O
specialists	O
of	O
the	O
urinary	ENTITY
system	ENTITY
.	O
is	O
thiol	ENTITY
disulfide	ENTITY
homeostasis	ENTITY
related	O
to	O
parity	O
and	O
gravidity	O
in	O
calcium	ENTITY
organelle	ENTITY
function	ENTITY
the	O
pathogenesis	O
diabetes	ENTITY
ankyrin	ENTITY
repeat	ENTITY
protein	ENTITY
darp	ENTITY
ankrd	ENTITY
modifies	ENTITY
role	ENTITY
glucose	ENTITY
journal	ENTITY
of	ENTITY
endocrinology	ENTITY
.	O
yun	O
li	O
prolonged	O
hyperglycemia	ENTITY
in	ENTITY
vitro	ENTITY
can	ENTITY
induce	ENTITY
similar	ENTITY
changes	ENTITY
suggesting	ENTITY
the	ENTITY
endocrine	ENTITY
system	ENTITY
consists	O
of	O
number	O
different	O
glands	ENTITY
which	ENTITY
secrete	ENTITY
hormones	ENTITY
that	ENTITY
dictate	ENTITY
how	ENTITY
cells	ENTITY
and	ENTITY
organs	ENTITY
.	O
homeostasis	ENTITY
of	ENTITY
glucose	ENTITY
levels	O
hormonal	O
control	O
and	O
diabetes	ENTITY
bbc	ENTITY
bitesize	ENTITY
gcse	ENTITY
biology	ENTITY
homeostasis	ENTITY
revision	O
the	O
role	O
of	O
the	O
kidneys	ENTITY
in	ENTITY
glucose	ENTITY
homeostasis	ENTITY
type	ENTITY
diabetes	ENTITY
ghrelin	ENTITY
and	O
open	O
access	O
cooperation	O
between	O
brain	ENTITY
islet	ENTITY
middle	ENTITY
imbalance	ENTITY
read	ENTITY
calcium	ENTITY
.	O
patients	O
with	O
diabetes	ENTITY
often	ENTITY
have	ENTITY
side	ENTITY
affects	ENTITY
such	ENTITY
as	ENTITY
frequent	ENTITY
urination	ENTITY
hunger	ENTITY
and	ENTITY
thirst	ENTITY
homeostasis	ENTITY
by	O
throwing	O
off	O
creating	O
imbalances	O
in	O
the	O
bodies	O
is	O
combination	O
of	O
two	O
words	O
homeo	O
means	O
similar	O
disease	ENTITY
.	O
diabetes	ENTITY
.	O
glucose	ENTITY
homeostasis	ENTITY
obesity	ENTITY
and	ENTITY
diabetescalcium	ENTITY
homeostasis	ENTITY
in	O
diabetes	ENTITY
mellitus	ENTITY
.	O
how	O
does	O
diabetes	ENTITY
.	O
diabetic	ENTITY
faqboundless	ENTITY
anatomy	ENTITY
and	O
physiology	O
lumen	O
.	O
diabetes	ENTITY
metabolic	ENTITY
disorder	ENTITY
caused	ENTITY
by	ENTITY
excess	ENTITY
blood	ENTITY
glucose	ENTITY
levels	ENTITY
is	O
key	O
example	O
of	O
disease	ENTITY
.	O
diabetes	ENTITY
for	ENTITY
example	ENTITY
is	ENTITY
disease	ENTITY
caused	ENTITY
by	ENTITY
broken	ENTITY
feedback	ENTITY
loop	ENTITY
involving	ENTITY
this	ENTITY
disrupts	ENTITY
the	ENTITY
homeostasis	ENTITY
process	ENTITY
due	ENTITY
to	ENTITY
low	ENTITY
levels	ENTITY
of	ENTITY
such	ENTITY
chemicals	ENTITY
recent	ENTITY
suggestion	ENTITY
that	ENTITY
diabetes	ENTITY
and	ENTITY
obesity	ENTITY
are	ENTITY
linked	ENTITY
their	ENTITY
common	ENTITY
insulin	ENTITY
like	ENTITY
molecules	ENTITY
have	ENTITY
played	ENTITY
key	ENTITY
role	ENTITY
in	ENTITY
energy	ENTITY
liver	ENTITY
glucose	ENTITY
studies	ENTITY
juvenile	ENTITY
onset	ENTITY
indicate	ENTITY
capable	ENTITY
altering	ENTITY
its	ENTITY
release	ENTITY
no	ENTITY
related	ENTITY
articles	ENTITY
found	ENTITY
body	ENTITY
has	ENTITY
target	ENTITY
set	ENTITY
point	ENTITY
which	ENTITY
it	ENTITY
tries	ENTITY
maintain	ENTITY
with	ENTITY
blood	ENTITY
levels	ENTITY
because	O
high	O
amount	O
os	O
can	O
lower	ENTITY
blood	ENTITY
glucose	ENTITY
levels	O
due	O
to	O
increased	O
respiration	O
in	O
the	O
muscles	ENTITY
.	O
in	O
hypothalamic	ENTITY
neurons	ENTITY
glycolysis	ENTITY
conveys	O
nutrient	O
sensing	O
that	O
is	O
related	O
to	O
feeding	O
tmg	ENTITY
also	ENTITY
be	ENTITY
elevated	ENTITY
in	ENTITY
individuals	ENTITY
with	ENTITY
diabetes	ENTITY
contributing	ENTITY
the	ENTITY
worsening	ENTITY
of	ENTITY
hyperglycemia	ENTITY
.	O
platelet	ENTITY
hyperactivity	ENTITY
and	ENTITY
abnormal	ENTITY
ca	ENTITY
homeostasis	ENTITY
in	ENTITY
diabetes	ENTITY
joslin	ENTITY
mellitus	ENTITY
edited	ENTITY
by	ENTITY
diabetes	ENTITY
is	ENTITY
group	ENTITY
of	ENTITY
metabolic	ENTITY
diseases	ENTITY
where	O
person	O
has	O
high	ENTITY
blood	ENTITY
sugar	ENTITY
level	ENTITY
.	O
googleusercontent	O
search	O
.	O
in	O
person	O
who	O
doesn	O
have	O
diabetes	ENTITY
the	ENTITY
body	ENTITY
has	ENTITY
number	ENTITY
of	ENTITY
mechanisms	ENTITY
in	ENTITY
place	ENTITY
to	ENTITY
keep	ENTITY
blood	ENTITY
glucose	ENTITY
fairly	O
limited	O
related	O
articles	O
diabetes	ENTITY
affects	ENTITY
homeostasis	ENTITY
by	ENTITY
disrupting	ENTITY
sugar	ENTITY
levels	O
and	O
water	O
.	O
homeostasis	ENTITY
diabetes	ENTITY
self	O
management	O
diabet	O
essel	O
fmanagement	O
homeostasis	O
url	O
.	O
webcache	O
.	O
the	O
role	O
of	O
ghrelin	ENTITY
in	ENTITY
the	ENTITY
development	ENTITY
diabetes	ENTITY
and	ENTITY
its	ENTITY
potential	ENTITY
utility	ENTITY
as	ENTITY
although	ENTITY
prominent	ENTITY
for	ENTITY
brain	ENTITY
glucose	ENTITY
homeostasis	ENTITY
was	O
that	O
similar	O
mechanism	O
contributes	O
to	O
remission	O
induced	O
by	O
is	O
important	O
factor	O
necessary	O
healthy	O
living	O
one	O
disorders	O
caused	O
due	O
disturbance	O
blood	ENTITY
sugar	ENTITY
levels	ENTITY
commonly	O
seen	O
example	O
homeostatic	O
imbalance	O
.	O
homeostasis	O
article	O
role	O
of	O
liver	ENTITY
in	ENTITY
glucose	ENTITY
homeostasis	ENTITY
feedback	O
loops	O
.	O
increased	O
tubular	O
reabsorption	O
be	O
due	O
to	O
an	O
and	O
nervous	O
tissue	O
help	O
protect	O
against	O
diabetes	ENTITY
.	O
homeostasis	O
in	O
the	O
human	O
body	O
learn	O
about	O
homeostasis	O
regulation	O
of	O
conditions	O
such	O
as	O
diabetes	ENTITY
is	ENTITY
condition	ENTITY
where	ENTITY
cannot	ENTITY
regulate	ENTITY
its	ENTITY
blood	ENTITY
glucose	ENTITY
levels	ENTITY
.	O
best	O
pract	O
res	O
clin	O
obstet	O
gynaecol	O
.	O
glycolysis	ENTITY
in	ENTITY
the	ENTITY
control	ENTITY
of	ENTITY
blood	ENTITY
glucose	ENTITY
.	O
in	O
ideal	O
circumstances	O
homeostatic	ENTITY
control	ENTITY
mechanisms	ENTITY
should	O
prevent	O
this	O
imbalance	O
from	O
occurring	O
energy	O
homeostasis	O
is	O
well	O
regulated	O
process	O
that	O
depends	O
on	O
the	O
coordination	O
diabetes	ENTITY
closely	ENTITY
related	ENTITY
to	ENTITY
obesity	ENTITY
so	ENTITY
increase	ENTITY
in	ENTITY
obesity	ENTITY
has	ENTITY
had	ENTITY
an	ENTITY
and	ENTITY
are	ENTITY
because	ENTITY
of	ENTITY
system	ENTITY
checks	ENTITY
balances	ENTITY
allows	ENTITY
for	ENTITY
proper	ENTITY
rise	ENTITY
fall	ENTITY
glucose	ENTITY
levels	ENTITY
hormonal	O
lessons	O
related	O
courses	O
temperature	ENTITY
regulation	ENTITY
.	O
diabetes	ENTITY
affects	ENTITY
homeostasis	ENTITY
by	ENTITY
katie	ENTITY
merritt	ENTITY
on	ENTITY
prezihow	ENTITY
diabetes	ENTITY
.	O
inadequate	O
sleep	O
is	O
related	O
to	O
number	O
of	O
health	O
problems	O
such	O
as	O
abstract	O
diabetes	ENTITY
mellitus	ENTITY
dm	O
becoming	O
lifestyle	O
pandemic	O
in	O
this	O
review	O
we	O
discuss	O
homeostatic	ENTITY
mechanism	ENTITY
that	O
links	O
calcium	ENTITY
and	ENTITY
dm	ENTITY
purpose	ENTITY
the	ENTITY
study	ENTITY
was	ENTITY
evaluate	ENTITY
relation	ENTITY
gestational	ENTITY
gdm	ENTITY
thiol	ENTITY
disulfide	ENTITY
balance	ENTITY
used	ENTITY
marker	ENTITY
oxidative	ENTITY
homeostasis	ENTITY
organelle	ENTITY
function	ENTITY
pathogenesis	ENTITY
obesity	ENTITY
articles	ENTITY
tissues	ENTITY
liver	ENTITY
adipose	ENTITY
tissue	ENTITY
context	O
metabolic	O
disease	O
particularly	O
ankyrin	ENTITY
repeat	ENTITY
protein	ENTITY
darp	O
ankrd	O
member	O
glucose	ENTITY
through	ENTITY
modulating	ENTITY
amp	ENTITY
activated	ENTITY
finally	ENTITY
some	ENTITY
present	ENTITY
approaches	ENTITY
for	ENTITY
therapy	ENTITY
regulation	ENTITY
development	ENTITY
platelet	ENTITY
hyperactivity	ENTITY
.	O
diabetes	ENTITY
treatment	ENTITY
in	ENTITY
nadipathy	ENTITY
what	ENTITY
is	ENTITY
diabetes	ENTITY
it	ENTITY
is	ENTITY
the	ENTITY
condition	ENTITY
that	ENTITY
body	ENTITY
cannot	ENTITY
balance	ENTITY
the	ENTITY
glucose	ENTITY
levels	ENTITY
due	O
to	O
lack	O
of	O
energy	O
to	O
pancreas	ENTITY
or	ENTITY
the	ENTITY
body	ENTITY
cannot	ENTITY
utilize	ENTITY
insulin	ENTITY
to	ENTITY
maintain	ENTITY
glucose	ENTITY
homeostasis	ENTITY
.	O
it	O
was	O
first	O
known	O
in	O
the	O
th	O
century	O
.	O
again	O
diabetes	ENTITY
is	ENTITY
differentiated	ENTITY
in	ENTITY
to	ENTITY
two	ENTITY
types	ENTITY
diabetes	ENTITY
mellitus	O
and	O
diabetes	ENTITY
insipidus	ENTITY
.	O
diabetes	ENTITY
mellitus	ENTITY
is	O
mainly	O
caused	O
by	O
deficiency	O
of	O
insulin	ENTITY
due	ENTITY
to	ENTITY
either	ENTITY
lack	ENTITY
of	ENTITY
energy	ENTITY
in	ENTITY
pancreas	ENTITY
or	ENTITY
any	ENTITY
auto	ENTITY
immune	ENTITY
disease	ENTITY
.	O
while	O
diabetes	ENTITY
insipidus	ENTITY
is	O
caused	O
by	O
defect	O
in	O
secretion	O
of	O
vasopressin	ENTITY
antidiuretic	ENTITY
hormone	ENTITY
which	O
is	O
secreted	O
from	O
pituitary	ENTITY
gland	ENTITY
present	O
in	O
hypothalamus	ENTITY
.	O
its	O
function	O
is	O
to	O
reabsorb	O
water	O
from	O
distal	O
tubules	O
in	O
the	O
kidney	ENTITY
.	O
but	O
its	O
deficiency	O
caused	O
increased	O
water	O
excretion	O
through	O
urine	O
even	O
in	O
low	O
intake	O
of	O
water	O
.	O
diabetes	ENTITY
mellitus	ENTITY
and	O
diabetes	ENTITY
insipidus	ENTITY
are	O
unrelated	O
although	O
they	O
have	O
similar	O
signs	O
and	O
symptoms	O
like	O
excessive	O
thirst	O
and	O
excessive	ENTITY
urination	ENTITY
.	O
diabetes	ENTITY
mellitus	ENTITY
is	O
more	O
common	O
than	O
the	O
diabetes	ENTITY
insipidus	ENTITY
.	O
diabetes	ENTITY
mellitus	ENTITY
.	O
type	O
diabetes	ENTITY
the	ENTITY
body	ENTITY
does	ENTITY
not	ENTITY
produce	ENTITY
insulin	ENTITY
.	O
such	O
diabetes	ENTITY
called	ENTITY
as	ENTITY
insulin	ENTITY
dependent	ENTITY
diabetes	ENTITY
.	O
people	O
usually	O
develop	O
type	O
diabetes	ENTITY
before	ENTITY
their	ENTITY
th	ENTITY
.	O
for	O
more	O
information	O
blog	O
.	O
diabetes	ENTITY
treatment	ENTITY
in	ENTITY
nadipathy	ENTITY
what	ENTITY
is	ENTITY
diabetes	ENTITY
it	ENTITY
is	ENTITY
the	ENTITY
condition	ENTITY
that	ENTITY
body	ENTITY
cannot	ENTITY
balance	ENTITY
the	ENTITY
glucose	ENTITY
levels	ENTITY
due	O
to	O
lack	O
of	O
energy	O
to	O
pancreas	ENTITY
or	ENTITY
the	ENTITY
body	ENTITY
cannot	ENTITY
utilize	ENTITY
insulin	ENTITY
to	ENTITY
maintain	ENTITY
glucose	ENTITY
homeostasis	ENTITY
.	O
it	O
was	O
first	O
known	O
in	O
the	O
th	O
century	O
.	O
again	O
diabetes	ENTITY
is	ENTITY
differentiated	ENTITY
in	ENTITY
to	ENTITY
two	ENTITY
types	ENTITY
diabetes	ENTITY
mellitus	ENTITY
and	O
diabetes	ENTITY
insipidus	ENTITY
.	O
diabetes	ENTITY
mellitus	ENTITY
is	O
mainly	O
caused	O
by	O
deficiency	ENTITY
of	ENTITY
insulin	ENTITY
due	O
to	O
either	O
lack	O
of	O
energy	O
in	O
pancreas	ENTITY
or	ENTITY
any	ENTITY
auto	ENTITY
immune	ENTITY
disease	ENTITY
.	O
while	O
diabetes	ENTITY
insipidus	ENTITY
is	O
caused	O
by	O
defect	O
in	O
secretion	O
of	O
vasopressin	ENTITY
antidiuretic	ENTITY
hormone	ENTITY
which	O
is	O
secreted	O
from	O
pituitary	ENTITY
gland	ENTITY
present	O
in	O
hypothalamus	ENTITY
.	O
its	O
function	O
is	O
to	O
reabsorb	O
water	O
from	O
distal	O
tubules	O
in	O
the	O
kidney	ENTITY
.	O
but	O
its	O
deficiency	O
caused	O
increased	O
water	O
excretion	O
through	O
urine	O
even	O
in	O
low	O
intake	O
of	O
water	O
.	O
diabetes	ENTITY
mellitus	ENTITY
and	O
diabetes	ENTITY
insipidus	ENTITY
are	O
unrelated	O
although	O
they	O
have	O
similar	O
signs	O
and	O
symptoms	O
like	O
excessive	O
thirst	O
and	O
excessive	ENTITY
urination	ENTITY
.	O
diabetes	ENTITY
mellitus	ENTITY
is	O
more	O
common	O
than	O
the	O
diabetes	ENTITY
insipidus	ENTITY
.	O
diabetes	ENTITY
mellitus	ENTITY
.	O
type	ENTITY
diabetes	ENTITY
the	ENTITY
body	ENTITY
does	ENTITY
not	ENTITY
produce	ENTITY
insulin	ENTITY
.	O
such	O
diabetes	ENTITY
called	ENTITY
as	ENTITY
insulin	ENTITY
dependent	ENTITY
diabetes	ENTITY
.	O
people	O
usually	O
develop	O
type	ENTITY
diabetes	ENTITY
before	ENTITY
their	ENTITY
th	ENTITY
.	O
today	O
type	O
diabetes	ENTITY
has	ENTITY
no	ENTITY
proper	ENTITY
treatment	ENTITY
.	O
so	O
these	O
individuals	O
are	O
insulin	ENTITY
.	O
approximately	O
of	O
all	O
diabetes	ENTITY
cases	ENTITY
are	ENTITY
type	ENTITY
common	ENTITY
symptoms	ENTITY
of	ENTITY
type	ENTITY
diabetes	ENTITY
.	O
fatigue	O
or	O
tiredness	O
.	O
excessive	O
thirst	O
.	O
increased	O
urination	ENTITY
.	O
nausea	ENTITY
perhaps	ENTITY
vomiting	ENTITY
.	O
for	O
more	O
information	O
blog	O
.	O
sugar	O
and	O
the	O
beating	O
heart	ENTITY
the	ENTITY
conundrum	ENTITY
of	ENTITY
heart	ENTITY
failure	ENTITY
in	O
diabetes	ENTITY
air	ENTITY
date	ENTITY
wednesday	ENTITY
february	ENTITY
pm	ENTITY
category	ENTITY
wals	ENTITY
wednesday	ENTITY
afternoon	ENTITY
lectures	ENTITY
runtime	ENTITY
description	ENTITY
nih	ENTITY
director	ENTITY
wednesday	ENTITY
afternoon	ENTITY
lecture	ENTITY
series	ENTITY
dr	ENTITY
abel	ENTITY
is	ENTITY
internationally	ENTITY
recognized	ENTITY
for	ENTITY
his	ENTITY
research	ENTITY
on	ENTITY
the	ENTITY
molecular	ENTITY
mechanisms	ENTITY
responsible	ENTITY
for	ENTITY
cardiac	ENTITY
dysfunction	ENTITY
in	O
obesity	ENTITY
type	ENTITY
diabetes	ENTITY
and	ENTITY
type	ENTITY
diabetes	ENTITY
and	ENTITY
for	ENTITY
studies	ENTITY
of	ENTITY
the	ENTITY
role	ENTITY
of	ENTITY
mitochondrial	ENTITY
dysfunction	ENTITY
in	O
the	O
development	O
of	O
insulin	ENTITY
resistance	ENTITY
obesity	ENTITY
and	ENTITY
its	ENTITY
complications	ENTITY
.	O
dr	O
.	O
he	O
was	O
rhodes	O
scholar	O
and	O
clinical	O
research	O
fellow	O
with	O
professor	O
john	O
leding	O
ham	O
at	O
the	O
university	O
of	O
oxford	O
england	O
where	O
he	O
also	O
earned	O
ph	O
in	O
physiology	O
.	O
he	O
completed	O
an	O
internship	O
and	O
residency	O
in	O
medicine	O
at	O
mcgraw	O
medical	O
center	O
part	O
of	O
northwestern	O
university	O
medical	O
school	O
where	O
he	O
served	O
as	O
chief	O
resident	O
of	O
internal	O
medicine	O
at	O
the	O
va	O
lakeside	O
medical	O
center	O
.	O
